date generated: 2023-11-20
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
x | |
---|---|
7SK | -3.1559183 |
A1BG | -0.8492416 |
A1CF | -5.5179610 |
A2LD1 | -1.6160879 |
A2M | -1.5724682 |
A2ML1 | -2.5948604 |
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 1654 |
num_genes_in_profile | 33930 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 10033 |
num_profile_genes_not_in_sets | 23897 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used:
GMT file of genesets: c2.cp.reactome.v2023.1.Hs.symbols.gmtGene sets metrics | |
---|---|
num_genesets | 1654 |
num_genesets_excluded | 374 |
num_genesets_included | 1280 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Top N= 50 gene sets
## Warning in kable_styling(., "hover", full_width = FALSE): Please specify format
## in kable. kableExtra can customize either HTML or LaTeX outputs. See
## https://haozhu233.github.io/kableExtra/ for details.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
REACTOME FORMATION OF LATERAL PLATE MESODERM | 5 | 4.70e-04 | 0.903 | 2.30e-03 |
REACTOME REGULATION OF GENE EXPRESSION IN EARLY PANCREATIC PRECURSOR CELLS | 8 | 1.27e-05 | 0.891 | 1.16e-04 |
REACTOME OLFACTORY SIGNALING PATHWAY | 373 | 0.00e+00 | -0.757 | 0.00e+00 |
REACTOME BETA DEFENSINS | 36 | 3.73e-14 | -0.729 | 2.17e-12 |
REACTOME METAL SEQUESTRATION BY ANTIMICROBIAL PROTEINS | 6 | 2.18e-03 | -0.722 | 7.96e-03 |
REACTOME VITAMINS | 6 | 2.86e-03 | 0.703 | 9.89e-03 |
REACTOME POU5F1 OCT4 SOX2 NANOG REPRESS GENES RELATED TO DIFFERENTIATION | 10 | 1.90e-04 | 0.681 | 1.12e-03 |
REACTOME DEFENSINS | 45 | 8.40e-15 | -0.668 | 5.26e-13 |
REACTOME ADRENOCEPTORS | 9 | 6.25e-04 | 0.658 | 2.87e-03 |
REACTOME FBXW7 MUTANTS AND NOTCH1 IN CANCER | 5 | 1.23e-02 | 0.647 | 3.13e-02 |
REACTOME G2 PHASE | 5 | 1.44e-02 | 0.632 | 3.53e-02 |
REACTOME INTERLEUKIN 9 SIGNALING | 7 | 5.46e-03 | 0.606 | 1.65e-02 |
REACTOME DEFECTIVE CHST3 CAUSES SEDCJD | 7 | 5.51e-03 | 0.606 | 1.66e-02 |
REACTOME DIGESTION OF DIETARY CARBOHYDRATE | 8 | 3.29e-03 | -0.600 | 1.12e-02 |
REACTOME DEFECTIVE CHSY1 CAUSES TPBS | 7 | 6.07e-03 | 0.599 | 1.80e-02 |
REACTOME ENDOSOMAL VACUOLAR PATHWAY | 9 | 1.87e-03 | 0.599 | 7.03e-03 |
REACTOME TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 30 | 1.68e-08 | 0.595 | 3.25e-07 |
REACTOME BIOSYNTHESIS OF MARESIN LIKE SPMS | 6 | 1.17e-02 | -0.594 | 3.02e-02 |
REACTOME BIOSYNTHESIS OF EPA DERIVED SPMS | 6 | 1.23e-02 | 0.590 | 3.13e-02 |
REACTOME ERKS ARE INACTIVATED | 13 | 2.77e-04 | 0.582 | 1.48e-03 |
REACTOME CD22 MEDIATED BCR REGULATION | 53 | 2.87e-13 | -0.579 | 1.42e-11 |
REACTOME ANTIMICROBIAL PEPTIDES | 86 | 1.94e-20 | -0.577 | 2.11e-18 |
REACTOME LIGAND RECEPTOR INTERACTIONS | 8 | 4.77e-03 | 0.576 | 1.51e-02 |
REACTOME RESPONSE TO METAL IONS | 14 | 1.95e-04 | 0.575 | 1.14e-03 |
REACTOME REGULATION OF GENE EXPRESSION IN ENDOCRINE COMMITTED NEUROG3 PROGENITOR CELLS | 5 | 2.78e-02 | 0.568 | 5.90e-02 |
REACTOME REGULATION OF GENE EXPRESSION BY HYPOXIA INDUCIBLE FACTOR | 11 | 1.20e-03 | 0.564 | 4.85e-03 |
REACTOME ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 56 | 3.61e-13 | 0.561 | 1.68e-11 |
REACTOME ERYTHROPOIETIN ACTIVATES STAT5 | 7 | 1.06e-02 | 0.558 | 2.78e-02 |
REACTOME CS DS DEGRADATION | 12 | 8.67e-04 | 0.555 | 3.76e-03 |
REACTOME REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 15 | 2.11e-04 | 0.552 | 1.20e-03 |
REACTOME METALLOTHIONEINS BIND METALS | 11 | 1.80e-03 | 0.543 | 6.88e-03 |
REACTOME RHO GTPASES ACTIVATE ROCKS | 19 | 4.34e-05 | 0.542 | 3.26e-04 |
REACTOME SIGNALING BY RNF43 MUTANTS | 8 | 8.90e-03 | 0.534 | 2.42e-02 |
REACTOME LIPID PARTICLE ORGANIZATION | 6 | 2.39e-02 | 0.532 | 5.26e-02 |
REACTOME REGULATION OF FZD BY UBIQUITINATION | 21 | 2.96e-05 | 0.526 | 2.37e-04 |
REACTOME NOSTRIN MEDIATED ENOS TRAFFICKING | 5 | 4.22e-02 | 0.525 | 8.24e-02 |
REACTOME FLT3 SIGNALING BY CBL MUTANTS | 7 | 1.63e-02 | 0.524 | 3.93e-02 |
REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 14 | 6.84e-04 | 0.524 | 3.08e-03 |
REACTOME BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 2.89e-04 | 0.523 | 1.54e-03 |
REACTOME NADE MODULATES DEATH SIGNALLING | 5 | 4.34e-02 | 0.521 | 8.40e-02 |
REACTOME CREATION OF C4 AND C2 ACTIVATORS | 63 | 8.36e-13 | -0.521 | 3.50e-11 |
REACTOME SUMOYLATION OF TRANSCRIPTION FACTORS | 20 | 5.61e-05 | 0.520 | 4.07e-04 |
REACTOME PROSTANOID LIGAND RECEPTORS | 9 | 6.97e-03 | 0.519 | 2.00e-02 |
REACTOME ACTIVATED NTRK2 SIGNALS THROUGH PI3K | 7 | 1.75e-02 | 0.519 | 4.14e-02 |
REACTOME NEGATIVE REGULATION OF ACTIVITY OF TFAP2 AP 2 FAMILY TRANSCRIPTION FACTORS | 10 | 4.53e-03 | 0.518 | 1.44e-02 |
REACTOME LRR FLII INTERACTING PROTEIN 1 LRRFIP1 ACTIVATES TYPE I IFN PRODUCTION | 5 | 4.49e-02 | 0.518 | 8.61e-02 |
REACTOME SENSORY PERCEPTION | 576 | 7.00e-100 | -0.513 | 5.46e-97 |
REACTOME DEFECTIVE CHST14 CAUSES EDS MUSCULOCONTRACTURAL TYPE | 7 | 1.88e-02 | 0.513 | 4.40e-02 |
REACTOME SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 14 | 1.02e-03 | 0.507 | 4.30e-03 |
REACTOME ROLE OF ABL IN ROBO SLIT SIGNALING | 8 | 1.32e-02 | 0.506 | 3.31e-02 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
REACTOME FORMATION OF LATERAL PLATE MESODERM | 5 | 4.70e-04 | 0.903000 | 2.30e-03 |
REACTOME REGULATION OF GENE EXPRESSION IN EARLY PANCREATIC PRECURSOR CELLS | 8 | 1.27e-05 | 0.891000 | 1.16e-04 |
REACTOME OLFACTORY SIGNALING PATHWAY | 373 | 0.00e+00 | -0.757000 | 0.00e+00 |
REACTOME BETA DEFENSINS | 36 | 3.73e-14 | -0.729000 | 2.17e-12 |
REACTOME METAL SEQUESTRATION BY ANTIMICROBIAL PROTEINS | 6 | 2.18e-03 | -0.722000 | 7.96e-03 |
REACTOME VITAMINS | 6 | 2.86e-03 | 0.703000 | 9.89e-03 |
REACTOME POU5F1 OCT4 SOX2 NANOG REPRESS GENES RELATED TO DIFFERENTIATION | 10 | 1.90e-04 | 0.681000 | 1.12e-03 |
REACTOME DEFENSINS | 45 | 8.40e-15 | -0.668000 | 5.26e-13 |
REACTOME ADRENOCEPTORS | 9 | 6.25e-04 | 0.658000 | 2.87e-03 |
REACTOME FBXW7 MUTANTS AND NOTCH1 IN CANCER | 5 | 1.23e-02 | 0.647000 | 3.13e-02 |
REACTOME G2 PHASE | 5 | 1.44e-02 | 0.632000 | 3.53e-02 |
REACTOME INTERLEUKIN 9 SIGNALING | 7 | 5.46e-03 | 0.606000 | 1.65e-02 |
REACTOME DEFECTIVE CHST3 CAUSES SEDCJD | 7 | 5.51e-03 | 0.606000 | 1.66e-02 |
REACTOME DIGESTION OF DIETARY CARBOHYDRATE | 8 | 3.29e-03 | -0.600000 | 1.12e-02 |
REACTOME DEFECTIVE CHSY1 CAUSES TPBS | 7 | 6.07e-03 | 0.599000 | 1.80e-02 |
REACTOME ENDOSOMAL VACUOLAR PATHWAY | 9 | 1.87e-03 | 0.599000 | 7.03e-03 |
REACTOME TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 30 | 1.68e-08 | 0.595000 | 3.25e-07 |
REACTOME BIOSYNTHESIS OF MARESIN LIKE SPMS | 6 | 1.17e-02 | -0.594000 | 3.02e-02 |
REACTOME BIOSYNTHESIS OF EPA DERIVED SPMS | 6 | 1.23e-02 | 0.590000 | 3.13e-02 |
REACTOME ERKS ARE INACTIVATED | 13 | 2.77e-04 | 0.582000 | 1.48e-03 |
REACTOME CD22 MEDIATED BCR REGULATION | 53 | 2.87e-13 | -0.579000 | 1.42e-11 |
REACTOME ANTIMICROBIAL PEPTIDES | 86 | 1.94e-20 | -0.577000 | 2.11e-18 |
REACTOME LIGAND RECEPTOR INTERACTIONS | 8 | 4.77e-03 | 0.576000 | 1.51e-02 |
REACTOME RESPONSE TO METAL IONS | 14 | 1.95e-04 | 0.575000 | 1.14e-03 |
REACTOME REGULATION OF GENE EXPRESSION IN ENDOCRINE COMMITTED NEUROG3 PROGENITOR CELLS | 5 | 2.78e-02 | 0.568000 | 5.90e-02 |
REACTOME REGULATION OF GENE EXPRESSION BY HYPOXIA INDUCIBLE FACTOR | 11 | 1.20e-03 | 0.564000 | 4.85e-03 |
REACTOME ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 56 | 3.61e-13 | 0.561000 | 1.68e-11 |
REACTOME ERYTHROPOIETIN ACTIVATES STAT5 | 7 | 1.06e-02 | 0.558000 | 2.78e-02 |
REACTOME CS DS DEGRADATION | 12 | 8.67e-04 | 0.555000 | 3.76e-03 |
REACTOME REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 15 | 2.11e-04 | 0.552000 | 1.20e-03 |
REACTOME METALLOTHIONEINS BIND METALS | 11 | 1.80e-03 | 0.543000 | 6.88e-03 |
REACTOME RHO GTPASES ACTIVATE ROCKS | 19 | 4.34e-05 | 0.542000 | 3.26e-04 |
REACTOME SIGNALING BY RNF43 MUTANTS | 8 | 8.90e-03 | 0.534000 | 2.42e-02 |
REACTOME LIPID PARTICLE ORGANIZATION | 6 | 2.39e-02 | 0.532000 | 5.26e-02 |
REACTOME REGULATION OF FZD BY UBIQUITINATION | 21 | 2.96e-05 | 0.526000 | 2.37e-04 |
REACTOME NOSTRIN MEDIATED ENOS TRAFFICKING | 5 | 4.22e-02 | 0.525000 | 8.24e-02 |
REACTOME FLT3 SIGNALING BY CBL MUTANTS | 7 | 1.63e-02 | 0.524000 | 3.93e-02 |
REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 14 | 6.84e-04 | 0.524000 | 3.08e-03 |
REACTOME BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 2.89e-04 | 0.523000 | 1.54e-03 |
REACTOME NADE MODULATES DEATH SIGNALLING | 5 | 4.34e-02 | 0.521000 | 8.40e-02 |
REACTOME CREATION OF C4 AND C2 ACTIVATORS | 63 | 8.36e-13 | -0.521000 | 3.50e-11 |
REACTOME SUMOYLATION OF TRANSCRIPTION FACTORS | 20 | 5.61e-05 | 0.520000 | 4.07e-04 |
REACTOME PROSTANOID LIGAND RECEPTORS | 9 | 6.97e-03 | 0.519000 | 2.00e-02 |
REACTOME ACTIVATED NTRK2 SIGNALS THROUGH PI3K | 7 | 1.75e-02 | 0.519000 | 4.14e-02 |
REACTOME NEGATIVE REGULATION OF ACTIVITY OF TFAP2 AP 2 FAMILY TRANSCRIPTION FACTORS | 10 | 4.53e-03 | 0.518000 | 1.44e-02 |
REACTOME LRR FLII INTERACTING PROTEIN 1 LRRFIP1 ACTIVATES TYPE I IFN PRODUCTION | 5 | 4.49e-02 | 0.518000 | 8.61e-02 |
REACTOME SENSORY PERCEPTION | 576 | 7.00e-100 | -0.513000 | 5.46e-97 |
REACTOME DEFECTIVE CHST14 CAUSES EDS MUSCULOCONTRACTURAL TYPE | 7 | 1.88e-02 | 0.513000 | 4.40e-02 |
REACTOME SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 14 | 1.02e-03 | 0.507000 | 4.30e-03 |
REACTOME ROLE OF ABL IN ROBO SLIT SIGNALING | 8 | 1.32e-02 | 0.506000 | 3.31e-02 |
REACTOME PP2A MEDIATED DEPHOSPHORYLATION OF KEY METABOLIC FACTORS | 6 | 3.25e-02 | 0.504000 | 6.71e-02 |
REACTOME IKBA VARIANT LEADS TO EDA ID | 6 | 3.28e-02 | 0.503000 | 6.76e-02 |
REACTOME INITIAL TRIGGERING OF COMPLEMENT | 70 | 6.70e-13 | -0.496000 | 2.87e-11 |
REACTOME SCAVENGING OF HEME FROM PLASMA | 60 | 2.87e-11 | -0.496000 | 9.97e-10 |
REACTOME REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 9 | 1.02e-02 | 0.494000 | 2.72e-02 |
REACTOME TACHYKININ RECEPTORS BIND TACHYKININS | 5 | 5.60e-02 | 0.493000 | 1.03e-01 |
REACTOME BINDING OF TCF LEF CTNNB1 TO TARGET GENE PROMOTERS | 8 | 1.57e-02 | 0.493000 | 3.82e-02 |
REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 1.40e-04 | 0.492000 | 8.83e-04 |
REACTOME NEGATIVE FEEDBACK REGULATION OF MAPK PATHWAY | 6 | 3.73e-02 | 0.491000 | 7.50e-02 |
REACTOME DERMATAN SULFATE BIOSYNTHESIS | 10 | 7.26e-03 | 0.490000 | 2.05e-02 |
REACTOME TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 19 | 2.40e-04 | 0.487000 | 1.31e-03 |
REACTOME FCGR ACTIVATION | 61 | 7.38e-11 | -0.482000 | 2.36e-09 |
REACTOME GASTRULATION | 48 | 8.31e-09 | 0.480000 | 1.78e-07 |
REACTOME ACTIVATION OF THE TFAP2 AP 2 FAMILY OF TRANSCRIPTION FACTORS | 11 | 5.81e-03 | 0.480000 | 1.73e-02 |
REACTOME POU5F1 OCT4 SOX2 NANOG ACTIVATE GENES RELATED TO PROLIFERATION | 12 | 4.03e-03 | 0.479000 | 1.33e-02 |
REACTOME SEMA4D IN SEMAPHORIN SIGNALING | 24 | 4.81e-05 | 0.479000 | 3.55e-04 |
REACTOME RHO GTPASES ACTIVATE CIT | 19 | 3.01e-04 | 0.479000 | 1.58e-03 |
REACTOME SMAC XIAP REGULATED APOPTOTIC RESPONSE | 6 | 4.22e-02 | 0.479000 | 8.24e-02 |
REACTOME SMALL INTERFERING RNA SIRNA BIOGENESIS | 5 | 6.59e-02 | 0.475000 | 1.18e-01 |
REACTOME DRUG MEDIATED INHIBITION OF CDK4 CDK6 ACTIVITY | 5 | 6.62e-02 | 0.474000 | 1.18e-01 |
REACTOME RUNX1 REGULATES EXPRESSION OF COMPONENTS OF TIGHT JUNCTIONS | 5 | 6.68e-02 | 0.473000 | 1.19e-01 |
REACTOME SIGNALING BY NOTCH1 T 7 9 NOTCH1 M1580 K2555 TRANSLOCATION MUTANT | 7 | 3.05e-02 | 0.472000 | 6.38e-02 |
REACTOME CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 9 | 1.47e-02 | 0.470000 | 3.59e-02 |
REACTOME MINERALOCORTICOID BIOSYNTHESIS | 6 | 4.70e-02 | -0.468000 | 8.92e-02 |
REACTOME MAPK3 ERK1 ACTIVATION | 10 | 1.06e-02 | 0.467000 | 2.78e-02 |
REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | 16 | 1.25e-03 | 0.466000 | 5.03e-03 |
REACTOME NTRK2 ACTIVATES RAC1 | 5 | 7.13e-02 | 0.466000 | 1.26e-01 |
REACTOME TFAP2 AP 2 FAMILY REGULATES TRANSCRIPTION OF CELL CYCLE FACTORS | 5 | 7.19e-02 | 0.465000 | 1.26e-01 |
REACTOME FGFRL1 MODULATION OF FGFR1 SIGNALING | 13 | 3.79e-03 | 0.464000 | 1.27e-02 |
REACTOME COHESIN LOADING ONTO CHROMATIN | 7 | 3.40e-02 | 0.463000 | 7.00e-02 |
REACTOME ACTIVATION OF CASPASES THROUGH APOPTOSOME MEDIATED CLEAVAGE | 5 | 7.37e-02 | 0.462000 | 1.28e-01 |
REACTOME VLDLR INTERNALISATION AND DEGRADATION | 16 | 1.47e-03 | 0.459000 | 5.76e-03 |
REACTOME RAF INDEPENDENT MAPK1 3 ACTIVATION | 22 | 2.06e-04 | 0.457000 | 1.18e-03 |
REACTOME NGF STIMULATED TRANSCRIPTION | 38 | 1.08e-06 | 0.457000 | 1.39e-05 |
REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 28 | 3.10e-05 | 0.455000 | 2.45e-04 |
REACTOME WNT LIGAND BIOGENESIS AND TRAFFICKING | 25 | 8.28e-05 | 0.455000 | 5.65e-04 |
REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 2.31e-03 | 0.454000 | 8.34e-03 |
REACTOME RELEASE OF HH NP FROM THE SECRETING CELL | 8 | 2.62e-02 | 0.454000 | 5.66e-02 |
REACTOME MECP2 REGULATES TRANSCRIPTION OF NEURONAL LIGANDS | 7 | 3.77e-02 | 0.454000 | 7.56e-02 |
REACTOME SIGNALING BY HIPPO | 19 | 6.21e-04 | 0.453000 | 2.87e-03 |
REACTOME CREATINE METABOLISM | 10 | 1.31e-02 | 0.453000 | 3.31e-02 |
REACTOME ERYTHROPOIETIN ACTIVATES PHOSPHOLIPASE C GAMMA PLCG | 7 | 3.95e-02 | 0.449000 | 7.84e-02 |
REACTOME REGULATION OF BETA CELL DEVELOPMENT | 41 | 6.68e-07 | 0.448000 | 9.15e-06 |
REACTOME RUNX3 REGULATES NOTCH SIGNALING | 13 | 5.12e-03 | 0.448000 | 1.58e-02 |
REACTOME FORMATION OF AXIAL MESODERM | 13 | 5.13e-03 | 0.448000 | 1.58e-02 |
REACTOME SIGNALING BY WNT IN CANCER | 32 | 1.16e-05 | 0.448000 | 1.07e-04 |
REACTOME DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 30 | 2.26e-05 | 0.447000 | 1.88e-04 |
REACTOME INACTIVATION OF CDC42 AND RAC1 | 8 | 2.87e-02 | 0.446000 | 6.04e-02 |
REACTOME AMINO ACID CONJUGATION | 9 | 2.06e-02 | -0.446000 | 4.72e-02 |
REACTOME PHYSIOLOGICAL FACTORS | 14 | 3.92e-03 | 0.445000 | 1.30e-02 |
REACTOME ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 19 | 8.55e-04 | 0.442000 | 3.73e-03 |
REACTOME SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 10 | 1.56e-02 | 0.442000 | 3.80e-02 |
REACTOME SIGNALING BY FGFR4 | 40 | 1.42e-06 | 0.440000 | 1.71e-05 |
REACTOME SIGNALING BY LEPTIN | 11 | 1.15e-02 | 0.440000 | 2.97e-02 |
REACTOME ONCOGENE INDUCED SENESCENCE | 32 | 1.67e-05 | 0.439000 | 1.45e-04 |
REACTOME GRB7 EVENTS IN ERBB2 SIGNALING | 5 | 8.90e-02 | 0.439000 | 1.48e-01 |
REACTOME TRANSPORT OF ORGANIC ANIONS | 10 | 1.67e-02 | -0.437000 | 3.98e-02 |
REACTOME SIGNALING BY MRAS COMPLEX MUTANTS | 7 | 4.55e-02 | 0.437000 | 8.70e-02 |
REACTOME RUNX3 REGULATES YAP1 MEDIATED TRANSCRIPTION | 7 | 4.60e-02 | 0.435000 | 8.76e-02 |
REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 59 | 7.51e-09 | 0.435000 | 1.63e-07 |
REACTOME SIGNALING BY FGFR4 IN DISEASE | 11 | 1.26e-02 | 0.434000 | 3.19e-02 |
REACTOME TRANSCRIPTIONAL REGULATION OF TESTIS DIFFERENTIATION | 12 | 9.24e-03 | 0.434000 | 2.48e-02 |
REACTOME NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 12 | 9.25e-03 | 0.434000 | 2.48e-02 |
REACTOME DOPAMINE RECEPTORS | 5 | 9.43e-02 | 0.432000 | 1.55e-01 |
REACTOME NEF MEDIATED CD8 DOWN REGULATION | 7 | 4.85e-02 | 0.431000 | 9.12e-02 |
REACTOME ACTIVATION OF RAC1 | 11 | 1.34e-02 | 0.430000 | 3.35e-02 |
REACTOME FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 30 | 4.51e-05 | 0.430000 | 3.36e-04 |
REACTOME SPRY REGULATION OF FGF SIGNALING | 16 | 2.97e-03 | 0.429000 | 1.03e-02 |
REACTOME RUNX3 REGULATES BCL2L11 BIM TRANSCRIPTION | 5 | 9.72e-02 | 0.428000 | 1.59e-01 |
REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 11 | 1.42e-02 | 0.427000 | 3.51e-02 |
REACTOME NR1H2 NR1H3 REGULATE GENE EXPRESSION LINKED TO TRIGLYCERIDE LIPOLYSIS IN ADIPOSE | 5 | 9.85e-02 | 0.427000 | 1.60e-01 |
REACTOME NEGATIVE REGULATION OF MAPK PATHWAY | 41 | 2.30e-06 | 0.426000 | 2.56e-05 |
REACTOME ALPHA DEFENSINS | 9 | 2.71e-02 | -0.425000 | 5.78e-02 |
REACTOME CALCITONIN LIKE LIGAND RECEPTORS | 10 | 2.00e-02 | 0.425000 | 4.62e-02 |
REACTOME BETA OXIDATION OF LAUROYL COA TO DECANOYL COA COA | 5 | 1.00e-01 | 0.425000 | 1.62e-01 |
REACTOME PI 3K CASCADE FGFR4 | 19 | 1.40e-03 | 0.423000 | 5.55e-03 |
REACTOME MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 12 | 1.12e-02 | 0.423000 | 2.91e-02 |
REACTOME BETA OXIDATION OF DECANOYL COA TO OCTANOYL COA COA | 6 | 7.32e-02 | 0.422000 | 1.27e-01 |
REACTOME BETA OXIDATION OF OCTANOYL COA TO HEXANOYL COA | 5 | 1.02e-01 | 0.422000 | 1.65e-01 |
REACTOME NEGATIVE REGULATION OF FGFR4 SIGNALING | 30 | 6.42e-05 | 0.421000 | 4.53e-04 |
REACTOME HDACS DEACETYLATE HISTONES | 29 | 8.99e-05 | 0.420000 | 6.06e-04 |
REACTOME ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 15 | 4.89e-03 | 0.420000 | 1.53e-02 |
REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 26 | 2.15e-04 | 0.419000 | 1.21e-03 |
REACTOME INLA MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELLS | 9 | 2.95e-02 | 0.419000 | 6.18e-02 |
REACTOME PHOSPHOLIPASE C MEDIATED CASCADE FGFR4 | 14 | 6.68e-03 | 0.419000 | 1.95e-02 |
REACTOME REGULATION OF CYTOSKELETAL REMODELING AND CELL SPREADING BY IPP COMPLEX COMPONENTS | 7 | 5.54e-02 | 0.418000 | 1.02e-01 |
REACTOME SIGNALING BY FGFR2 IIIA TM | 19 | 1.61e-03 | 0.418000 | 6.23e-03 |
REACTOME SODIUM COUPLED PHOSPHATE COTRANSPORTERS | 5 | 1.06e-01 | 0.417000 | 1.70e-01 |
REACTOME ERK MAPK TARGETS | 20 | 1.26e-03 | 0.416000 | 5.09e-03 |
REACTOME NR1H2 NR1H3 REGULATE GENE EXPRESSION TO LIMIT CHOLESTEROL UPTAKE | 5 | 1.07e-01 | 0.416000 | 1.71e-01 |
REACTOME SUMO IS TRANSFERRED FROM E1 TO E2 UBE2I UBC9 | 7 | 5.66e-02 | 0.416000 | 1.04e-01 |
REACTOME PROCESSING AND ACTIVATION OF SUMO | 10 | 2.28e-02 | 0.416000 | 5.06e-02 |
REACTOME BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 17 | 3.09e-03 | 0.414000 | 1.07e-02 |
REACTOME P75NTR SIGNALS VIA NF KB | 15 | 5.56e-03 | 0.413000 | 1.67e-02 |
REACTOME NEGATIVE REGULATION OF FGFR1 SIGNALING | 32 | 5.22e-05 | 0.413000 | 3.81e-04 |
REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 19 | 1.83e-03 | 0.413000 | 6.94e-03 |
REACTOME ACTIVATION OF SMO | 17 | 3.22e-03 | 0.413000 | 1.10e-02 |
REACTOME PI3K AKT ACTIVATION | 9 | 3.22e-02 | 0.412000 | 6.66e-02 |
REACTOME ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 63 | 1.50e-08 | -0.412000 | 2.94e-07 |
REACTOME SYNTHESIS OF GDP MANNOSE | 5 | 1.11e-01 | 0.412000 | 1.76e-01 |
REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 29 | 1.24e-04 | 0.412000 | 8.09e-04 |
REACTOME NEGATIVE REGULATION OF FGFR3 SIGNALING | 28 | 1.65e-04 | 0.411000 | 9.98e-04 |
REACTOME PI 3K CASCADE FGFR1 | 21 | 1.13e-03 | 0.410000 | 4.64e-03 |
REACTOME DEFECTIVE CHST6 CAUSES MCDC1 | 8 | 4.45e-02 | 0.410000 | 8.57e-02 |
REACTOME INHIBITION OF DNA RECOMBINATION AT TELOMERE | 19 | 1.97e-03 | 0.410000 | 7.33e-03 |
REACTOME THE ACTIVATION OF ARYLSULFATASES | 8 | 4.49e-02 | 0.409000 | 8.61e-02 |
REACTOME ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 3.55e-03 | 0.408000 | 1.20e-02 |
REACTOME HIV ELONGATION ARREST AND RECOVERY | 25 | 4.13e-04 | 0.408000 | 2.05e-03 |
REACTOME RAP1 SIGNALLING | 16 | 4.75e-03 | 0.408000 | 1.50e-02 |
REACTOME SIGNALING BY FGFR3 | 39 | 1.05e-05 | 0.408000 | 9.86e-05 |
REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 24 | 5.53e-04 | 0.407000 | 2.61e-03 |
REACTOME PI 3K CASCADE FGFR3 | 17 | 3.68e-03 | 0.407000 | 1.24e-02 |
REACTOME EPITHELIAL MESENCHYMAL TRANSITION EMT DURING GASTRULATION | 6 | 8.60e-02 | 0.405000 | 1.44e-01 |
REACTOME GERM LAYER FORMATION AT GASTRULATION | 16 | 5.14e-03 | 0.404000 | 1.58e-02 |
REACTOME REPRESSION OF WNT TARGET GENES | 13 | 1.18e-02 | 0.404000 | 3.02e-02 |
REACTOME RHO GTPASES ACTIVATE KTN1 | 11 | 2.05e-02 | 0.403000 | 4.72e-02 |
REACTOME MAPK1 ERK2 ACTIVATION | 9 | 3.62e-02 | 0.403000 | 7.35e-02 |
REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | 18 | 3.15e-03 | 0.402000 | 1.08e-02 |
REACTOME NEGATIVE REGULATION OF FGFR2 SIGNALING | 33 | 6.69e-05 | 0.401000 | 4.68e-04 |
REACTOME INTERLEUKIN 15 SIGNALING | 13 | 1.23e-02 | 0.401000 | 3.14e-02 |
REACTOME REGULATION OF PTEN MRNA TRANSLATION | 5 | 1.21e-01 | 0.400000 | 1.88e-01 |
REACTOME WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 1.25e-02 | 0.400000 | 3.16e-02 |
REACTOME SIGNALING BY MAPK MUTANTS | 6 | 8.97e-02 | 0.400000 | 1.49e-01 |
REACTOME DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 38 | 1.98e-05 | 0.400000 | 1.67e-04 |
REACTOME SIGNALING BY FGFR2 IN DISEASE | 42 | 7.31e-06 | 0.400000 | 7.13e-05 |
REACTOME PEXOPHAGY | 11 | 2.17e-02 | 0.400000 | 4.91e-02 |
REACTOME METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 7.47e-03 | 0.399000 | 2.10e-02 |
REACTOME NEPHRIN FAMILY INTERACTIONS | 21 | 1.59e-03 | 0.398000 | 6.16e-03 |
REACTOME DEFECTIVE GALNT3 CAUSES HFTC | 16 | 5.86e-03 | -0.398000 | 1.75e-02 |
REACTOME SIGNALING BY FGFR2 | 72 | 5.21e-09 | 0.398000 | 1.21e-07 |
REACTOME RMTS METHYLATE HISTONE ARGININES | 28 | 2.73e-04 | 0.397000 | 1.47e-03 |
REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 29 | 2.22e-04 | 0.396000 | 1.24e-03 |
REACTOME PRE NOTCH PROCESSING IN THE ENDOPLASMIC RETICULUM | 6 | 9.42e-02 | 0.395000 | 1.55e-01 |
REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 2.36e-04 | 0.394000 | 1.30e-03 |
REACTOME FORMATION OF PARAXIAL MESODERM | 21 | 1.76e-03 | 0.394000 | 6.73e-03 |
REACTOME POLB DEPENDENT LONG PATCH BASE EXCISION REPAIR | 7 | 7.11e-02 | 0.394000 | 1.25e-01 |
REACTOME MELANIN BIOSYNTHESIS | 5 | 1.28e-01 | -0.394000 | 1.97e-01 |
REACTOME TELOMERE EXTENSION BY TELOMERASE | 22 | 1.40e-03 | 0.393000 | 5.55e-03 |
REACTOME KSRP KHSRP BINDS AND DESTABILIZES MRNA | 17 | 5.00e-03 | 0.393000 | 1.56e-02 |
REACTOME MICRORNA MIRNA BIOGENESIS | 21 | 1.83e-03 | 0.393000 | 6.94e-03 |
REACTOME PI 3K CASCADE FGFR2 | 22 | 1.45e-03 | 0.392000 | 5.68e-03 |
REACTOME CYCLIN D ASSOCIATED EVENTS IN G1 | 46 | 4.21e-06 | 0.392000 | 4.40e-05 |
REACTOME FGFR2 MUTANT RECEPTOR ACTIVATION | 32 | 1.32e-04 | 0.390000 | 8.48e-04 |
REACTOME ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 72 | 1.05e-08 | -0.390000 | 2.14e-07 |
REACTOME RAF ACTIVATION | 32 | 1.36e-04 | 0.390000 | 8.68e-04 |
REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 76 | 4.25e-09 | -0.389000 | 1.02e-07 |
REACTOME SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 14 | 1.17e-02 | 0.389000 | 3.01e-02 |
REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | 89 | 2.29e-10 | 0.388000 | 6.78e-09 |
REACTOME REGULATION OF PTEN GENE TRANSCRIPTION | 57 | 4.30e-07 | 0.387000 | 6.43e-06 |
REACTOME INTERLEUKIN 6 SIGNALING | 11 | 2.64e-02 | 0.387000 | 5.68e-02 |
REACTOME STAT5 ACTIVATION | 7 | 7.70e-02 | 0.386000 | 1.32e-01 |
REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | 11 | 2.67e-02 | 0.386000 | 5.73e-02 |
REACTOME SIGNALING BY ALK IN CANCER | 51 | 1.87e-06 | 0.386000 | 2.13e-05 |
REACTOME APOPTOTIC FACTOR MEDIATED RESPONSE | 17 | 5.93e-03 | 0.385000 | 1.76e-02 |
REACTOME CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 2.11e-02 | 0.384000 | 4.81e-02 |
REACTOME TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 19 | 3.72e-03 | 0.384000 | 1.25e-02 |
REACTOME FGFR2 ALTERNATIVE SPLICING | 27 | 5.49e-04 | 0.384000 | 2.60e-03 |
REACTOME G0 AND EARLY G1 | 27 | 5.51e-04 | 0.384000 | 2.61e-03 |
REACTOME INTERLEUKIN 36 PATHWAY | 7 | 7.89e-02 | -0.383000 | 1.35e-01 |
REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 31 | 2.21e-04 | 0.383000 | 1.24e-03 |
REACTOME SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 53 | 1.40e-06 | 0.383000 | 1.71e-05 |
REACTOME SYNTHESIS OF 15 EICOSATETRAENOIC ACID DERIVATIVES | 6 | 1.05e-01 | 0.382000 | 1.69e-01 |
REACTOME SIGNALING BY FGFR1 | 49 | 3.65e-06 | 0.382000 | 3.83e-05 |
REACTOME DIGESTION | 19 | 3.98e-03 | -0.382000 | 1.31e-02 |
REACTOME DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 27 | 5.99e-04 | 0.381000 | 2.77e-03 |
REACTOME SYNTHESIS OF DIPHTHAMIDE EEF2 | 6 | 1.06e-01 | 0.381000 | 1.70e-01 |
REACTOME DISPLACEMENT OF DNA GLYCOSYLASE BY APEX1 | 9 | 4.84e-02 | 0.380000 | 9.11e-02 |
REACTOME ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 9 | 4.87e-02 | 0.379000 | 9.14e-02 |
REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 29 | 4.06e-04 | 0.379000 | 2.03e-03 |
REACTOME PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 17 | 6.80e-03 | 0.379000 | 1.97e-02 |
REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 32 | 2.10e-04 | 0.378000 | 1.20e-03 |
REACTOME RUNX3 REGULATES WNT SIGNALING | 8 | 6.39e-02 | 0.378000 | 1.15e-01 |
REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 24 | 1.34e-03 | 0.378000 | 5.34e-03 |
REACTOME TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 166 | 3.72e-17 | 0.378000 | 3.19e-15 |
REACTOME ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 2.34e-02 | 0.378000 | 5.18e-02 |
REACTOME DECTIN 2 FAMILY | 26 | 8.84e-04 | -0.377000 | 3.82e-03 |
REACTOME POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 42 | 2.50e-05 | 0.376000 | 2.04e-04 |
REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 44 | 1.74e-05 | 0.374000 | 1.50e-04 |
REACTOME CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 4.79e-03 | 0.374000 | 1.51e-02 |
REACTOME DEFECTIVE B4GALT1 CAUSES B4GALT1 CDG CDG 2D | 8 | 6.73e-02 | 0.374000 | 1.20e-01 |
REACTOME BETA OXIDATION OF HEXANOYL COA TO BUTANOYL COA | 5 | 1.48e-01 | 0.373000 | 2.21e-01 |
REACTOME REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 28 | 6.25e-04 | 0.373000 | 2.87e-03 |
REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | 15 | 1.24e-02 | 0.373000 | 3.15e-02 |
REACTOME SIGNALING BY WNT | 257 | 6.35e-25 | 0.372000 | 1.03e-22 |
REACTOME CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 1.27e-02 | 0.372000 | 3.19e-02 |
REACTOME TOXICITY OF BOTULINUM TOXIN TYPE D BOTD | 5 | 1.50e-01 | 0.372000 | 2.23e-01 |
REACTOME FLT3 SIGNALING IN DISEASE | 28 | 6.73e-04 | 0.371000 | 3.05e-03 |
REACTOME TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 14 | 1.63e-02 | 0.371000 | 3.93e-02 |
REACTOME HYALURONAN UPTAKE AND DEGRADATION | 11 | 3.33e-02 | 0.371000 | 6.84e-02 |
REACTOME RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 73 | 4.32e-08 | 0.370000 | 7.75e-07 |
REACTOME ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 4.31e-02 | 0.369000 | 8.38e-02 |
REACTOME TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 47 | 1.17e-05 | 0.369000 | 1.08e-04 |
REACTOME RHO GTPASES ACTIVATE PAKS | 19 | 5.32e-03 | 0.369000 | 1.62e-02 |
REACTOME ELASTIC FIBRE FORMATION | 44 | 2.24e-05 | 0.369000 | 1.87e-04 |
REACTOME REGULATION OF TP53 EXPRESSION AND DEGRADATION | 37 | 1.06e-04 | 0.368000 | 7.08e-04 |
REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | 8 | 7.13e-02 | 0.368000 | 1.26e-01 |
REACTOME COMPLEMENT CASCADE | 104 | 8.98e-11 | -0.368000 | 2.81e-09 |
REACTOME DEFECTIVE C1GALT1C1 CAUSES TNPS | 16 | 1.09e-02 | -0.367000 | 2.86e-02 |
REACTOME NEF MEDIATED CD4 DOWN REGULATION | 9 | 5.63e-02 | 0.367000 | 1.04e-01 |
REACTOME HYALURONAN METABOLISM | 15 | 1.40e-02 | 0.366000 | 3.46e-02 |
REACTOME INTERLEUKIN 7 SIGNALING | 21 | 3.69e-03 | 0.366000 | 1.24e-02 |
REACTOME CHOLINE CATABOLISM | 6 | 1.21e-01 | 0.366000 | 1.88e-01 |
REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 12 | 2.84e-02 | 0.365000 | 5.99e-02 |
REACTOME DIGESTION OF DIETARY LIPID | 7 | 9.43e-02 | -0.365000 | 1.55e-01 |
REACTOME HATS ACETYLATE HISTONES | 65 | 3.49e-07 | 0.365000 | 5.31e-06 |
REACTOME LYSINE CATABOLISM | 10 | 4.56e-02 | 0.365000 | 8.71e-02 |
REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 2.28e-02 | 0.365000 | 5.06e-02 |
REACTOME TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 17 | 9.28e-03 | 0.364000 | 2.49e-02 |
REACTOME PROLONGED ERK ACTIVATION EVENTS | 14 | 1.84e-02 | 0.364000 | 4.34e-02 |
REACTOME DEFECTIVE INTRINSIC PATHWAY FOR APOPTOSIS | 25 | 1.65e-03 | 0.364000 | 6.36e-03 |
REACTOME SIGNALING BY FGFR | 85 | 6.71e-09 | 0.363000 | 1.52e-07 |
REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | 12 | 2.93e-02 | 0.363000 | 6.15e-02 |
REACTOME SIGNALING BY BMP | 27 | 1.09e-03 | 0.363000 | 4.56e-03 |
REACTOME RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 2.64e-03 | 0.362000 | 9.28e-03 |
REACTOME CALCINEURIN ACTIVATES NFAT | 9 | 6.00e-02 | 0.362000 | 1.10e-01 |
REACTOME PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 21 | 4.11e-03 | 0.362000 | 1.34e-02 |
REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | 21 | 4.16e-03 | 0.361000 | 1.35e-02 |
REACTOME COMPLEX I BIOGENESIS | 45 | 2.76e-05 | 0.361000 | 2.21e-04 |
REACTOME RUNX3 REGULATES P14 ARF | 10 | 4.81e-02 | 0.361000 | 9.09e-02 |
REACTOME LINOLEIC ACID LA METABOLISM | 7 | 9.85e-02 | 0.361000 | 1.60e-01 |
REACTOME ASSEMBLY OF THE HIV VIRION | 14 | 1.95e-02 | 0.360000 | 4.53e-02 |
REACTOME NETRIN MEDIATED REPULSION SIGNALS | 8 | 7.81e-02 | 0.360000 | 1.33e-01 |
REACTOME TP53 REGULATES TRANSCRIPTION OF DEATH RECEPTORS AND LIGANDS | 12 | 3.12e-02 | 0.359000 | 6.50e-02 |
REACTOME RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 1.58e-04 | 0.359000 | 9.74e-04 |
REACTOME SIGNALING BY ERBB2 ECD MUTANTS | 15 | 1.64e-02 | 0.358000 | 3.94e-02 |
REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | 12 | 3.19e-02 | 0.358000 | 6.61e-02 |
REACTOME EPHA MEDIATED GROWTH CONE COLLAPSE | 29 | 8.59e-04 | 0.357000 | 3.74e-03 |
REACTOME TELOMERE MAINTENANCE | 61 | 1.41e-06 | 0.357000 | 1.71e-05 |
REACTOME FORMATION OF THE EARLY ELONGATION COMPLEX | 28 | 1.08e-03 | 0.357000 | 4.53e-03 |
REACTOME CA2 PATHWAY | 58 | 2.63e-06 | 0.356000 | 2.88e-05 |
REACTOME DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 81 | 2.87e-08 | 0.356000 | 5.25e-07 |
REACTOME ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 26 | 1.66e-03 | 0.356000 | 6.38e-03 |
REACTOME CHROMATIN MODIFYING ENZYMES | 171 | 8.73e-16 | 0.356000 | 6.47e-14 |
REACTOME SIGNALING BY FGFR1 IN DISEASE | 37 | 1.84e-04 | 0.355000 | 1.09e-03 |
REACTOME FORMATION OF APOPTOSOME | 10 | 5.18e-02 | 0.355000 | 9.66e-02 |
REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 39 | 1.27e-04 | -0.355000 | 8.15e-04 |
REACTOME LGI ADAM INTERACTIONS | 14 | 2.17e-02 | 0.354000 | 4.90e-02 |
REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 49 | 1.79e-05 | 0.354000 | 1.52e-04 |
REACTOME CHOLESTEROL BIOSYNTHESIS | 23 | 3.30e-03 | 0.354000 | 1.12e-02 |
REACTOME SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 7.19e-05 | 0.354000 | 4.99e-04 |
REACTOME SIGNALING BY FGFR IN DISEASE | 61 | 1.75e-06 | 0.354000 | 2.02e-05 |
REACTOME TRANSCRIPTIONAL REGULATION BY E2F6 | 32 | 5.34e-04 | 0.354000 | 2.54e-03 |
REACTOME CRMPS IN SEMA3A SIGNALING | 15 | 1.77e-02 | 0.354000 | 4.19e-02 |
REACTOME REGULATION OF BACH1 ACTIVITY | 11 | 4.26e-02 | 0.353000 | 8.29e-02 |
REACTOME ENOS ACTIVATION | 11 | 4.26e-02 | 0.353000 | 8.29e-02 |
REACTOME MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 37 | 2.02e-04 | 0.353000 | 1.17e-03 |
REACTOME G BETA GAMMA SIGNALLING THROUGH CDC42 | 19 | 7.73e-03 | 0.353000 | 2.15e-02 |
REACTOME WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 1.80e-02 | 0.353000 | 4.26e-02 |
REACTOME RHOT1 GTPASE CYCLE | 5 | 1.72e-01 | 0.352000 | 2.48e-01 |
REACTOME FGFR1C LIGAND BINDING AND ACTIVATION | 11 | 4.33e-02 | 0.352000 | 8.39e-02 |
REACTOME EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 25 | 2.33e-03 | 0.352000 | 8.41e-03 |
REACTOME LECTIN PATHWAY OF COMPLEMENT ACTIVATION | 8 | 8.51e-02 | -0.352000 | 1.43e-01 |
REACTOME SUMO IS PROTEOLYTICALLY PROCESSED | 6 | 1.36e-01 | 0.351000 | 2.07e-01 |
REACTOME FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 1.89e-02 | 0.350000 | 4.41e-02 |
REACTOME SIGNALING BY NOTCH1 | 69 | 5.37e-07 | 0.349000 | 7.82e-06 |
REACTOME SIGNALING BY NTRK2 TRKB | 25 | 2.55e-03 | 0.349000 | 9.04e-03 |
REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLUCOSE DEPENDENT INSULINOTROPIC POLYPEPTIDE GIP | 12 | 3.67e-02 | 0.348000 | 7.42e-02 |
REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | 20 | 7.05e-03 | 0.348000 | 2.02e-02 |
REACTOME MRNA CAPPING | 28 | 1.43e-03 | 0.348000 | 5.66e-03 |
REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | 24 | 3.17e-03 | 0.348000 | 1.09e-02 |
REACTOME RHOV GTPASE CYCLE | 36 | 3.03e-04 | 0.348000 | 1.59e-03 |
REACTOME VIRAL MESSENGER RNA SYNTHESIS | 41 | 1.21e-04 | 0.347000 | 7.93e-04 |
REACTOME PERK REGULATES GENE EXPRESSION | 30 | 1.03e-03 | 0.346000 | 4.34e-03 |
REACTOME PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 9.10e-03 | 0.346000 | 2.46e-02 |
REACTOME HIV TRANSCRIPTION ELONGATION | 34 | 4.88e-04 | 0.345000 | 2.38e-03 |
REACTOME MEIOTIC SYNAPSIS | 31 | 9.07e-04 | 0.344000 | 3.90e-03 |
REACTOME TFAP2 AP 2 FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS | 13 | 3.17e-02 | 0.344000 | 6.58e-02 |
REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 36 | 3.59e-04 | 0.344000 | 1.82e-03 |
REACTOME REGULATION OF PTEN LOCALIZATION | 8 | 9.26e-02 | 0.343000 | 1.52e-01 |
REACTOME CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 10 | 6.02e-02 | 0.343000 | 1.10e-01 |
REACTOME SIGNALING BY ALK | 26 | 2.48e-03 | 0.343000 | 8.84e-03 |
REACTOME DEADENYLATION DEPENDENT MRNA DECAY | 48 | 3.98e-05 | 0.343000 | 3.02e-04 |
REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 17 | 1.46e-02 | 0.342000 | 3.58e-02 |
REACTOME REGULATED PROTEOLYSIS OF P75NTR | 11 | 4.95e-02 | 0.342000 | 9.28e-02 |
REACTOME RET SIGNALING | 40 | 1.89e-04 | 0.341000 | 1.12e-03 |
REACTOME EPIGENETIC REGULATION OF GENE EXPRESSION | 82 | 9.37e-08 | 0.341000 | 1.57e-06 |
REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | 48 | 4.39e-05 | 0.341000 | 3.28e-04 |
REACTOME FRS MEDIATED FGFR4 SIGNALING | 21 | 6.87e-03 | 0.341000 | 1.98e-02 |
REACTOME MODULATION BY MTB OF HOST IMMUNE SYSTEM | 6 | 1.49e-01 | 0.340000 | 2.22e-01 |
REACTOME B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 28 | 1.84e-03 | 0.340000 | 6.94e-03 |
REACTOME NEGATIVE REGULATION OF FLT3 | 15 | 2.26e-02 | 0.340000 | 5.04e-02 |
REACTOME NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 15 | 2.29e-02 | 0.339000 | 5.07e-02 |
REACTOME CITRIC ACID CYCLE TCA CYCLE | 21 | 7.15e-03 | 0.339000 | 2.03e-02 |
REACTOME KERATAN SULFATE DEGRADATION | 13 | 3.44e-02 | 0.339000 | 7.06e-02 |
REACTOME UNFOLDED PROTEIN RESPONSE UPR | 85 | 6.56e-08 | 0.339000 | 1.12e-06 |
REACTOME FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 16 | 1.90e-02 | 0.339000 | 4.44e-02 |
REACTOME TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 42 | 1.46e-04 | 0.339000 | 9.12e-04 |
REACTOME CHREBP ACTIVATES METABOLIC GENE EXPRESSION | 8 | 9.75e-02 | 0.338000 | 1.59e-01 |
REACTOME MITOTIC TELOPHASE CYTOKINESIS | 10 | 6.43e-02 | 0.338000 | 1.15e-01 |
REACTOME EXTENSION OF TELOMERES | 48 | 5.11e-05 | 0.338000 | 3.75e-04 |
REACTOME FGFR1 MUTANT RECEPTOR ACTIVATION | 30 | 1.37e-03 | 0.338000 | 5.45e-03 |
REACTOME RNA POLYMERASE II TRANSCRIPTION | 1233 | 7.32e-91 | 0.338000 | 3.98e-88 |
REACTOME ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 11 | 5.26e-02 | 0.337000 | 9.79e-02 |
REACTOME IRE1ALPHA ACTIVATES CHAPERONES | 47 | 6.35e-05 | 0.337000 | 4.50e-04 |
REACTOME FGFR2 LIGAND BINDING AND ACTIVATION | 19 | 1.10e-02 | 0.337000 | 2.86e-02 |
REACTOME FLT3 SIGNALING THROUGH SRC FAMILY KINASES | 6 | 1.53e-01 | 0.337000 | 2.27e-01 |
REACTOME SHC MEDIATED CASCADE FGFR4 | 19 | 1.12e-02 | 0.336000 | 2.90e-02 |
REACTOME MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 17 | 1.64e-02 | 0.336000 | 3.94e-02 |
REACTOME FRS MEDIATED FGFR1 SIGNALING | 23 | 5.26e-03 | 0.336000 | 1.61e-02 |
REACTOME RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 29 | 1.73e-03 | 0.336000 | 6.64e-03 |
REACTOME MITOCHONDRIAL UNCOUPLING | 5 | 1.94e-01 | 0.335000 | 2.72e-01 |
REACTOME REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 13 | 3.65e-02 | 0.335000 | 7.39e-02 |
REACTOME STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS | 10 | 6.70e-02 | 0.334000 | 1.19e-01 |
REACTOME CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 25 | 3.79e-03 | 0.334000 | 1.27e-02 |
REACTOME HEDGEHOG ON STATE | 83 | 1.37e-07 | 0.334000 | 2.27e-06 |
REACTOME SARS COV 1 TARGETS HOST INTRACELLULAR SIGNALLING AND REGULATORY PATHWAYS | 16 | 2.06e-02 | 0.334000 | 4.72e-02 |
REACTOME SIGNALING BY NTRKS | 131 | 3.74e-11 | 0.334000 | 1.24e-09 |
REACTOME TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 13 | 3.70e-02 | 0.334000 | 7.48e-02 |
REACTOME TRANSCRIPTIONAL REGULATION BY MECP2 | 56 | 1.54e-05 | 0.334000 | 1.35e-04 |
REACTOME ESTROGEN DEPENDENT GENE EXPRESSION | 83 | 1.48e-07 | 0.333000 | 2.41e-06 |
REACTOME SENSING OF DNA DOUBLE STRAND BREAKS | 5 | 1.97e-01 | 0.333000 | 2.75e-01 |
REACTOME SIGNALING BY FLT3 ITD AND TKD MUTANTS | 16 | 2.10e-02 | 0.333000 | 4.80e-02 |
REACTOME NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 19 | 1.21e-02 | 0.332000 | 3.09e-02 |
REACTOME ZINC EFFLUX AND COMPARTMENTALIZATION BY THE SLC30 FAMILY | 5 | 1.98e-01 | 0.332000 | 2.76e-01 |
REACTOME REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 6.90e-02 | 0.332000 | 1.22e-01 |
REACTOME ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 25 | 4.10e-03 | 0.332000 | 1.34e-02 |
REACTOME SHC MEDIATED CASCADE FGFR1 | 21 | 8.52e-03 | 0.332000 | 2.33e-02 |
REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 22 | 7.11e-03 | 0.331000 | 2.02e-02 |
REACTOME FCERI MEDIATED CA 2 MOBILIZATION | 77 | 4.85e-07 | -0.331000 | 7.13e-06 |
REACTOME NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 24 | 4.95e-03 | 0.331000 | 1.55e-02 |
REACTOME MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 15 | 2.64e-02 | 0.331000 | 5.68e-02 |
REACTOME MYOCLONIC EPILEPSY OF LAFORA | 9 | 8.60e-02 | 0.330000 | 1.44e-01 |
REACTOME RHOC GTPASE CYCLE | 67 | 2.92e-06 | 0.330000 | 3.12e-05 |
REACTOME STAT3 NUCLEAR EVENTS DOWNSTREAM OF ALK SIGNALING | 9 | 8.64e-02 | 0.330000 | 1.45e-01 |
REACTOME SYNTHESIS OF UDP N ACETYL GLUCOSAMINE | 7 | 1.31e-01 | 0.330000 | 2.00e-01 |
REACTOME NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 21 | 8.96e-03 | 0.329000 | 2.43e-02 |
REACTOME RHOU GTPASE CYCLE | 37 | 5.23e-04 | 0.329000 | 2.51e-03 |
REACTOME ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 7.14e-02 | 0.329000 | 1.26e-01 |
REACTOME RNA POLYMERASE I TRANSCRIPTION INITIATION | 42 | 2.27e-04 | 0.329000 | 1.26e-03 |
REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 30 | 1.83e-03 | 0.329000 | 6.94e-03 |
REACTOME CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 10 | 7.19e-02 | 0.329000 | 1.26e-01 |
REACTOME RNA POLYMERASE I TRANSCRIPTION | 45 | 1.38e-04 | 0.328000 | 8.76e-04 |
REACTOME SEMAPHORIN INTERACTIONS | 61 | 9.30e-06 | 0.328000 | 8.91e-05 |
REACTOME SUMOYLATION OF DNA REPLICATION PROTEINS | 43 | 1.97e-04 | 0.328000 | 1.15e-03 |
REACTOME PKMTS METHYLATE HISTONE LYSINES | 32 | 1.33e-03 | 0.328000 | 5.33e-03 |
REACTOME TRNA PROCESSING IN THE NUCLEUS | 53 | 3.66e-05 | 0.328000 | 2.82e-04 |
REACTOME SIGNAL AMPLIFICATION | 33 | 1.12e-03 | 0.328000 | 4.64e-03 |
REACTOME ACTIVATED NTRK2 SIGNALS THROUGH RAS | 9 | 8.90e-02 | 0.327000 | 1.48e-01 |
REACTOME SUMOYLATION | 162 | 6.28e-13 | 0.327000 | 2.77e-11 |
REACTOME DNA DOUBLE STRAND BREAK RESPONSE | 39 | 4.13e-04 | 0.327000 | 2.05e-03 |
REACTOME RHOB GTPASE CYCLE | 64 | 6.11e-06 | 0.327000 | 6.23e-05 |
REACTOME TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 10 | 7.40e-02 | 0.326000 | 1.28e-01 |
REACTOME MRNA SPLICING | 192 | 5.70e-15 | 0.326000 | 3.87e-13 |
REACTOME REGULATION OF NPAS4 MRNA TRANSLATION | 5 | 2.07e-01 | 0.326000 | 2.85e-01 |
REACTOME RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 10 | 7.44e-02 | 0.326000 | 1.28e-01 |
REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 3.49e-02 | 0.326000 | 7.12e-02 |
REACTOME CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 24 | 5.80e-03 | 0.325000 | 1.73e-02 |
REACTOME SIGNALING BY NOTCH4 | 79 | 5.86e-07 | 0.325000 | 8.45e-06 |
REACTOME NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 44 | 1.95e-04 | 0.324000 | 1.14e-03 |
REACTOME CHROMOSOME MAINTENANCE | 81 | 4.37e-07 | 0.324000 | 6.48e-06 |
REACTOME REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 26 | 4.19e-03 | 0.324000 | 1.35e-02 |
REACTOME SIGNALING BY ACTIVIN | 15 | 2.97e-02 | 0.324000 | 6.21e-02 |
REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 36 | 7.72e-04 | 0.324000 | 3.44e-03 |
REACTOME ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 11 | 6.32e-02 | 0.323000 | 1.14e-01 |
REACTOME SIGNALING BY TGFB FAMILY MEMBERS | 119 | 1.07e-09 | 0.323000 | 2.85e-08 |
REACTOME LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 19 | 1.48e-02 | 0.323000 | 3.62e-02 |
REACTOME SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 8 | 1.14e-01 | 0.323000 | 1.79e-01 |
REACTOME RNA POLYMERASE II TRANSCRIPTION TERMINATION | 63 | 9.22e-06 | 0.323000 | 8.90e-05 |
REACTOME PTEN REGULATION | 128 | 2.69e-10 | 0.323000 | 7.82e-09 |
REACTOME EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 30 | 2.23e-03 | 0.322000 | 8.09e-03 |
REACTOME FRS MEDIATED FGFR2 SIGNALING | 24 | 6.23e-03 | 0.322000 | 1.84e-02 |
REACTOME TELOMERE C STRAND SYNTHESIS INITIATION | 11 | 6.41e-02 | 0.322000 | 1.15e-01 |
REACTOME RHOF GTPASE CYCLE | 39 | 4.99e-04 | 0.322000 | 2.42e-03 |
REACTOME RNA POLYMERASE II PRE TRANSCRIPTION EVENTS | 67 | 5.20e-06 | 0.322000 | 5.37e-05 |
REACTOME ACTIVATED NTRK2 SIGNALS THROUGH CDK5 | 6 | 1.73e-01 | 0.321000 | 2.49e-01 |
REACTOME REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 71 | 2.93e-06 | 0.321000 | 3.12e-05 |
REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 255 | 1.21e-18 | 0.320000 | 1.16e-16 |
REACTOME SUMO IS CONJUGATED TO E1 UBA2 SAE1 | 5 | 2.16e-01 | 0.319000 | 2.93e-01 |
REACTOME SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 58 | 2.57e-05 | 0.319000 | 2.08e-04 |
REACTOME TRANSCRIPTION OF THE HIV GENOME | 57 | 3.04e-05 | 0.319000 | 2.42e-04 |
REACTOME RHO GTPASES ACTIVATE PKNS | 33 | 1.51e-03 | 0.319000 | 5.88e-03 |
REACTOME INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 18 | 1.94e-02 | 0.318000 | 4.50e-02 |
REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 14 | 3.93e-02 | 0.318000 | 7.83e-02 |
REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | 91 | 1.57e-07 | 0.318000 | 2.51e-06 |
REACTOME ETHANOL OXIDATION | 12 | 5.70e-02 | 0.317000 | 1.05e-01 |
REACTOME FRS MEDIATED FGFR3 SIGNALING | 19 | 1.67e-02 | 0.317000 | 3.98e-02 |
REACTOME INACTIVATION OF CSF3 G CSF SIGNALING | 23 | 8.45e-03 | 0.317000 | 2.32e-02 |
REACTOME FGFR2B LIGAND BINDING AND ACTIVATION | 10 | 8.27e-02 | 0.317000 | 1.40e-01 |
REACTOME LDL CLEARANCE | 19 | 1.69e-02 | 0.316000 | 4.03e-02 |
REACTOME HDMS DEMETHYLATE HISTONES | 16 | 2.85e-02 | 0.316000 | 6.00e-02 |
REACTOME SUPPRESSION OF APOPTOSIS | 7 | 1.47e-01 | 0.316000 | 2.20e-01 |
REACTOME RHOBTB1 GTPASE CYCLE | 22 | 1.03e-02 | 0.316000 | 2.72e-02 |
REACTOME DISEASES ASSOCIATED WITH SURFACTANT METABOLISM | 9 | 1.01e-01 | 0.316000 | 1.63e-01 |
REACTOME P75NTR NEGATIVELY REGULATES CELL CYCLE VIA SC1 | 6 | 1.81e-01 | 0.315000 | 2.58e-01 |
REACTOME REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 7.15e-05 | 0.315000 | 4.98e-04 |
REACTOME SUMOYLATION OF SUMOYLATION PROTEINS | 32 | 2.03e-03 | 0.315000 | 7.52e-03 |
REACTOME RECEPTOR MEDIATED MITOPHAGY | 10 | 8.46e-02 | 0.315000 | 1.43e-01 |
REACTOME ESR MEDIATED SIGNALING | 153 | 1.72e-11 | 0.315000 | 6.22e-10 |
REACTOME EPHRIN SIGNALING | 17 | 2.47e-02 | 0.314000 | 5.42e-02 |
REACTOME ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 22 | 1.07e-02 | 0.314000 | 2.82e-02 |
REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 76 | 2.17e-06 | 0.314000 | 2.44e-05 |
REACTOME RNA POLYMERASE III CHAIN ELONGATION | 18 | 2.11e-02 | 0.314000 | 4.81e-02 |
REACTOME RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 29 | 3.44e-03 | 0.314000 | 1.17e-02 |
REACTOME SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 49 | 1.44e-04 | 0.314000 | 9.04e-04 |
REACTOME DEFECTIVE ST3GAL3 CAUSES MCT12 AND EIEE15 | 8 | 1.24e-01 | 0.314000 | 1.92e-01 |
REACTOME NEUROFASCIN INTERACTIONS | 6 | 1.83e-01 | 0.314000 | 2.60e-01 |
REACTOME DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 409 | 8.95e-28 | 0.313000 | 2.08e-25 |
REACTOME MASTL FACILITATES MITOTIC PROGRESSION | 10 | 8.61e-02 | 0.313000 | 1.44e-01 |
REACTOME REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 51 | 1.07e-04 | 0.313000 | 7.11e-04 |
REACTOME BASE EXCISION REPAIR AP SITE FORMATION | 17 | 2.54e-02 | 0.313000 | 5.53e-02 |
REACTOME HIV TRANSCRIPTION INITIATION | 42 | 4.49e-04 | 0.313000 | 2.21e-03 |
REACTOME INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 18 | 2.16e-02 | 0.313000 | 4.90e-02 |
REACTOME DNA DAMAGE RECOGNITION IN GG NER | 36 | 1.16e-03 | 0.313000 | 4.74e-03 |
REACTOME ACTIVATED NTRK3 SIGNALS THROUGH PI3K | 6 | 1.86e-01 | 0.312000 | 2.64e-01 |
REACTOME INTERLEUKIN 27 SIGNALING | 11 | 7.34e-02 | 0.312000 | 1.27e-01 |
REACTOME DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 15 | 3.66e-02 | 0.312000 | 7.41e-02 |
REACTOME RHOBTB GTPASE CYCLE | 34 | 1.66e-03 | 0.312000 | 6.39e-03 |
REACTOME BETA CATENIN INDEPENDENT WNT SIGNALING | 140 | 1.90e-10 | 0.311000 | 5.72e-09 |
REACTOME TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 53 | 8.87e-05 | 0.311000 | 6.00e-04 |
REACTOME INTERACTION WITH CUMULUS CELLS AND THE ZONA PELLUCIDA | 11 | 7.41e-02 | -0.311000 | 1.28e-01 |
REACTOME ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 12 | 6.24e-02 | 0.311000 | 1.13e-01 |
REACTOME EPH EPHRIN SIGNALING | 89 | 4.14e-07 | 0.310000 | 6.25e-06 |
REACTOME SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 70 | 7.11e-06 | 0.310000 | 6.98e-05 |
REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 29 | 3.83e-03 | 0.310000 | 1.28e-02 |
REACTOME TERMINAL PATHWAY OF COMPLEMENT | 8 | 1.29e-01 | -0.310000 | 1.98e-01 |
REACTOME FCGR3A MEDIATED IL10 SYNTHESIS | 86 | 6.55e-07 | -0.310000 | 9.13e-06 |
REACTOME CELLULAR RESPONSE TO HYPOXIA | 71 | 6.22e-06 | 0.310000 | 6.24e-05 |
REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 46 | 2.75e-04 | 0.310000 | 1.48e-03 |
REACTOME ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 62 | 2.43e-05 | 0.310000 | 1.99e-04 |
REACTOME REGULATION OF TP53 ACTIVITY | 151 | 4.91e-11 | 0.309000 | 1.60e-09 |
REACTOME SHC MEDIATED CASCADE FGFR3 | 17 | 2.72e-02 | 0.309000 | 5.80e-02 |
REACTOME SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 17 | 2.74e-02 | 0.309000 | 5.82e-02 |
REACTOME TRANSCRIPTIONAL REGULATION BY RUNX2 | 116 | 9.22e-09 | 0.308000 | 1.90e-07 |
REACTOME CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 83 | 1.17e-06 | 0.308000 | 1.46e-05 |
REACTOME NPAS4 REGULATES EXPRESSION OF TARGET GENES | 20 | 1.70e-02 | 0.308000 | 4.05e-02 |
REACTOME FORMYL PEPTIDE RECEPTORS BIND FORMYL PEPTIDES AND MANY OTHER LIGANDS | 8 | 1.31e-01 | -0.308000 | 2.01e-01 |
REACTOME GP1B IX V ACTIVATION SIGNALLING | 11 | 7.70e-02 | 0.308000 | 1.32e-01 |
REACTOME MITOPHAGY | 25 | 7.70e-03 | 0.308000 | 2.15e-02 |
REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION OF SATURATED FATTY ACIDS | 10 | 9.20e-02 | 0.308000 | 1.52e-01 |
REACTOME UCH PROTEINASES | 81 | 1.69e-06 | 0.307000 | 1.97e-05 |
REACTOME COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 38 | 1.05e-03 | 0.307000 | 4.40e-03 |
REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 85 | 9.72e-07 | 0.307000 | 1.26e-05 |
REACTOME SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 7 | 1.60e-01 | 0.307000 | 2.35e-01 |
REACTOME SUMOYLATION OF UBIQUITINYLATION PROTEINS | 36 | 1.45e-03 | 0.307000 | 5.68e-03 |
REACTOME DISEASES OF PROGRAMMED CELL DEATH | 42 | 5.87e-04 | 0.306000 | 2.73e-03 |
REACTOME TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 32 | 2.71e-03 | 0.306000 | 9.50e-03 |
REACTOME ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 28 | 5.04e-03 | 0.306000 | 1.56e-02 |
REACTOME PROCESSING OF INTRONLESS PRE MRNAS | 19 | 2.10e-02 | 0.306000 | 4.80e-02 |
REACTOME SIGNALING BY NOTCH3 | 47 | 2.91e-04 | 0.305000 | 1.55e-03 |
REACTOME MAPK6 MAPK4 SIGNALING | 85 | 1.13e-06 | 0.305000 | 1.43e-05 |
REACTOME BUDDING AND MATURATION OF HIV VIRION | 26 | 7.08e-03 | 0.305000 | 2.02e-02 |
REACTOME FCERI MEDIATED MAPK ACTIVATION | 79 | 2.72e-06 | -0.305000 | 2.96e-05 |
REACTOME CONDENSATION OF PROMETAPHASE CHROMOSOMES | 11 | 8.00e-02 | 0.305000 | 1.36e-01 |
REACTOME BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 89 | 6.61e-07 | -0.305000 | 9.13e-06 |
REACTOME SIGNALING BY CSF3 G CSF | 28 | 5.27e-03 | 0.305000 | 1.61e-02 |
REACTOME DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 5.23e-05 | 0.304000 | 3.81e-04 |
REACTOME CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 25 | 8.45e-03 | 0.304000 | 2.32e-02 |
REACTOME OXIDATIVE STRESS INDUCED SENESCENCE | 62 | 3.40e-05 | 0.304000 | 2.66e-04 |
REACTOME EICOSANOID LIGAND BINDING RECEPTORS | 14 | 4.87e-02 | 0.304000 | 9.14e-02 |
REACTOME HDR THROUGH SINGLE STRAND ANNEALING SSA | 35 | 1.84e-03 | 0.304000 | 6.94e-03 |
REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 79 | 2.95e-06 | 0.304000 | 3.12e-05 |
REACTOME RUNX2 REGULATES BONE DEVELOPMENT | 29 | 4.60e-03 | 0.304000 | 1.46e-02 |
REACTOME CONJUGATION OF BENZOATE WITH GLYCINE | 6 | 1.97e-01 | -0.304000 | 2.75e-01 |
REACTOME MIRO GTPASE CYCLE | 8 | 1.37e-01 | 0.304000 | 2.07e-01 |
REACTOME LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 11 | 8.13e-02 | 0.304000 | 1.38e-01 |
REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 19 | 2.21e-02 | 0.303000 | 4.95e-02 |
REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 3.58e-02 | 0.303000 | 7.28e-02 |
REACTOME NEGATIVE REGULATION OF NOTCH4 SIGNALING | 52 | 1.57e-04 | 0.303000 | 9.71e-04 |
REACTOME SIGNALING BY RETINOIC ACID | 41 | 7.91e-04 | 0.303000 | 3.49e-03 |
REACTOME DEX H BOX HELICASES ACTIVATE TYPE I IFN AND INFLAMMATORY CYTOKINES PRODUCTION | 7 | 1.65e-01 | 0.303000 | 2.40e-01 |
REACTOME DNA DAMAGE BYPASS | 44 | 5.14e-04 | 0.302000 | 2.48e-03 |
REACTOME DEFECTIVE CSF2RB CAUSES SMDP5 | 7 | 1.66e-01 | 0.302000 | 2.41e-01 |
REACTOME TRANSCRIPTIONAL REGULATION BY RUNX1 | 164 | 2.18e-11 | 0.302000 | 7.72e-10 |
REACTOME CELLULAR SENESCENCE | 123 | 6.81e-09 | 0.302000 | 1.52e-07 |
REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 7.01e-02 | 0.302000 | 1.24e-01 |
REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 91 | 6.29e-07 | 0.302000 | 9.00e-06 |
REACTOME G1 S DNA DAMAGE CHECKPOINTS | 65 | 2.56e-05 | 0.302000 | 2.08e-04 |
REACTOME SIGNALING BY FLT3 FUSION PROTEINS | 19 | 2.30e-02 | 0.301000 | 5.08e-02 |
REACTOME ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 39 | 1.14e-03 | 0.301000 | 4.66e-03 |
REACTOME SIGNAL TRANSDUCTION BY L1 | 20 | 1.97e-02 | 0.301000 | 4.57e-02 |
REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 9 | 1.18e-01 | 0.301000 | 1.84e-01 |
REACTOME IRS MEDIATED SIGNALLING | 47 | 3.58e-04 | 0.301000 | 1.82e-03 |
REACTOME PLATELET SENSITIZATION BY LDL | 16 | 3.73e-02 | 0.301000 | 7.50e-02 |
REACTOME RESPIRATORY ELECTRON TRANSPORT | 86 | 1.50e-06 | 0.300000 | 1.80e-05 |
REACTOME TRANSCRIPTIONAL REGULATION BY RUNX3 | 92 | 6.53e-07 | 0.300000 | 9.13e-06 |
REACTOME NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 11 | 8.52e-02 | 0.300000 | 1.43e-01 |
REACTOME G PROTEIN ACTIVATION | 24 | 1.10e-02 | 0.300000 | 2.87e-02 |
REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 35 | 2.16e-03 | 0.299000 | 7.92e-03 |
REACTOME FASL CD95L SIGNALING | 5 | 2.47e-01 | 0.299000 | 3.27e-01 |
REACTOME ORC1 REMOVAL FROM CHROMATIN | 69 | 1.70e-05 | 0.299000 | 1.47e-04 |
REACTOME TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 7.28e-02 | 0.299000 | 1.27e-01 |
REACTOME RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 25 | 9.75e-03 | 0.299000 | 2.61e-02 |
REACTOME KERATINIZATION | 215 | 4.15e-14 | -0.298000 | 2.33e-12 |
REACTOME SYNTHESIS OF PC | 27 | 7.29e-03 | 0.298000 | 2.06e-02 |
REACTOME TRANSCRIPTIONAL REGULATION BY TP53 | 327 | 1.42e-20 | 0.298000 | 1.79e-18 |
REACTOME DARPP 32 EVENTS | 24 | 1.15e-02 | 0.298000 | 2.97e-02 |
REACTOME CREB3 FACTORS ACTIVATE GENES | 7 | 1.72e-01 | 0.298000 | 2.48e-01 |
REACTOME TRANSCRIPTIONAL REGULATION BY NPAS4 | 28 | 6.40e-03 | 0.298000 | 1.88e-02 |
REACTOME HCMV LATE EVENTS | 49 | 3.12e-04 | 0.298000 | 1.63e-03 |
REACTOME ERYTHROPOIETIN ACTIVATES RAS | 14 | 5.39e-02 | 0.297000 | 1.00e-01 |
REACTOME HIV LIFE CYCLE | 131 | 4.13e-09 | 0.297000 | 1.02e-07 |
REACTOME MITOTIC G1 PHASE AND G1 S TRANSITION | 144 | 7.57e-10 | 0.297000 | 2.09e-08 |
REACTOME SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 52 | 2.19e-04 | 0.296000 | 1.23e-03 |
REACTOME OPSINS | 7 | 1.75e-01 | -0.296000 | 2.51e-01 |
REACTOME RHO GTPASES ACTIVATE WASPS AND WAVES | 34 | 2.84e-03 | 0.296000 | 9.87e-03 |
REACTOME CIRCADIAN CLOCK | 65 | 3.72e-05 | 0.296000 | 2.86e-04 |
REACTOME SIGNALING BY KIT IN DISEASE | 20 | 2.21e-02 | 0.296000 | 4.95e-02 |
REACTOME INTERLEUKIN 17 SIGNALING | 66 | 3.28e-05 | 0.295000 | 2.59e-04 |
REACTOME GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 42 | 9.29e-04 | 0.295000 | 3.97e-03 |
REACTOME NUCLEOTIDE EXCISION REPAIR | 106 | 1.49e-07 | 0.295000 | 2.41e-06 |
REACTOME POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 24 | 1.23e-02 | 0.295000 | 3.14e-02 |
REACTOME LYSOSPHINGOLIPID AND LPA RECEPTORS | 9 | 1.26e-01 | 0.294000 | 1.95e-01 |
REACTOME RESOLUTION OF ABASIC SITES AP SITES | 37 | 1.95e-03 | 0.294000 | 7.28e-03 |
REACTOME FOLDING OF ACTIN BY CCT TRIC | 10 | 1.07e-01 | 0.294000 | 1.71e-01 |
REACTOME MEIOSIS | 55 | 1.60e-04 | 0.294000 | 9.79e-04 |
REACTOME CELLULAR RESPONSE TO HEAT STRESS | 94 | 8.58e-07 | 0.293000 | 1.17e-05 |
REACTOME CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 60 | 8.48e-05 | 0.293000 | 5.76e-04 |
REACTOME REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 76 | 9.77e-06 | 0.293000 | 9.31e-05 |
REACTOME ACTIVATED NTRK2 SIGNALS THROUGH FYN | 7 | 1.79e-01 | 0.293000 | 2.56e-01 |
REACTOME COBALAMIN CBL METABOLISM | 6 | 2.14e-01 | 0.293000 | 2.92e-01 |
REACTOME ORGANIC ANION TRANSPORTERS | 10 | 1.09e-01 | 0.293000 | 1.73e-01 |
REACTOME SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 53 | 2.22e-04 | 0.293000 | 1.24e-03 |
REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 7.28e-03 | 0.293000 | 2.06e-02 |
REACTOME LAGGING STRAND SYNTHESIS | 19 | 2.71e-02 | 0.293000 | 5.78e-02 |
REACTOME BASE EXCISION REPAIR | 44 | 7.71e-04 | 0.293000 | 3.44e-03 |
REACTOME WNT MEDIATED ACTIVATION OF DVL | 8 | 1.51e-01 | 0.293000 | 2.24e-01 |
REACTOME ELECTRIC TRANSMISSION ACROSS GAP JUNCTIONS | 5 | 2.57e-01 | 0.293000 | 3.39e-01 |
REACTOME SYNTHESIS OF DOLICHYL PHOSPHATE | 6 | 2.14e-01 | 0.293000 | 2.92e-01 |
REACTOME MITOCHONDRIAL PROTEIN IMPORT | 51 | 2.97e-04 | 0.293000 | 1.57e-03 |
REACTOME HEDGEHOG LIGAND BIOGENESIS | 63 | 5.85e-05 | 0.293000 | 4.19e-04 |
REACTOME PROTEIN FOLDING | 94 | 9.43e-07 | 0.292000 | 1.23e-05 |
REACTOME SIGNALING BY NUCLEAR RECEPTORS | 226 | 3.22e-14 | 0.292000 | 1.94e-12 |
REACTOME SIGNALING BY PDGFR IN DISEASE | 20 | 2.36e-02 | 0.292000 | 5.21e-02 |
REACTOME PCP CE PATHWAY | 90 | 1.63e-06 | 0.292000 | 1.93e-05 |
REACTOME VITAMIN B1 THIAMIN METABOLISM | 5 | 2.58e-01 | 0.292000 | 3.39e-01 |
REACTOME ATTENUATION PHASE | 27 | 8.62e-03 | 0.292000 | 2.36e-02 |
REACTOME ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 1.10e-01 | 0.292000 | 1.75e-01 |
REACTOME PINK1 PRKN MEDIATED MITOPHAGY | 19 | 2.77e-02 | 0.292000 | 5.87e-02 |
REACTOME MITOTIC PROPHASE | 76 | 1.08e-05 | 0.292000 | 1.01e-04 |
REACTOME STABILIZATION OF P53 | 54 | 2.08e-04 | 0.292000 | 1.20e-03 |
REACTOME KERATAN SULFATE BIOSYNTHESIS | 27 | 8.76e-03 | 0.291000 | 2.39e-02 |
REACTOME TRNA PROCESSING | 91 | 1.63e-06 | 0.291000 | 1.93e-05 |
REACTOME RECYCLING OF EIF2 GDP | 7 | 1.83e-01 | 0.290000 | 2.60e-01 |
REACTOME SUMOYLATION OF RNA BINDING PROTEINS | 44 | 8.53e-04 | 0.290000 | 3.73e-03 |
REACTOME DNA REPAIR | 265 | 3.58e-16 | 0.290000 | 2.78e-14 |
REACTOME PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 57 | 1.51e-04 | 0.290000 | 9.45e-04 |
REACTOME KERATAN SULFATE KERATIN METABOLISM | 33 | 3.95e-03 | 0.290000 | 1.31e-02 |
REACTOME ER QUALITY CONTROL COMPARTMENT ERQC | 20 | 2.49e-02 | 0.290000 | 5.45e-02 |
REACTOME RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 16 | 4.49e-02 | 0.290000 | 8.61e-02 |
REACTOME ESTABLISHMENT OF SISTER CHROMATID COHESION | 8 | 1.56e-01 | 0.290000 | 2.30e-01 |
REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 24 | 1.41e-02 | 0.289000 | 3.48e-02 |
REACTOME NR1H2 NR1H3 REGULATE GENE EXPRESSION TO CONTROL BILE ACID HOMEOSTASIS | 9 | 1.33e-01 | 0.289000 | 2.03e-01 |
REACTOME HOMOLOGY DIRECTED REPAIR | 96 | 9.43e-07 | 0.289000 | 1.23e-05 |
REACTOME TRANSLESION SYNTHESIS BY POLH | 17 | 3.89e-02 | 0.289000 | 7.75e-02 |
REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 7.03e-03 | 0.289000 | 2.01e-02 |
REACTOME DNA DOUBLE STRAND BREAK REPAIR | 126 | 2.05e-08 | 0.289000 | 3.88e-07 |
REACTOME HSF1 DEPENDENT TRANSACTIVATION | 37 | 2.36e-03 | 0.289000 | 8.47e-03 |
REACTOME DIGESTION AND ABSORPTION | 24 | 1.43e-02 | -0.289000 | 3.53e-02 |
REACTOME MET ACTIVATES PI3K AKT SIGNALING | 6 | 2.21e-01 | 0.289000 | 2.98e-01 |
REACTOME TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 41 | 1.40e-03 | 0.288000 | 5.55e-03 |
REACTOME SIGNALING BY ERYTHROPOIETIN | 25 | 1.27e-02 | 0.288000 | 3.19e-02 |
REACTOME HEME BIOSYNTHESIS | 13 | 7.24e-02 | 0.288000 | 1.26e-01 |
REACTOME RESOLUTION OF D LOOP STRUCTURES | 32 | 4.90e-03 | 0.287000 | 1.53e-02 |
REACTOME GABA RECEPTOR ACTIVATION | 57 | 1.79e-04 | 0.287000 | 1.07e-03 |
REACTOME AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 9 | 1.37e-01 | 0.286000 | 2.07e-01 |
REACTOME SURFACTANT METABOLISM | 27 | 1.00e-02 | 0.286000 | 2.67e-02 |
REACTOME TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 75 | 1.81e-05 | 0.286000 | 1.54e-04 |
REACTOME RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 8.79e-03 | 0.286000 | 2.39e-02 |
REACTOME HUR ELAVL1 BINDS AND STABILIZES MRNA | 8 | 1.61e-01 | 0.286000 | 2.36e-01 |
REACTOME CALNEXIN CALRETICULIN CYCLE | 25 | 1.33e-02 | 0.286000 | 3.34e-02 |
REACTOME REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 11 | 1.01e-01 | 0.286000 | 1.63e-01 |
REACTOME RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 45 | 9.20e-04 | 0.285000 | 3.95e-03 |
REACTOME SOS MEDIATED SIGNALLING | 7 | 1.91e-01 | 0.285000 | 2.69e-01 |
REACTOME POLYMERASE SWITCHING | 13 | 7.50e-02 | 0.285000 | 1.29e-01 |
REACTOME SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 8.72e-02 | 0.285000 | 1.46e-01 |
REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 6.47e-02 | 0.285000 | 1.16e-01 |
REACTOME SIGNALING BY NTRK3 TRKC | 16 | 4.84e-02 | 0.285000 | 9.11e-02 |
REACTOME DEGRADATION OF GLI1 BY THE PROTEASOME | 58 | 1.74e-04 | 0.285000 | 1.04e-03 |
REACTOME FLT3 SIGNALING | 38 | 2.37e-03 | 0.285000 | 8.49e-03 |
REACTOME REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 86 | 4.90e-06 | 0.285000 | 5.09e-05 |
REACTOME INSULIN RECEPTOR SIGNALLING CASCADE | 53 | 3.38e-04 | 0.284000 | 1.74e-03 |
REACTOME DEGRADATION OF AXIN | 53 | 3.42e-04 | 0.284000 | 1.76e-03 |
REACTOME MRNA SPLICING MINOR PATHWAY | 48 | 6.57e-04 | 0.284000 | 2.98e-03 |
REACTOME FGFR1B LIGAND BINDING AND ACTIVATION | 6 | 2.28e-01 | 0.284000 | 3.07e-01 |
REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 34 | 4.17e-03 | 0.284000 | 1.35e-02 |
REACTOME RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 66 | 6.63e-05 | 0.284000 | 4.66e-04 |
REACTOME FORMATION OF TC NER PRE INCISION COMPLEX | 50 | 5.19e-04 | 0.284000 | 2.49e-03 |
REACTOME GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 81 | 1.01e-05 | 0.284000 | 9.50e-05 |
REACTOME FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 11 | 1.03e-01 | 0.284000 | 1.66e-01 |
REACTOME AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 3.56e-04 | 0.283000 | 1.82e-03 |
REACTOME GLYCOSAMINOGLYCAN METABOLISM | 115 | 1.49e-07 | 0.283000 | 2.41e-06 |
REACTOME MET RECEPTOR ACTIVATION | 6 | 2.30e-01 | -0.283000 | 3.09e-01 |
REACTOME INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 34 | 4.26e-03 | 0.283000 | 1.37e-02 |
REACTOME REGULATION OF TLR BY ENDOGENOUS LIGAND | 20 | 2.84e-02 | -0.283000 | 6.00e-02 |
REACTOME SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 7.75e-02 | 0.283000 | 1.32e-01 |
REACTOME DNA REPLICATION INITIATION | 7 | 1.95e-01 | 0.283000 | 2.73e-01 |
REACTOME TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 8.40e-03 | 0.283000 | 2.31e-02 |
REACTOME VITAMIN C ASCORBATE METABOLISM | 8 | 1.66e-01 | 0.283000 | 2.41e-01 |
REACTOME NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 24 | 1.65e-02 | 0.283000 | 3.96e-02 |
REACTOME BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 10 | 1.22e-01 | 0.282000 | 1.89e-01 |
REACTOME MITOCHONDRIAL TRANSLATION | 92 | 2.91e-06 | 0.282000 | 3.12e-05 |
REACTOME PTK6 REGULATES RTKS AND THEIR EFFECTORS AKT1 AND DOK1 | 9 | 1.43e-01 | 0.282000 | 2.16e-01 |
REACTOME UB SPECIFIC PROCESSING PROTEASES | 151 | 2.23e-09 | 0.282000 | 5.78e-08 |
REACTOME GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 14 | 6.82e-02 | 0.281000 | 1.21e-01 |
REACTOME NUCLEAR EVENTS STIMULATED BY ALK SIGNALING IN CANCER | 18 | 3.87e-02 | 0.281000 | 7.72e-02 |
REACTOME DUAL INCISION IN TC NER | 62 | 1.26e-04 | 0.281000 | 8.15e-04 |
REACTOME EPH EPHRIN MEDIATED REPULSION OF CELLS | 50 | 5.81e-04 | 0.281000 | 2.71e-03 |
REACTOME REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 14 | 6.87e-02 | 0.281000 | 1.22e-01 |
REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | 49 | 6.81e-04 | 0.280000 | 3.07e-03 |
REACTOME REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 3.95e-02 | 0.280000 | 7.84e-02 |
REACTOME THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 137 | 1.42e-08 | 0.280000 | 2.81e-07 |
REACTOME COPI MEDIATED ANTEROGRADE TRANSPORT | 101 | 1.11e-06 | 0.280000 | 1.41e-05 |
REACTOME INOSITOL PHOSPHATE METABOLISM | 45 | 1.14e-03 | 0.280000 | 4.68e-03 |
REACTOME MYD88 INDEPENDENT TLR4 CASCADE | 103 | 9.07e-07 | 0.280000 | 1.21e-05 |
REACTOME HSF1 ACTIVATION | 29 | 9.22e-03 | 0.279000 | 2.48e-02 |
REACTOME TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 35 | 4.24e-03 | 0.279000 | 1.36e-02 |
REACTOME EPHB MEDIATED FORWARD SIGNALING | 40 | 2.25e-03 | 0.279000 | 8.16e-03 |
REACTOME HIV INFECTION | 208 | 3.67e-12 | 0.279000 | 1.43e-10 |
REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 10 | 1.27e-01 | 0.279000 | 1.96e-01 |
REACTOME REGULATION OF NF KAPPA B SIGNALING | 17 | 4.69e-02 | 0.278000 | 8.92e-02 |
REACTOME DEUBIQUITINATION | 220 | 1.04e-12 | 0.278000 | 4.22e-11 |
REACTOME PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 21 | 2.74e-02 | 0.278000 | 5.82e-02 |
REACTOME VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 3.60e-02 | 0.278000 | 7.32e-02 |
REACTOME COPII MEDIATED VESICLE TRANSPORT | 65 | 1.07e-04 | 0.278000 | 7.11e-04 |
REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 1.42e-02 | 0.278000 | 3.51e-02 |
REACTOME INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 14 | 7.21e-02 | 0.278000 | 1.26e-01 |
REACTOME SIGNALING BY EGFR | 49 | 7.72e-04 | 0.278000 | 3.44e-03 |
REACTOME SIGNALING BY NOTCH2 | 31 | 7.52e-03 | 0.277000 | 2.11e-02 |
REACTOME MATURATION OF SARS COV 2 NUCLEOPROTEIN | 15 | 6.33e-02 | 0.277000 | 1.14e-01 |
REACTOME NUCLEAR IMPORT OF REV PROTEIN | 31 | 7.68e-03 | 0.277000 | 2.15e-02 |
REACTOME RHO GTPASES ACTIVATE FORMINS | 128 | 6.42e-08 | 0.276000 | 1.12e-06 |
REACTOME BIOSYNTHESIS OF MARESINS | 8 | 1.76e-01 | -0.276000 | 2.52e-01 |
REACTOME G ALPHA 12 13 SIGNALLING EVENTS | 74 | 3.97e-05 | 0.276000 | 3.02e-04 |
REACTOME NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 33 | 6.05e-03 | 0.276000 | 1.79e-02 |
REACTOME RUNX3 REGULATES CDKN1A TRANSCRIPTION | 7 | 2.06e-01 | 0.276000 | 2.84e-01 |
REACTOME SIGNALING BY HEDGEHOG | 146 | 8.52e-09 | 0.276000 | 1.79e-07 |
REACTOME TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 36 | 4.20e-03 | 0.276000 | 1.35e-02 |
REACTOME NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 1.14e-01 | 0.275000 | 1.79e-01 |
REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | 18 | 4.34e-02 | 0.275000 | 8.39e-02 |
REACTOME SEMA4D MEDIATED INHIBITION OF CELL ATTACHMENT AND MIGRATION | 8 | 1.78e-01 | 0.275000 | 2.55e-01 |
REACTOME FGFR3 LIGAND BINDING AND ACTIVATION | 12 | 9.94e-02 | 0.275000 | 1.61e-01 |
REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | 7 | 2.09e-01 | 0.274000 | 2.87e-01 |
REACTOME RNA POLYMERASE III TRANSCRIPTION | 41 | 2.37e-03 | 0.274000 | 8.49e-03 |
REACTOME MUCOPOLYSACCHARIDOSES | 10 | 1.34e-01 | 0.274000 | 2.04e-01 |
REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | 65 | 1.33e-04 | 0.274000 | 8.50e-04 |
REACTOME METABOLISM OF RNA | 640 | 1.24e-32 | 0.274000 | 4.03e-30 |
REACTOME RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 22 | 2.62e-02 | 0.274000 | 5.66e-02 |
REACTOME TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 99 | 2.50e-06 | 0.274000 | 2.75e-05 |
REACTOME PROCESSING OF SMDT1 | 10 | 1.35e-01 | 0.273000 | 2.05e-01 |
REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 20 | 3.46e-02 | 0.273000 | 7.08e-02 |
REACTOME TRANSLESION SYNTHESIS BY POLK | 17 | 5.14e-02 | 0.273000 | 9.59e-02 |
REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 9 | 1.57e-01 | 0.273000 | 2.31e-01 |
REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 29 | 1.12e-02 | 0.272000 | 2.90e-02 |
REACTOME TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 16 | 5.94e-02 | 0.272000 | 1.09e-01 |
REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 13 | 8.93e-02 | 0.272000 | 1.49e-01 |
REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 7.09e-04 | 0.271000 | 3.18e-03 |
REACTOME APOPTOTIC EXECUTION PHASE | 43 | 2.08e-03 | 0.271000 | 7.69e-03 |
REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 171 | 9.65e-10 | -0.271000 | 2.62e-08 |
REACTOME TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 4.14e-02 | 0.270000 | 8.14e-02 |
REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION OF UNSATURATED FATTY ACIDS | 6 | 2.52e-01 | 0.270000 | 3.33e-01 |
REACTOME ARMS MEDIATED ACTIVATION | 7 | 2.16e-01 | 0.270000 | 2.93e-01 |
REACTOME ACTIVATION OF RAC1 DOWNSTREAM OF NMDARS | 7 | 2.16e-01 | 0.270000 | 2.93e-01 |
REACTOME SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 6.19e-02 | 0.270000 | 1.12e-01 |
REACTOME APOPTOSIS | 164 | 2.42e-09 | 0.270000 | 6.17e-08 |
REACTOME PHASE 4 RESTING MEMBRANE POTENTIAL | 19 | 4.19e-02 | 0.270000 | 8.21e-02 |
REACTOME RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF MYELOID CELLS | 7 | 2.17e-01 | 0.269000 | 2.94e-01 |
REACTOME REGULATION OF PTEN STABILITY AND ACTIVITY | 66 | 1.55e-04 | 0.269000 | 9.63e-04 |
REACTOME CARNITINE METABOLISM | 13 | 9.31e-02 | 0.269000 | 1.53e-01 |
REACTOME REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 14 | 8.15e-02 | 0.269000 | 1.38e-01 |
REACTOME DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 38 | 4.15e-03 | 0.269000 | 1.35e-02 |
REACTOME ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 20 | 3.75e-02 | 0.269000 | 7.53e-02 |
REACTOME REGULATION OF NPAS4 GENE EXPRESSION | 9 | 1.64e-01 | 0.268000 | 2.40e-01 |
REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 31 | 9.98e-03 | 0.267000 | 2.66e-02 |
REACTOME CLATHRIN MEDIATED ENDOCYTOSIS | 137 | 6.54e-08 | 0.267000 | 1.12e-06 |
REACTOME S PHASE | 156 | 8.55e-09 | 0.267000 | 1.79e-07 |
REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 19 | 4.42e-02 | 0.267000 | 8.52e-02 |
REACTOME IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 17 | 5.70e-02 | 0.267000 | 1.05e-01 |
REACTOME EXTRA NUCLEAR ESTROGEN SIGNALING | 74 | 7.28e-05 | 0.267000 | 5.03e-04 |
REACTOME CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 19 | 4.43e-02 | 0.266000 | 8.53e-02 |
REACTOME RELEASE OF APOPTOTIC FACTORS FROM THE MITOCHONDRIA | 5 | 3.02e-01 | 0.266000 | 3.85e-01 |
REACTOME TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 40 | 3.54e-03 | 0.266000 | 1.20e-02 |
REACTOME HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR IN THE PRESENCE OF LIGAND | 55 | 6.32e-04 | 0.266000 | 2.89e-03 |
REACTOME POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 25 | 2.13e-02 | 0.266000 | 4.83e-02 |
REACTOME DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 14 | 8.50e-02 | 0.266000 | 1.43e-01 |
REACTOME DNA REPLICATION | 123 | 3.48e-07 | 0.266000 | 5.31e-06 |
REACTOME SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 26 | 1.90e-02 | 0.266000 | 4.44e-02 |
REACTOME SHC RELATED EVENTS TRIGGERED BY IGF1R | 9 | 1.68e-01 | 0.266000 | 2.42e-01 |
REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 22 | 3.13e-02 | 0.265000 | 6.50e-02 |
REACTOME RHOJ GTPASE CYCLE | 50 | 1.19e-03 | 0.265000 | 4.83e-03 |
REACTOME SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 89 | 1.54e-05 | 0.265000 | 1.35e-04 |
REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 37 | 5.29e-03 | 0.265000 | 1.62e-02 |
REACTOME SIGNAL ATTENUATION | 10 | 1.47e-01 | 0.265000 | 2.20e-01 |
REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 1.28e-01 | 0.265000 | 1.98e-01 |
REACTOME SIGNALING BY ERBB2 IN CANCER | 25 | 2.20e-02 | 0.264000 | 4.95e-02 |
REACTOME HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 64 | 2.55e-04 | 0.264000 | 1.38e-03 |
REACTOME PLASMA LIPOPROTEIN CLEARANCE | 37 | 5.43e-03 | 0.264000 | 1.65e-02 |
REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 51 | 1.11e-03 | 0.264000 | 4.59e-03 |
REACTOME ER TO GOLGI ANTEROGRADE TRANSPORT | 151 | 2.15e-08 | 0.264000 | 4.02e-07 |
REACTOME GLYCOGEN METABOLISM | 22 | 3.23e-02 | 0.264000 | 6.68e-02 |
REACTOME GPER1 SIGNALING | 44 | 2.49e-03 | 0.263000 | 8.88e-03 |
REACTOME HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 40 | 3.94e-03 | 0.263000 | 1.31e-02 |
REACTOME SYNTHESIS OF DNA | 117 | 8.74e-07 | 0.263000 | 1.18e-05 |
REACTOME GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 25 | 2.29e-02 | 0.263000 | 5.07e-02 |
REACTOME DISEASES OF MITOTIC CELL CYCLE | 36 | 6.38e-03 | 0.263000 | 1.88e-02 |
REACTOME FICOLINS BIND TO REPETITIVE CARBOHYDRATE STRUCTURES ON THE TARGET CELL SURFACE | 5 | 3.10e-01 | -0.262000 | 3.93e-01 |
REACTOME NUCLEOTIDE BIOSYNTHESIS | 12 | 1.16e-01 | 0.262000 | 1.81e-01 |
REACTOME MAPK FAMILY SIGNALING CASCADES | 306 | 2.45e-15 | 0.262000 | 1.74e-13 |
REACTOME PREGNENOLONE BIOSYNTHESIS | 10 | 1.51e-01 | 0.262000 | 2.24e-01 |
REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 78 | 6.19e-05 | 0.262000 | 4.41e-04 |
REACTOME DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 19 | 4.80e-02 | 0.262000 | 9.07e-02 |
REACTOME ONCOGENIC MAPK SIGNALING | 76 | 7.74e-05 | 0.262000 | 5.32e-04 |
REACTOME TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 47 | 1.88e-03 | 0.262000 | 7.05e-03 |
REACTOME MET RECEPTOR RECYCLING | 10 | 1.51e-01 | 0.262000 | 2.24e-01 |
REACTOME DISINHIBITION OF SNARE FORMATION | 5 | 3.10e-01 | 0.262000 | 3.93e-01 |
REACTOME HCMV INFECTION | 91 | 1.57e-05 | 0.262000 | 1.37e-04 |
REACTOME CELL CYCLE | 588 | 1.17e-27 | 0.262000 | 2.39e-25 |
REACTOME DEGRADATION OF DVL | 55 | 7.89e-04 | 0.262000 | 3.49e-03 |
REACTOME PRC2 METHYLATES HISTONES AND DNA | 12 | 1.18e-01 | 0.260000 | 1.84e-01 |
REACTOME GLI PROTEINS BIND PROMOTERS OF HH RESPONSIVE GENES TO PROMOTE TRANSCRIPTION | 7 | 2.33e-01 | 0.260000 | 3.13e-01 |
REACTOME INTERLEUKIN 35 SIGNALLING | 12 | 1.19e-01 | 0.260000 | 1.85e-01 |
REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 45 | 2.62e-03 | 0.259000 | 9.23e-03 |
REACTOME SIGNALING BY PTK6 | 54 | 9.85e-04 | 0.259000 | 4.17e-03 |
REACTOME PHENYLALANINE METABOLISM | 5 | 3.17e-01 | 0.259000 | 3.99e-01 |
REACTOME GLUCOCORTICOID BIOSYNTHESIS | 10 | 1.57e-01 | -0.259000 | 2.31e-01 |
REACTOME CELL CYCLE CHECKPOINTS | 238 | 6.03e-12 | 0.258000 | 2.23e-10 |
REACTOME FANCONI ANEMIA PATHWAY | 33 | 1.02e-02 | 0.258000 | 2.72e-02 |
REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | 53 | 1.16e-03 | 0.258000 | 4.74e-03 |
REACTOME G2 M CHECKPOINTS | 125 | 6.35e-07 | 0.258000 | 9.00e-06 |
REACTOME CELL CYCLE MITOTIC | 468 | 8.67e-22 | 0.258000 | 1.18e-19 |
REACTOME TAK1 DEPENDENT IKK AND NF KAPPA B ACTIVATION | 41 | 4.38e-03 | 0.257000 | 1.40e-02 |
REACTOME ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 10 | 1.59e-01 | 0.257000 | 2.34e-01 |
REACTOME G1 S SPECIFIC TRANSCRIPTION | 28 | 1.87e-02 | 0.257000 | 4.40e-02 |
REACTOME TRANSPORT OF NUCLEOTIDE SUGARS | 8 | 2.09e-01 | 0.256000 | 2.87e-01 |
REACTOME NGF INDEPENDANT TRKA ACTIVATION | 5 | 3.21e-01 | 0.256000 | 4.04e-01 |
REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 11 | 1.41e-01 | 0.256000 | 2.13e-01 |
REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX IN CANCER | 8 | 2.10e-01 | 0.256000 | 2.87e-01 |
REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 16 | 7.62e-02 | 0.256000 | 1.31e-01 |
REACTOME INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 291 | 5.06e-14 | 0.256000 | 2.75e-12 |
REACTOME ORGANIC ANION TRANSPORT | 5 | 3.22e-01 | -0.256000 | 4.05e-01 |
REACTOME AMINO ACIDS REGULATE MTORC1 | 48 | 2.17e-03 | 0.256000 | 7.93e-03 |
REACTOME TERMINATION OF TRANSLESION DNA SYNTHESIS | 31 | 1.37e-02 | 0.256000 | 3.41e-02 |
REACTOME RHOQ GTPASE CYCLE | 57 | 8.38e-04 | 0.256000 | 3.68e-03 |
REACTOME GLYCOGEN SYNTHESIS | 13 | 1.11e-01 | 0.255000 | 1.76e-01 |
REACTOME HOST INTERACTIONS OF HIV FACTORS | 121 | 1.20e-06 | 0.255000 | 1.49e-05 |
REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | 41 | 4.74e-03 | 0.255000 | 1.50e-02 |
REACTOME INTRA GOLGI TRAFFIC | 42 | 4.27e-03 | 0.255000 | 1.37e-02 |
REACTOME MISMATCH REPAIR | 15 | 8.77e-02 | 0.255000 | 1.47e-01 |
REACTOME RNA POLYMERASE I PROMOTER ESCAPE | 27 | 2.20e-02 | 0.255000 | 4.95e-02 |
REACTOME RNA POLYMERASE I TRANSCRIPTION TERMINATION | 26 | 2.47e-02 | 0.254000 | 5.40e-02 |
REACTOME RND2 GTPASE CYCLE | 40 | 5.40e-03 | 0.254000 | 1.64e-02 |
REACTOME FORMATION OF INCISION COMPLEX IN GG NER | 40 | 5.46e-03 | 0.254000 | 1.65e-02 |
REACTOME SIGNALING BY NOTCH | 176 | 6.10e-09 | 0.254000 | 1.40e-07 |
REACTOME CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 98 | 1.44e-05 | 0.253000 | 1.29e-04 |
REACTOME SENSORY PERCEPTION OF SALTY TASTE | 6 | 2.83e-01 | -0.253000 | 3.65e-01 |
REACTOME TYPE I HEMIDESMOSOME ASSEMBLY | 11 | 1.46e-01 | -0.253000 | 2.19e-01 |
REACTOME FATTY ACIDS | 15 | 9.00e-02 | -0.253000 | 1.49e-01 |
REACTOME REGULATION OF RAS BY GAPS | 66 | 3.83e-04 | 0.253000 | 1.92e-03 |
REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 50 | 2.00e-03 | 0.253000 | 7.42e-03 |
REACTOME MTORC1 MEDIATED SIGNALLING | 21 | 4.52e-02 | 0.252000 | 8.65e-02 |
REACTOME HORMONE LIGAND BINDING RECEPTORS | 12 | 1.30e-01 | -0.252000 | 2.00e-01 |
REACTOME RHOBTB2 GTPASE CYCLE | 22 | 4.07e-02 | 0.252000 | 8.04e-02 |
REACTOME SIGNALLING TO ERKS | 34 | 1.10e-02 | 0.252000 | 2.86e-02 |
REACTOME IRAK4 DEFICIENCY TLR2 4 | 17 | 7.21e-02 | -0.252000 | 1.26e-01 |
REACTOME MITOTIC METAPHASE AND ANAPHASE | 216 | 1.72e-10 | 0.252000 | 5.28e-09 |
REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | 9 | 1.92e-01 | 0.251000 | 2.69e-01 |
REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 17 | 7.28e-02 | 0.251000 | 1.27e-01 |
REACTOME REGULATION OF IFNA IFNB SIGNALING | 26 | 2.68e-02 | -0.251000 | 5.73e-02 |
REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV 1 INFECTION | 5 | 3.31e-01 | 0.251000 | 4.15e-01 |
REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 16 | 8.24e-02 | 0.251000 | 1.40e-01 |
REACTOME PROTEIN UBIQUITINATION | 58 | 9.49e-04 | 0.251000 | 4.04e-03 |
REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | 23 | 3.74e-02 | -0.251000 | 7.51e-02 |
REACTOME DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 60 | 7.84e-04 | 0.251000 | 3.48e-03 |
REACTOME MITOTIC SPINDLE CHECKPOINT | 101 | 1.33e-05 | 0.250000 | 1.21e-04 |
REACTOME M PHASE | 328 | 6.13e-15 | 0.250000 | 4.00e-13 |
REACTOME CARGO CONCENTRATION IN THE ER | 31 | 1.61e-02 | 0.250000 | 3.89e-02 |
REACTOME SARS COV 2 MODULATES AUTOPHAGY | 11 | 1.52e-01 | 0.249000 | 2.25e-01 |
REACTOME NOD1 2 SIGNALING PATHWAY | 33 | 1.31e-02 | 0.249000 | 3.31e-02 |
REACTOME HEDGEHOG OFF STATE | 110 | 6.17e-06 | 0.249000 | 6.24e-05 |
REACTOME INTERLEUKIN 6 FAMILY SIGNALING | 24 | 3.45e-02 | 0.249000 | 7.08e-02 |
REACTOME NETRIN 1 SIGNALING | 48 | 2.81e-03 | 0.249000 | 9.79e-03 |
REACTOME DEADENYLATION OF MRNA | 21 | 4.82e-02 | 0.249000 | 9.09e-02 |
REACTOME TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 33 | 1.34e-02 | 0.249000 | 3.35e-02 |
REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 32 | 1.50e-02 | 0.248000 | 3.67e-02 |
REACTOME DISEASES OF BASE EXCISION REPAIR | 5 | 3.37e-01 | 0.248000 | 4.20e-01 |
REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 1.08e-01 | 0.248000 | 1.73e-01 |
REACTOME SPHINGOLIPID METABOLISM | 78 | 1.54e-04 | 0.248000 | 9.57e-04 |
REACTOME GLUCAGON TYPE LIGAND RECEPTORS | 32 | 1.53e-02 | 0.248000 | 3.73e-02 |
REACTOME KEAP1 NFE2L2 PATHWAY | 102 | 1.53e-05 | 0.248000 | 1.35e-04 |
REACTOME HCMV EARLY EVENTS | 69 | 3.75e-04 | 0.247000 | 1.88e-03 |
REACTOME ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 42 | 5.51e-03 | 0.247000 | 1.66e-02 |
REACTOME SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 606 | 2.31e-25 | 0.246000 | 4.18e-23 |
REACTOME TRNA AMINOACYLATION | 24 | 3.71e-02 | 0.246000 | 7.49e-02 |
REACTOME DNA REPLICATION PRE INITIATION | 95 | 3.44e-05 | 0.246000 | 2.68e-04 |
REACTOME G PROTEIN BETA GAMMA SIGNALLING | 30 | 1.98e-02 | 0.246000 | 4.57e-02 |
REACTOME ACTIVATION OF PUMA AND TRANSLOCATION TO MITOCHONDRIA | 9 | 2.02e-01 | 0.246000 | 2.80e-01 |
REACTOME SEPARATION OF SISTER CHROMATIDS | 174 | 2.17e-08 | 0.246000 | 4.02e-07 |
REACTOME RESOLUTION OF SISTER CHROMATID COHESION | 112 | 7.07e-06 | 0.245000 | 6.98e-05 |
REACTOME RHO GTPASE EFFECTORS | 245 | 3.44e-11 | 0.245000 | 1.17e-09 |
REACTOME DUAL INCISION IN GG NER | 39 | 8.04e-03 | 0.245000 | 2.23e-02 |
REACTOME GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 32 | 1.64e-02 | 0.245000 | 3.94e-02 |
REACTOME NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 38 | 8.98e-03 | 0.245000 | 2.44e-02 |
REACTOME TIE2 SIGNALING | 18 | 7.22e-02 | 0.245000 | 1.26e-01 |
REACTOME DISEASES OF DNA REPAIR | 48 | 3.37e-03 | 0.245000 | 1.15e-02 |
REACTOME HIGHLY CALCIUM PERMEABLE NICOTINIC ACETYLCHOLINE RECEPTORS | 9 | 2.04e-01 | -0.245000 | 2.82e-01 |
REACTOME RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 2.52e-02 | 0.244000 | 5.50e-02 |
REACTOME CROSSLINKING OF COLLAGEN FIBRILS | 16 | 9.07e-02 | 0.244000 | 1.50e-01 |
REACTOME TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 34 | 1.37e-02 | 0.244000 | 3.41e-02 |
REACTOME JOSEPHIN DOMAIN DUBS | 10 | 1.82e-01 | 0.244000 | 2.59e-01 |
REACTOME CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 1.61e-01 | 0.244000 | 2.36e-01 |
REACTOME HDR THROUGH MMEJ ALT NHEJ | 11 | 1.61e-01 | 0.244000 | 2.36e-01 |
REACTOME CHL1 INTERACTIONS | 9 | 2.05e-01 | 0.244000 | 2.84e-01 |
REACTOME SIGNALING BY INSULIN RECEPTOR | 80 | 1.63e-04 | 0.244000 | 9.93e-04 |
REACTOME FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 1.84e-01 | 0.242000 | 2.61e-01 |
REACTOME ESTROGEN BIOSYNTHESIS | 6 | 3.04e-01 | 0.242000 | 3.87e-01 |
REACTOME DEFECTS IN COBALAMIN B12 METABOLISM | 12 | 1.47e-01 | 0.242000 | 2.20e-01 |
REACTOME SEROTONIN RECEPTORS | 11 | 1.65e-01 | 0.242000 | 2.40e-01 |
REACTOME CELLULAR RESPONSES TO STIMULI | 695 | 8.51e-28 | 0.242000 | 2.08e-25 |
REACTOME VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 42 | 6.73e-03 | 0.242000 | 1.96e-02 |
REACTOME ASSEMBLY OF THE ORC COMPLEX AT THE ORIGIN OF REPLICATION | 9 | 2.09e-01 | 0.242000 | 2.87e-01 |
REACTOME O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 35 | 1.34e-02 | 0.241000 | 3.35e-02 |
REACTOME EGFR DOWNREGULATION | 30 | 2.21e-02 | 0.241000 | 4.95e-02 |
REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 288 | 1.62e-12 | 0.241000 | 6.43e-11 |
REACTOME PTK6 REGULATES CELL CYCLE | 6 | 3.06e-01 | 0.241000 | 3.89e-01 |
REACTOME SIGNALING BY ROBO RECEPTORS | 202 | 3.41e-09 | 0.241000 | 8.54e-08 |
REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 30 | 2.28e-02 | 0.240000 | 5.06e-02 |
REACTOME IRON UPTAKE AND TRANSPORT | 56 | 1.87e-03 | 0.240000 | 7.04e-03 |
REACTOME VOLTAGE GATED POTASSIUM CHANNELS | 42 | 7.17e-03 | 0.240000 | 2.03e-02 |
REACTOME SIGNALING BY RECEPTOR TYROSINE KINASES | 507 | 1.67e-20 | 0.240000 | 1.94e-18 |
REACTOME ABC TRANSPORTER DISORDERS | 75 | 3.37e-04 | 0.239000 | 1.74e-03 |
REACTOME GLYCOSPHINGOLIPID METABOLISM | 37 | 1.18e-02 | 0.239000 | 3.02e-02 |
REACTOME HDL REMODELING | 10 | 1.90e-01 | 0.239000 | 2.68e-01 |
REACTOME RHOD GTPASE CYCLE | 48 | 4.16e-03 | 0.239000 | 1.35e-02 |
REACTOME GENE SILENCING BY RNA | 73 | 4.18e-04 | 0.239000 | 2.07e-03 |
REACTOME FATTY ACIDS BOUND TO GPR40 FFAR1 REGULATE INSULIN SECRETION | 8 | 2.43e-01 | 0.238000 | 3.23e-01 |
REACTOME ATORVASTATIN ADME | 9 | 2.16e-01 | -0.238000 | 2.93e-01 |
REACTOME WAX AND PLASMALOGEN BIOSYNTHESIS | 5 | 3.57e-01 | 0.238000 | 4.40e-01 |
REACTOME RAC2 GTPASE CYCLE | 80 | 2.30e-04 | 0.238000 | 1.28e-03 |
REACTOME RHO GTPASE CYCLE | 411 | 1.02e-16 | 0.238000 | 8.28e-15 |
REACTOME G2 M DNA DAMAGE CHECKPOINT | 54 | 2.51e-03 | 0.238000 | 8.91e-03 |
REACTOME PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 14 | 1.24e-01 | 0.238000 | 1.92e-01 |
REACTOME NEDDYLATION | 228 | 6.59e-10 | 0.237000 | 1.85e-08 |
REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 15 | 1.12e-01 | 0.237000 | 1.78e-01 |
REACTOME REGULATION OF LIPID METABOLISM BY PPARALPHA | 113 | 1.38e-05 | 0.237000 | 1.24e-04 |
REACTOME OTHER INTERLEUKIN SIGNALING | 22 | 5.49e-02 | 0.236000 | 1.02e-01 |
REACTOME SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 25 | 4.08e-02 | 0.236000 | 8.04e-02 |
REACTOME OPIOID SIGNALLING | 88 | 1.26e-04 | 0.236000 | 8.15e-04 |
REACTOME NUCLEAR EVENTS MEDIATED BY NFE2L2 | 76 | 3.67e-04 | 0.236000 | 1.85e-03 |
REACTOME GLUTAMATE AND GLUTAMINE METABOLISM | 11 | 1.75e-01 | 0.236000 | 2.52e-01 |
REACTOME NUCLEAR ENVELOPE BREAKDOWN | 49 | 4.28e-03 | 0.236000 | 1.37e-02 |
REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | 11 | 1.76e-01 | 0.236000 | 2.52e-01 |
REACTOME MEMBRANE TRAFFICKING | 592 | 7.10e-23 | 0.236000 | 1.05e-20 |
REACTOME SENSORY PERCEPTION OF TASTE | 47 | 5.23e-03 | -0.235000 | 1.61e-02 |
REACTOME TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 29 | 2.83e-02 | 0.235000 | 5.99e-02 |
REACTOME INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 196 | 1.28e-08 | 0.235000 | 2.59e-07 |
REACTOME AUTOPHAGY | 135 | 2.31e-06 | 0.235000 | 2.56e-05 |
REACTOME IRAK1 RECRUITS IKK COMPLEX | 12 | 1.59e-01 | 0.235000 | 2.33e-01 |
REACTOME TBC RABGAPS | 41 | 9.24e-03 | 0.235000 | 2.48e-02 |
REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 50 | 4.07e-03 | 0.235000 | 1.34e-02 |
REACTOME MITOCHONDRIAL BIOGENESIS | 65 | 1.06e-03 | 0.235000 | 4.45e-03 |
REACTOME SIGNALING BY ERBB4 | 57 | 2.19e-03 | 0.234000 | 7.98e-03 |
REACTOME INTERLEUKIN 1 SIGNALING | 109 | 2.35e-05 | 0.234000 | 1.95e-04 |
REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 73 | 5.37e-04 | 0.234000 | 2.55e-03 |
REACTOME PROGRAMMED CELL DEATH | 194 | 1.79e-08 | 0.234000 | 3.43e-07 |
REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | 15 | 1.17e-01 | 0.234000 | 1.83e-01 |
REACTOME SMOOTH MUSCLE CONTRACTION | 40 | 1.04e-02 | 0.234000 | 2.76e-02 |
REACTOME PI5P REGULATES TP53 ACETYLATION | 8 | 2.53e-01 | 0.234000 | 3.34e-01 |
REACTOME ASPIRIN ADME | 43 | 8.03e-03 | -0.234000 | 2.23e-02 |
REACTOME FOXO MEDIATED TRANSCRIPTION | 64 | 1.24e-03 | 0.233000 | 5.00e-03 |
REACTOME ASPARAGINE N LINKED GLYCOSYLATION | 294 | 5.15e-12 | 0.233000 | 1.95e-10 |
REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | 34 | 1.85e-02 | 0.233000 | 4.36e-02 |
REACTOME REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 82 | 2.67e-04 | 0.233000 | 1.44e-03 |
REACTOME NUCLEAR ENVELOPE NE REASSEMBLY | 72 | 6.38e-04 | 0.233000 | 2.91e-03 |
REACTOME SIGNALING BY ERBB2 | 49 | 4.84e-03 | 0.233000 | 1.52e-02 |
REACTOME HIGHLY SODIUM PERMEABLE POSTSYNAPTIC ACETYLCHOLINE NICOTINIC RECEPTORS | 7 | 2.87e-01 | 0.232000 | 3.69e-01 |
REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | 20 | 7.22e-02 | 0.232000 | 1.26e-01 |
REACTOME RAC3 GTPASE CYCLE | 84 | 2.36e-04 | 0.232000 | 1.30e-03 |
REACTOME SUMOYLATION OF INTRACELLULAR RECEPTORS | 29 | 3.08e-02 | 0.232000 | 6.42e-02 |
REACTOME REGULATION OF KIT SIGNALING | 16 | 1.09e-01 | 0.231000 | 1.74e-01 |
REACTOME REGULATION OF SIGNALING BY CBL | 22 | 6.07e-02 | 0.231000 | 1.11e-01 |
REACTOME E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 41 | 1.05e-02 | 0.231000 | 2.77e-02 |
REACTOME PROTEIN LOCALIZATION | 144 | 1.67e-06 | 0.231000 | 1.96e-05 |
REACTOME MEIOTIC RECOMBINATION | 25 | 4.57e-02 | 0.231000 | 8.71e-02 |
REACTOME LATE ENDOSOMAL MICROAUTOPHAGY | 31 | 2.62e-02 | 0.231000 | 5.66e-02 |
REACTOME SIGNALING BY NODAL | 22 | 6.13e-02 | 0.230000 | 1.12e-01 |
REACTOME SULFUR AMINO ACID METABOLISM | 27 | 3.82e-02 | 0.230000 | 7.64e-02 |
REACTOME RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 52 | 4.05e-03 | 0.230000 | 1.33e-02 |
REACTOME TNF SIGNALING | 52 | 4.06e-03 | 0.230000 | 1.34e-02 |
REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | 89 | 1.74e-04 | 0.230000 | 1.04e-03 |
REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 20 | 7.49e-02 | 0.230000 | 1.29e-01 |
REACTOME MITOTIC PROMETAPHASE | 184 | 7.28e-08 | 0.230000 | 1.24e-06 |
REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 14 | 1.37e-01 | 0.230000 | 2.07e-01 |
REACTOME DOWNREGULATION OF ERBB4 SIGNALING | 9 | 2.33e-01 | 0.230000 | 3.13e-01 |
REACTOME RORA ACTIVATES GENE EXPRESSION | 16 | 1.12e-01 | 0.229000 | 1.77e-01 |
REACTOME NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 2.09e-01 | 0.229000 | 2.87e-01 |
REACTOME UBIQUINOL BIOSYNTHESIS | 8 | 2.61e-01 | 0.229000 | 3.42e-01 |
REACTOME NONHOMOLOGOUS END JOINING NHEJ | 29 | 3.25e-02 | 0.229000 | 6.71e-02 |
REACTOME SIGNALING BY VEGF | 103 | 5.86e-05 | 0.229000 | 4.19e-04 |
REACTOME RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 78 | 4.70e-04 | 0.229000 | 2.30e-03 |
REACTOMEMATURATION OF SARS COV 1 NUCLEOPROTEIN | 11 | 1.89e-01 | 0.229000 | 2.67e-01 |
REACTOME SELECTIVE AUTOPHAGY | 76 | 5.62e-04 | 0.229000 | 2.64e-03 |
REACTOME ACYL CHAIN REMODELLING OF PI | 16 | 1.13e-01 | -0.229000 | 1.79e-01 |
REACTOME OVARIAN TUMOR DOMAIN PROTEASES | 35 | 1.93e-02 | 0.228000 | 4.48e-02 |
REACTOME NONCANONICAL ACTIVATION OF NOTCH3 | 8 | 2.63e-01 | 0.228000 | 3.44e-01 |
REACTOME SNRNP ASSEMBLY | 50 | 5.24e-03 | 0.228000 | 1.61e-02 |
REACTOME MITOTIC G2 G2 M PHASES | 190 | 5.85e-08 | 0.228000 | 1.04e-06 |
REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 71 | 8.99e-04 | 0.228000 | 3.88e-03 |
REACTOME INWARDLY RECTIFYING K CHANNELS | 35 | 1.97e-02 | 0.228000 | 4.57e-02 |
REACTOME COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 32 | 2.59e-02 | 0.227000 | 5.62e-02 |
REACTOME FATTY ACYL COA BIOSYNTHESIS | 32 | 2.59e-02 | 0.227000 | 5.62e-02 |
REACTOME TRAF6 MEDIATED NF KB ACTIVATION | 23 | 5.92e-02 | 0.227000 | 1.08e-01 |
REACTOME TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 1.92e-01 | 0.227000 | 2.70e-01 |
REACTOME RND3 GTPASE CYCLE | 41 | 1.19e-02 | 0.227000 | 3.05e-02 |
REACTOME NR1H2 NR1H3 REGULATE GENE EXPRESSION LINKED TO LIPOGENESIS | 9 | 2.39e-01 | 0.227000 | 3.19e-01 |
REACTOME GOLGI TO ER RETROGRADE TRANSPORT | 132 | 6.68e-06 | 0.227000 | 6.64e-05 |
REACTOME NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 33 | 2.43e-02 | 0.227000 | 5.32e-02 |
REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 77 | 5.90e-04 | 0.226000 | 2.74e-03 |
REACTOME DNA STRAND ELONGATION | 31 | 2.92e-02 | 0.226000 | 6.14e-02 |
REACTOME LAMININ INTERACTIONS | 28 | 3.84e-02 | 0.226000 | 7.67e-02 |
REACTOME TLR3 MEDIATED TICAM1 DEPENDENT PROGRAMMED CELL DEATH | 6 | 3.38e-01 | 0.226000 | 4.21e-01 |
REACTOME 2 LTR CIRCLE FORMATION | 7 | 3.01e-01 | 0.226000 | 3.84e-01 |
REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 353 | 2.98e-13 | 0.225000 | 1.43e-11 |
REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 182 | 1.58e-07 | 0.225000 | 2.51e-06 |
REACTOME PI3K AKT SIGNALING IN CANCER | 103 | 8.20e-05 | 0.224000 | 5.62e-04 |
REACTOME RAB REGULATION OF TRAFFICKING | 108 | 5.64e-05 | 0.224000 | 4.07e-04 |
REACTOME APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 85 | 3.59e-04 | 0.224000 | 1.82e-03 |
REACTOME ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 1.34e-01 | 0.224000 | 2.04e-01 |
REACTOME REGULATION BY C FLIP | 11 | 1.99e-01 | 0.224000 | 2.77e-01 |
REACTOME TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 23 | 6.40e-02 | 0.223000 | 1.15e-01 |
REACTOME SIGNALING BY CSF1 M CSF IN MYELOID CELLS | 30 | 3.48e-02 | 0.223000 | 7.12e-02 |
REACTOME PHOSPHATE BOND HYDROLYSIS BY NUDT PROTEINS | 6 | 3.46e-01 | 0.222000 | 4.29e-01 |
REACTOME LYSOSOME VESICLE BIOGENESIS | 33 | 2.73e-02 | 0.222000 | 5.82e-02 |
REACTOME SIGNALING BY BRAF AND RAF1 FUSIONS | 61 | 2.83e-03 | 0.221000 | 9.85e-03 |
REACTOME SIGNALING BY LRP5 MUTANTS | 6 | 3.49e-01 | 0.221000 | 4.32e-01 |
REACTOME P38MAPK EVENTS | 13 | 1.68e-01 | 0.221000 | 2.43e-01 |
REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | 1257 | 2.02e-40 | 0.221000 | 8.25e-38 |
REACTOME SARS COV 1 ACTIVATES MODULATES INNATE IMMUNE RESPONSES | 35 | 2.41e-02 | 0.220000 | 5.30e-02 |
REACTOME G ALPHA Z SIGNALLING EVENTS | 48 | 8.33e-03 | 0.220000 | 2.30e-02 |
REACTOME MTOR SIGNALLING | 38 | 1.90e-02 | 0.220000 | 4.44e-02 |
REACTOME GLYCOLYSIS | 66 | 2.01e-03 | 0.220000 | 7.43e-03 |
REACTOME PTK6 PROMOTES HIF1A STABILIZATION | 6 | 3.52e-01 | -0.219000 | 4.35e-01 |
REACTOME APEX1 INDEPENDENT RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | 7 | 3.15e-01 | 0.219000 | 3.97e-01 |
REACTOME REGULATION OF EXPRESSION OF SLITS AND ROBOS | 158 | 2.11e-06 | 0.218000 | 2.39e-05 |
REACTOME TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 70 | 1.59e-03 | 0.218000 | 6.16e-03 |
REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | 29 | 4.20e-02 | -0.218000 | 8.21e-02 |
REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 59 | 3.77e-03 | 0.218000 | 1.26e-02 |
REACTOME NERVOUS SYSTEM DEVELOPMENT | 543 | 3.05e-18 | 0.217000 | 2.77e-16 |
REACTOME TRANSCRIPTIONAL REGULATION BY VENTX | 37 | 2.21e-02 | 0.217000 | 4.95e-02 |
REACTOME SIGNALLING TO RAS | 20 | 9.23e-02 | 0.217000 | 1.52e-01 |
REACTOME COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 52 | 6.67e-03 | 0.217000 | 1.95e-02 |
REACTOME DEATH RECEPTOR SIGNALING | 141 | 8.29e-06 | 0.217000 | 8.04e-05 |
REACTOME ACTIVATION OF TRKA RECEPTORS | 6 | 3.57e-01 | 0.217000 | 4.41e-01 |
REACTOME SIGNALING BY SCF KIT | 43 | 1.39e-02 | 0.217000 | 3.46e-02 |
REACTOME AURKA ACTIVATION BY TPX2 | 67 | 2.16e-03 | 0.217000 | 7.92e-03 |
REACTOME INTERLEUKIN 2 SIGNALING | 11 | 2.14e-01 | 0.216000 | 2.92e-01 |
REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 69 | 1.89e-03 | 0.216000 | 7.05e-03 |
REACTOME SARS COV 2 TARGETS HOST INTRACELLULAR SIGNALLING AND REGULATORY PATHWAYS | 12 | 1.95e-01 | 0.216000 | 2.73e-01 |
REACTOME SIGNALING BY EGFR IN CANCER | 25 | 6.15e-02 | 0.216000 | 1.12e-01 |
REACTOME SIGNALING BY MEMBRANE TETHERED FUSIONS OF PDGFRA OR PDGFRB | 5 | 4.03e-01 | 0.216000 | 4.88e-01 |
REACTOME TIGHT JUNCTION INTERACTIONS | 27 | 5.23e-02 | 0.216000 | 9.75e-02 |
REACTOME TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 1.14e-01 | 0.215000 | 1.79e-01 |
REACTOME RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 16 | 1.37e-01 | 0.215000 | 2.07e-01 |
REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 21 | 8.93e-02 | 0.214000 | 1.49e-01 |
REACTOME RHOH GTPASE CYCLE | 35 | 2.84e-02 | 0.214000 | 5.99e-02 |
REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 25 | 6.42e-02 | 0.214000 | 1.15e-01 |
REACTOME UPTAKE OF DIETARY COBALAMINS INTO ENTEROCYTES | 9 | 2.67e-01 | -0.214000 | 3.48e-01 |
REACTOME CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII CAMKK CAMKIV CASCASDE | 8 | 2.96e-01 | 0.213000 | 3.79e-01 |
REACTOME FGFR3B LIGAND BINDING AND ACTIVATION | 7 | 3.29e-01 | 0.213000 | 4.12e-01 |
REACTOME METABOLISM OF CARBOHYDRATES | 269 | 1.70e-09 | 0.213000 | 4.47e-08 |
REACTOME RIPK1 MEDIATED REGULATED NECROSIS | 29 | 4.73e-02 | 0.213000 | 8.97e-02 |
REACTOME SYNTHESIS OF WYBUTOSINE AT G37 OF TRNA PHE | 6 | 3.67e-01 | 0.213000 | 4.50e-01 |
REACTOME PLATELET HOMEOSTASIS | 81 | 9.32e-04 | 0.213000 | 3.97e-03 |
REACTOME METABOLISM OF POLYAMINES | 53 | 7.40e-03 | 0.213000 | 2.08e-02 |
REACTOME CTLA4 INHIBITORY SIGNALING | 21 | 9.20e-02 | 0.212000 | 1.52e-01 |
REACTOME PREVENTION OF PHAGOSOMAL LYSOSOMAL FUSION | 9 | 2.70e-01 | 0.212000 | 3.51e-01 |
REACTOME NEGATIVE REGULATION OF MET ACTIVITY | 20 | 1.01e-01 | 0.212000 | 1.63e-01 |
REACTOME PTK6 EXPRESSION | 5 | 4.12e-01 | 0.212000 | 4.94e-01 |
REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | 16 | 1.43e-01 | 0.212000 | 2.15e-01 |
REACTOME METALLOPROTEASE DUBS | 16 | 1.43e-01 | 0.211000 | 2.15e-01 |
REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 1.32e-02 | 0.211000 | 3.32e-02 |
REACTOME CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 16 | 1.44e-01 | 0.211000 | 2.16e-01 |
REACTOME THE NLRP3 INFLAMMASOME | 16 | 1.45e-01 | 0.210000 | 2.18e-01 |
REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 53 | 8.05e-03 | 0.210000 | 2.23e-02 |
REACTOME TRANSLATION | 262 | 4.24e-09 | 0.210000 | 1.02e-07 |
REACTOME GABA B RECEPTOR ACTIVATION | 43 | 1.71e-02 | 0.210000 | 4.07e-02 |
REACTOME POTASSIUM CHANNELS | 102 | 2.44e-04 | 0.210000 | 1.33e-03 |
REACTOME COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 98 | 3.23e-04 | 0.210000 | 1.68e-03 |
REACTOME CDC42 GTPASE CYCLE | 142 | 1.54e-05 | 0.210000 | 1.35e-04 |
REACTOME PRE NOTCH EXPRESSION AND PROCESSING | 55 | 7.14e-03 | 0.210000 | 2.03e-02 |
REACTOME RHOA GTPASE CYCLE | 136 | 2.42e-05 | 0.209000 | 1.99e-04 |
REACTOME NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 4.04e-02 | 0.209000 | 7.99e-02 |
REACTOME AMPK INHIBITS CHREBP TRANSCRIPTIONAL ACTIVATION ACTIVITY | 8 | 3.06e-01 | 0.209000 | 3.88e-01 |
REACTOME BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 8.27e-02 | 0.209000 | 1.40e-01 |
REACTOME RHOG GTPASE CYCLE | 69 | 2.72e-03 | 0.209000 | 9.51e-03 |
REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 15 | 1.63e-01 | 0.208000 | 2.38e-01 |
REACTOME TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 14 | 1.78e-01 | 0.208000 | 2.55e-01 |
REACTOME METABOLISM OF COFACTORS | 19 | 1.17e-01 | 0.207000 | 1.84e-01 |
REACTOME SIGNALING BY PDGF | 57 | 6.77e-03 | 0.207000 | 1.97e-02 |
REACTOME SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 42 | 2.02e-02 | 0.207000 | 4.64e-02 |
REACTOME CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 2.35e-01 | 0.207000 | 3.14e-01 |
REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | 32 | 4.29e-02 | 0.207000 | 8.34e-02 |
REACTOME EICOSANOIDS | 12 | 2.15e-01 | -0.207000 | 2.92e-01 |
REACTOME ACTIVATION OF BH3 ONLY PROTEINS | 30 | 5.09e-02 | 0.206000 | 9.51e-02 |
REACTOME GLYCOGEN STORAGE DISEASES | 14 | 1.83e-01 | 0.206000 | 2.60e-01 |
REACTOME TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 109 | 2.05e-04 | 0.206000 | 1.18e-03 |
REACTOME CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 13 | 1.99e-01 | 0.206000 | 2.77e-01 |
REACTOME RRNA PROCESSING | 181 | 1.78e-06 | 0.206000 | 2.04e-05 |
REACTOME INTEGRATION OF ENERGY METABOLISM | 105 | 2.71e-04 | 0.205000 | 1.46e-03 |
REACTOME IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 2.38e-01 | 0.205000 | 3.19e-01 |
REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | 245 | 2.90e-08 | 0.205000 | 5.25e-07 |
REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | 22 | 9.56e-02 | 0.205000 | 1.57e-01 |
REACTOME RAS SIGNALING DOWNSTREAM OF NF1 LOSS OF FUNCTION VARIANTS | 7 | 3.47e-01 | 0.205000 | 4.30e-01 |
REACTOME RA BIOSYNTHESIS PATHWAY | 22 | 9.58e-02 | 0.205000 | 1.57e-01 |
REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 19 | 1.22e-01 | 0.205000 | 1.89e-01 |
REACTOME DISEASES OF MISMATCH REPAIR MMR | 5 | 4.30e-01 | 0.204000 | 5.13e-01 |
REACTOME REGULATION OF NPAS4 GENE TRANSCRIPTION | 5 | 4.30e-01 | 0.204000 | 5.13e-01 |
REACTOME STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 13 | 2.03e-01 | 0.204000 | 2.81e-01 |
REACTOME MET ACTIVATES RAP1 AND RAC1 | 11 | 2.42e-01 | 0.204000 | 3.23e-01 |
REACTOME PHASE 1 INACTIVATION OF FAST NA CHANNELS | 6 | 3.88e-01 | -0.203000 | 4.73e-01 |
REACTOME CLEC7A DECTIN 1 SIGNALING | 96 | 5.73e-04 | 0.203000 | 2.69e-03 |
REACTOME VEGFR2 MEDIATED VASCULAR PERMEABILITY | 26 | 7.42e-02 | 0.202000 | 1.28e-01 |
REACTOME SARS COV 1 HOST INTERACTIONS | 88 | 1.11e-03 | 0.201000 | 4.59e-03 |
REACTOME RND1 GTPASE CYCLE | 41 | 2.59e-02 | 0.201000 | 5.62e-02 |
REACTOME XENOBIOTICS | 23 | 9.57e-02 | -0.201000 | 1.57e-01 |
REACTOME INTRAFLAGELLAR TRANSPORT | 48 | 1.62e-02 | 0.201000 | 3.91e-02 |
REACTOME ESTROGEN STIMULATED SIGNALING THROUGH PRKCZ | 6 | 3.95e-01 | 0.200000 | 4.80e-01 |
REACTOME THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 76 | 2.59e-03 | 0.200000 | 9.17e-03 |
REACTOME TRAFFICKING OF AMPA RECEPTORS | 29 | 6.31e-02 | 0.199000 | 1.14e-01 |
REACTOME MITOCHONDRIAL CALCIUM ION TRANSPORT | 16 | 1.70e-01 | 0.198000 | 2.45e-01 |
REACTOME REGULATION OF INSULIN SECRETION | 77 | 2.64e-03 | 0.198000 | 9.28e-03 |
REACTOME NR1H2 AND NR1H3 MEDIATED SIGNALING | 42 | 2.64e-02 | 0.198000 | 5.68e-02 |
REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | 10 | 2.79e-01 | 0.198000 | 3.61e-01 |
REACTOME UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 2.57e-01 | 0.197000 | 3.39e-01 |
REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 22 | 1.09e-01 | 0.197000 | 1.74e-01 |
REACTOME ROBO RECEPTORS BIND AKAP5 | 9 | 3.06e-01 | 0.197000 | 3.88e-01 |
REACTOME METABOLISM OF INGESTED SEMET SEC MESEC INTO H2SE | 8 | 3.37e-01 | 0.196000 | 4.20e-01 |
REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 118 | 2.40e-04 | 0.196000 | 1.31e-03 |
REACTOME HEME DEGRADATION | 15 | 1.90e-01 | -0.196000 | 2.68e-01 |
REACTOME INFLUENZA INFECTION | 147 | 4.20e-05 | 0.195000 | 3.17e-04 |
REACTOME DEFECTIVE LFNG CAUSES SCDO3 | 5 | 4.50e-01 | 0.195000 | 5.33e-01 |
REACTOME AGGREPHAGY | 41 | 3.06e-02 | 0.195000 | 6.38e-02 |
REACTOME NEUROTRANSMITTER RELEASE CYCLE | 47 | 2.07e-02 | 0.195000 | 4.74e-02 |
REACTOME HS GAG BIOSYNTHESIS | 28 | 7.45e-02 | 0.195000 | 1.28e-01 |
REACTOME CD163 MEDIATING AN ANTI INFLAMMATORY RESPONSE | 9 | 3.14e-01 | 0.194000 | 3.97e-01 |
REACTOME LOSS OF FUNCTION OF SMAD2 3 IN CANCER | 7 | 3.75e-01 | 0.193000 | 4.59e-01 |
REACTOME CELL CELL COMMUNICATION | 117 | 2.97e-04 | 0.193000 | 1.57e-03 |
REACTOME SYNTHESIS OF 12 EICOSATETRAENOIC ACID DERIVATIVES | 7 | 3.78e-01 | 0.192000 | 4.62e-01 |
REACTOME ORGANELLE BIOGENESIS AND MAINTENANCE | 249 | 1.69e-07 | 0.192000 | 2.62e-06 |
REACTOME PYRUVATE METABOLISM | 27 | 8.44e-02 | 0.192000 | 1.43e-01 |
REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | 14 | 2.14e-01 | 0.192000 | 2.92e-01 |
REACTOME ATTACHMENT OF GPI ANCHOR TO UPAR | 7 | 3.80e-01 | 0.192000 | 4.64e-01 |
REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | 97 | 1.11e-03 | 0.191000 | 4.59e-03 |
REACTOME MAP2K AND MAPK ACTIVATION | 38 | 4.17e-02 | 0.191000 | 8.19e-02 |
REACTOME SARS COV 1 INFECTION | 131 | 1.60e-04 | 0.191000 | 9.79e-04 |
REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 13 | 2.34e-01 | 0.191000 | 3.13e-01 |
REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 111 | 5.29e-04 | 0.190000 | 2.53e-03 |
REACTOME PI3K EVENTS IN ERBB2 SIGNALING | 16 | 1.89e-01 | 0.190000 | 2.67e-01 |
REACTOME CHAPERONE MEDIATED AUTOPHAGY | 20 | 1.43e-01 | 0.189000 | 2.15e-01 |
REACTOME CONDENSATION OF PROPHASE CHROMOSOMES | 11 | 2.78e-01 | 0.189000 | 3.59e-01 |
REACTOME DISEASES OF CARBOHYDRATE METABOLISM | 30 | 7.39e-02 | 0.188000 | 1.28e-01 |
REACTOME DOWNREGULATION OF ERBB2 SIGNALING | 28 | 8.46e-02 | 0.188000 | 1.43e-01 |
REACTOME CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 3.03e-01 | 0.188000 | 3.86e-01 |
REACTOME TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 18 | 1.68e-01 | 0.188000 | 2.42e-01 |
REACTOME GAP JUNCTION DEGRADATION | 12 | 2.60e-01 | 0.188000 | 3.42e-01 |
REACTOME BH3 ONLY PROTEINS ASSOCIATE WITH AND INACTIVATE ANTI APOPTOTIC BCL 2 MEMBERS | 9 | 3.32e-01 | 0.187000 | 4.15e-01 |
REACTOME CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 2.36e-02 | 0.187000 | 5.21e-02 |
REACTOME CYP2E1 REACTIONS | 11 | 2.84e-01 | -0.187000 | 3.66e-01 |
REACTOME CELLULAR RESPONSE TO CHEMICAL STRESS | 185 | 1.30e-05 | 0.186000 | 1.18e-04 |
REACTOME RHO GTPASES ACTIVATE IQGAPS | 31 | 7.46e-02 | 0.185000 | 1.28e-01 |
REACTOME ACTIVATION OF C3 AND C5 | 6 | 4.33e-01 | -0.185000 | 5.16e-01 |
REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 9 | 3.37e-01 | 0.185000 | 4.20e-01 |
REACTOME DEFECTIVE RIPK1 MEDIATED REGULATED NECROSIS | 7 | 3.97e-01 | 0.185000 | 4.82e-01 |
REACTOME CIPROFLOXACIN ADME | 5 | 4.74e-01 | -0.185000 | 5.58e-01 |
REACTOME NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 2.89e-01 | 0.185000 | 3.71e-01 |
REACTOME ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN | 13 | 2.50e-01 | 0.184000 | 3.30e-01 |
REACTOME CELL CELL JUNCTION ORGANIZATION | 57 | 1.60e-02 | 0.184000 | 3.87e-02 |
REACTOME NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 193 | 9.86e-06 | 0.184000 | 9.35e-05 |
REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 19 | 1.65e-01 | 0.184000 | 2.40e-01 |
REACTOME RAC1 GTPASE CYCLE | 168 | 3.92e-05 | 0.184000 | 3.00e-04 |
REACTOME CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 77 | 5.42e-03 | 0.183000 | 1.64e-02 |
REACTOME ECM PROTEOGLYCANS | 73 | 6.85e-03 | 0.183000 | 1.98e-02 |
REACTOME ACTIVATION OF NOXA AND TRANSLOCATION TO MITOCHONDRIA | 5 | 4.79e-01 | 0.183000 | 5.61e-01 |
REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | 23 | 1.29e-01 | 0.183000 | 1.99e-01 |
REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | 23 | 1.29e-01 | 0.183000 | 1.99e-01 |
REACTOME TRIF MEDIATED PROGRAMMED CELL DEATH | 9 | 3.43e-01 | 0.182000 | 4.26e-01 |
REACTOME NRAGE SIGNALS DEATH THROUGH JNK | 53 | 2.19e-02 | 0.182000 | 4.94e-02 |
REACTOME TP53 REGULATES METABOLIC GENES | 74 | 6.88e-03 | 0.182000 | 1.98e-02 |
REACTOME AZATHIOPRINE ADME | 22 | 1.41e-01 | 0.181000 | 2.13e-01 |
REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 75 | 6.88e-03 | 0.180000 | 1.98e-02 |
REACTOME INTEGRIN SIGNALING | 27 | 1.05e-01 | 0.180000 | 1.69e-01 |
REACTOME RECYCLING PATHWAY OF L1 | 42 | 4.33e-02 | 0.180000 | 8.39e-02 |
REACTOME DISEASES OF GLYCOSYLATION | 132 | 3.47e-04 | 0.180000 | 1.78e-03 |
REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 26 | 1.12e-01 | 0.180000 | 1.77e-01 |
REACTOME REGULATION OF IFNG SIGNALING | 14 | 2.44e-01 | 0.180000 | 3.24e-01 |
REACTOME CATION COUPLED CHLORIDE COTRANSPORTERS | 7 | 4.10e-01 | 0.180000 | 4.93e-01 |
REACTOME BASIGIN INTERACTIONS | 24 | 1.28e-01 | 0.179000 | 1.97e-01 |
REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | 98 | 2.14e-03 | 0.179000 | 7.88e-03 |
REACTOME DEFECTS OF CONTACT ACTIVATION SYSTEM CAS AND KALLIKREIN KININ SYSTEM KKS | 14 | 2.46e-01 | 0.179000 | 3.26e-01 |
REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | 30 | 9.02e-02 | -0.179000 | 1.49e-01 |
REACTOME MRNA EDITING C TO U CONVERSION | 8 | 3.82e-01 | -0.179000 | 4.66e-01 |
REACTOME BUTYROPHILIN BTN FAMILY INTERACTIONS | 12 | 2.85e-01 | 0.178000 | 3.67e-01 |
REACTOME RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN WNT SIGNALING | 5 | 4.91e-01 | 0.178000 | 5.72e-01 |
REACTOME MOLYBDENUM COFACTOR BIOSYNTHESIS | 6 | 4.52e-01 | 0.177000 | 5.34e-01 |
REACTOME RECYCLING OF BILE ACIDS AND SALTS | 16 | 2.20e-01 | -0.177000 | 2.97e-01 |
REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | 254 | 1.14e-06 | 0.177000 | 1.43e-05 |
REACTOME CELL JUNCTION ORGANIZATION | 82 | 5.60e-03 | 0.177000 | 1.68e-02 |
REACTOME SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 31 | 8.87e-02 | 0.177000 | 1.48e-01 |
REACTOME THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 27 | 1.13e-01 | 0.176000 | 1.78e-01 |
REACTOME MET ACTIVATES RAS SIGNALING | 11 | 3.11e-01 | 0.176000 | 3.94e-01 |
REACTOME CILIUM ASSEMBLY | 184 | 3.64e-05 | 0.176000 | 2.82e-04 |
REACTOME GLUCOSE METABOLISM | 85 | 5.04e-03 | 0.176000 | 1.56e-02 |
REACTOME ACTIVATION OF MATRIX METALLOPROTEINASES | 30 | 9.57e-02 | -0.176000 | 1.57e-01 |
REACTOME INTERLEUKIN 1 PROCESSING | 9 | 3.62e-01 | -0.176000 | 4.45e-01 |
REACTOME INTERLEUKIN 21 SIGNALING | 9 | 3.62e-01 | 0.175000 | 4.46e-01 |
REACTOME FATTY ACID METABOLISM | 163 | 1.10e-04 | 0.175000 | 7.25e-04 |
REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 15 | 2.41e-01 | 0.175000 | 3.21e-01 |
REACTOME EARLY PHASE OF HIV LIFE CYCLE | 14 | 2.57e-01 | 0.175000 | 3.39e-01 |
REACTOME SIGNALING BY MET | 78 | 7.70e-03 | 0.174000 | 2.15e-02 |
REACTOME ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 41 | 5.44e-02 | 0.174000 | 1.01e-01 |
REACTOME INTERLEUKIN 1 FAMILY SIGNALING | 145 | 3.04e-04 | 0.174000 | 1.59e-03 |
REACTOME DEPOLYMERISATION OF THE NUCLEAR LAMINA | 14 | 2.61e-01 | 0.173000 | 3.42e-01 |
REACTOME PHASE 3 RAPID REPOLARISATION | 8 | 3.96e-01 | 0.173000 | 4.81e-01 |
REACTOME NEURONAL SYSTEM | 387 | 4.47e-09 | 0.173000 | 1.06e-07 |
REACTOME G ALPHA Q SIGNALLING EVENTS | 203 | 2.06e-05 | 0.173000 | 1.73e-04 |
REACTOME DISEASES OF METABOLISM | 229 | 6.24e-06 | 0.173000 | 6.24e-05 |
REACTOME PI METABOLISM | 78 | 8.25e-03 | 0.173000 | 2.28e-02 |
REACTOME TOLL LIKE RECEPTOR CASCADES | 154 | 2.10e-04 | 0.173000 | 1.20e-03 |
REACTOME PRE NOTCH PROCESSING IN GOLGI | 18 | 2.06e-01 | 0.172000 | 2.84e-01 |
REACTOME RAB GERANYLGERANYLATION | 56 | 2.59e-02 | 0.172000 | 5.62e-02 |
REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | 11 | 3.24e-01 | -0.172000 | 4.06e-01 |
REACTOME TRAIL SIGNALING | 8 | 4.01e-01 | 0.171000 | 4.85e-01 |
REACTOME SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 14 | 2.67e-01 | 0.171000 | 3.48e-01 |
REACTOME LOSS OF MECP2 BINDING ABILITY TO THE NCOR SMRT COMPLEX | 5 | 5.09e-01 | 0.171000 | 5.88e-01 |
REACTOME NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 20 | 1.87e-01 | 0.170000 | 2.65e-01 |
REACTOME ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 87 | 6.14e-03 | 0.170000 | 1.81e-02 |
REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 26 | 1.35e-01 | 0.169000 | 2.05e-01 |
REACTOME PTK6 REGULATES PROTEINS INVOLVED IN RNA PROCESSING | 5 | 5.12e-01 | 0.169000 | 5.91e-01 |
REACTOME PHASE 2 PLATEAU PHASE | 14 | 2.73e-01 | 0.169000 | 3.54e-01 |
REACTOME DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 166 | 1.69e-04 | 0.169000 | 1.02e-03 |
REACTOME ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 89 | 5.88e-03 | 0.169000 | 1.75e-02 |
REACTOME CELLULAR RESPONSE TO STARVATION | 142 | 5.15e-04 | 0.169000 | 2.48e-03 |
REACTOME RELAXIN RECEPTORS | 8 | 4.10e-01 | 0.168000 | 4.93e-01 |
REACTOME ALPHA OXIDATION OF PHYTANATE | 6 | 4.76e-01 | 0.168000 | 5.59e-01 |
REACTOME PLATELET AGGREGATION PLUG FORMATION | 39 | 7.00e-02 | 0.168000 | 1.24e-01 |
REACTOME DAG AND IP3 SIGNALING | 39 | 7.05e-02 | 0.167000 | 1.24e-01 |
REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 14 | 2.80e-01 | 0.167000 | 3.61e-01 |
REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 19 | 2.08e-01 | 0.167000 | 2.87e-01 |
REACTOME MISCELLANEOUS SUBSTRATES | 12 | 3.17e-01 | -0.167000 | 4.00e-01 |
REACTOME INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 45 | 5.30e-02 | 0.167000 | 9.86e-02 |
REACTOME RAS PROCESSING | 20 | 1.98e-01 | 0.166000 | 2.76e-01 |
REACTOME SCAVENGING BY CLASS F RECEPTORS | 6 | 4.81e-01 | 0.166000 | 5.62e-01 |
REACTOME VESICLE MEDIATED TRANSPORT | 678 | 1.19e-13 | 0.166000 | 6.14e-12 |
REACTOME METABOLISM OF LIPIDS | 678 | 1.21e-13 | 0.166000 | 6.14e-12 |
REACTOME ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 2.11e-01 | 0.166000 | 2.88e-01 |
REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 89 | 6.88e-03 | 0.166000 | 1.98e-02 |
REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | 14 | 2.83e-01 | 0.166000 | 3.65e-01 |
REACTOME RESPONSE OF MTB TO PHAGOCYTOSIS | 22 | 1.79e-01 | 0.165000 | 2.56e-01 |
REACTOME TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 29 | 1.23e-01 | 0.165000 | 1.90e-01 |
REACTOME CD28 CO STIMULATION | 32 | 1.06e-01 | 0.165000 | 1.70e-01 |
REACTOME SULFIDE OXIDATION TO SULFATE | 5 | 5.23e-01 | 0.165000 | 6.01e-01 |
REACTOME SERINE BIOSYNTHESIS | 9 | 3.92e-01 | 0.165000 | 4.76e-01 |
REACTOME REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 11 | 3.44e-01 | 0.165000 | 4.27e-01 |
REACTOME FORMATION OF THE CORNIFIED ENVELOPE | 128 | 1.27e-03 | -0.165000 | 5.09e-03 |
REACTOME SYNTHESIS OF PE | 11 | 3.45e-01 | 0.165000 | 4.27e-01 |
REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | 12 | 3.24e-01 | 0.164000 | 4.06e-01 |
REACTOME G PROTEIN MEDIATED EVENTS | 52 | 4.03e-02 | 0.164000 | 7.97e-02 |
REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 115 | 2.35e-03 | 0.164000 | 8.45e-03 |
REACTOME DEVELOPMENTAL BIOLOGY | 1052 | 1.15e-19 | 0.164000 | 1.17e-17 |
REACTOME ZINC TRANSPORTERS | 15 | 2.74e-01 | 0.163000 | 3.55e-01 |
REACTOME BETA OXIDATION OF PRISTANOYL COA | 9 | 3.97e-01 | 0.163000 | 4.82e-01 |
REACTOME HEME SIGNALING | 45 | 5.90e-02 | 0.163000 | 1.08e-01 |
REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 2.20e-01 | 0.163000 | 2.97e-01 |
REACTOME SHC1 EVENTS IN ERBB2 SIGNALING | 22 | 1.90e-01 | 0.161000 | 2.68e-01 |
REACTOME CRISTAE FORMATION | 9 | 4.04e-01 | 0.161000 | 4.88e-01 |
REACTOME RUNX2 REGULATES CHONDROCYTE MATURATION | 5 | 5.34e-01 | 0.160000 | 6.12e-01 |
REACTOME PEPTIDE LIGAND BINDING RECEPTORS | 181 | 1.93e-04 | 0.160000 | 1.14e-03 |
REACTOME SIALIC ACID METABOLISM | 33 | 1.13e-01 | 0.159000 | 1.78e-01 |
REACTOME PURINE CATABOLISM | 15 | 2.87e-01 | 0.159000 | 3.68e-01 |
REACTOME PLATELET CALCIUM HOMEOSTASIS | 27 | 1.54e-01 | 0.158000 | 2.28e-01 |
REACTOME PKA ACTIVATION IN GLUCAGON SIGNALLING | 17 | 2.60e-01 | 0.158000 | 3.41e-01 |
REACTOME CYTOSOLIC TRNA AMINOACYLATION | 6 | 5.03e-01 | 0.158000 | 5.83e-01 |
REACTOME PARASITE INFECTION | 106 | 5.04e-03 | -0.158000 | 1.56e-02 |
REACTOME PEROXISOMAL LIPID METABOLISM | 28 | 1.49e-01 | 0.157000 | 2.22e-01 |
REACTOME NON INTEGRIN MEMBRANE ECM INTERACTIONS | 55 | 4.36e-02 | 0.157000 | 8.43e-02 |
REACTOME RUNX1 REGULATES ESTROGEN RECEPTOR MEDIATED TRANSCRIPTION | 6 | 5.05e-01 | 0.157000 | 5.85e-01 |
REACTOME TNFR2 NON CANONICAL NF KB PATHWAY | 95 | 8.40e-03 | 0.156000 | 2.31e-02 |
REACTOME KILLING MECHANISMS | 11 | 3.70e-01 | 0.156000 | 4.53e-01 |
REACTOME CYTOPROTECTION BY HMOX1 | 58 | 3.96e-02 | 0.156000 | 7.85e-02 |
REACTOME DSCAM INTERACTIONS | 11 | 3.71e-01 | 0.156000 | 4.54e-01 |
REACTOME AQUAPORIN MEDIATED TRANSPORT | 51 | 5.47e-02 | 0.155000 | 1.01e-01 |
REACTOME GAP JUNCTION TRAFFICKING AND REGULATION | 49 | 6.03e-02 | 0.155000 | 1.10e-01 |
REACTOME RHOBTB3 ATPASE CYCLE | 8 | 4.49e-01 | 0.155000 | 5.31e-01 |
REACTOME PD 1 SIGNALING | 24 | 1.92e-01 | -0.154000 | 2.70e-01 |
REACTOME NUCLEAR SIGNALING BY ERBB4 | 32 | 1.32e-01 | 0.154000 | 2.02e-01 |
REACTOME ERYTHROCYTES TAKE UP OXYGEN AND RELEASE CARBON DIOXIDE | 9 | 4.24e-01 | 0.154000 | 5.07e-01 |
REACTOME METABOLISM OF STEROIDS | 143 | 1.51e-03 | 0.154000 | 5.88e-03 |
REACTOME PROTEIN METHYLATION | 12 | 3.58e-01 | 0.153000 | 4.41e-01 |
REACTOME ACYL CHAIN REMODELING OF DAG AND TAG | 5 | 5.53e-01 | 0.153000 | 6.30e-01 |
REACTOME INSULIN PROCESSING | 23 | 2.04e-01 | 0.153000 | 2.83e-01 |
REACTOME PREDNISONE ADME | 10 | 4.04e-01 | -0.152000 | 4.88e-01 |
REACTOME REPRODUCTION | 81 | 1.77e-02 | 0.152000 | 4.19e-02 |
REACTOME UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 29 | 1.56e-01 | 0.152000 | 2.30e-01 |
REACTOME DEFECTIVE FACTOR VIII CAUSES HEMOPHILIA A | 5 | 5.55e-01 | 0.152000 | 6.31e-01 |
REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | 7 | 4.86e-01 | 0.152000 | 5.66e-01 |
REACTOME ADHERENS JUNCTIONS INTERACTIONS | 28 | 1.65e-01 | 0.152000 | 2.40e-01 |
REACTOME NONSENSE MEDIATED DECAY NMD | 108 | 6.46e-03 | 0.152000 | 1.89e-02 |
REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 23 | 2.09e-01 | 0.151000 | 2.87e-01 |
REACTOME PEROXISOMAL PROTEIN IMPORT | 62 | 4.01e-02 | 0.151000 | 7.94e-02 |
REACTOME INTEGRIN CELL SURFACE INTERACTIONS | 82 | 1.84e-02 | 0.150000 | 4.34e-02 |
REACTOME METAL ION SLC TRANSPORTERS | 23 | 2.13e-01 | 0.150000 | 2.90e-01 |
REACTOME METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 15 | 3.15e-01 | -0.150000 | 3.97e-01 |
REACTOME METHYLATION | 14 | 3.32e-01 | 0.150000 | 4.15e-01 |
REACTOME AMINE LIGAND BINDING RECEPTORS | 40 | 1.01e-01 | 0.150000 | 1.63e-01 |
REACTOME MULTIFUNCTIONAL ANION EXCHANGERS | 9 | 4.38e-01 | -0.149000 | 5.20e-01 |
REACTOME MHC CLASS II ANTIGEN PRESENTATION | 119 | 4.93e-03 | 0.149000 | 1.54e-02 |
REACTOME PECAM1 INTERACTIONS | 11 | 3.92e-01 | 0.149000 | 4.77e-01 |
REACTOME TRANSPORT AND SYNTHESIS OF PAPS | 6 | 5.28e-01 | 0.149000 | 6.06e-01 |
REACTOME ACTIVATION OF PPARGC1A PGC 1ALPHA BY PHOSPHORYLATION | 10 | 4.15e-01 | 0.149000 | 4.98e-01 |
REACTOME MYOGENESIS | 29 | 1.66e-01 | 0.148000 | 2.41e-01 |
REACTOME SODIUM COUPLED SULPHATE DI AND TRI CARBOXYLATE TRANSPORTERS | 5 | 5.67e-01 | -0.148000 | 6.41e-01 |
REACTOME FERTILIZATION | 26 | 1.92e-01 | -0.148000 | 2.70e-01 |
REACTOME INTERLEUKIN 12 SIGNALING | 44 | 9.02e-02 | 0.148000 | 1.49e-01 |
REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 100 | 1.09e-02 | 0.147000 | 2.86e-02 |
REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 2.23e-01 | 0.147000 | 3.00e-01 |
REACTOME INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 25 | 2.06e-01 | 0.146000 | 2.84e-01 |
REACTOME SIGNALING BY INTERLEUKINS | 434 | 1.69e-07 | 0.146000 | 2.62e-06 |
REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 105 | 1.02e-02 | 0.145000 | 2.71e-02 |
REACTOME INTERFERON SIGNALING | 194 | 4.90e-04 | 0.145000 | 2.38e-03 |
REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 178 | 8.55e-04 | -0.145000 | 3.73e-03 |
REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 4.30e-01 | 0.144000 | 5.13e-01 |
REACTOME TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 55 | 6.44e-02 | 0.144000 | 1.15e-01 |
REACTOME GAP JUNCTION ASSEMBLY | 36 | 1.35e-01 | 0.144000 | 2.05e-01 |
REACTOME ACTIVATED NTRK3 SIGNALS THROUGH RAS | 8 | 4.82e-01 | 0.144000 | 5.63e-01 |
REACTOME INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 25 | 2.16e-01 | 0.143000 | 2.93e-01 |
REACTOME ASPARTATE AND ASPARAGINE METABOLISM | 11 | 4.12e-01 | 0.143000 | 4.94e-01 |
REACTOME VXPX CARGO TARGETING TO CILIUM | 20 | 2.69e-01 | 0.143000 | 3.50e-01 |
REACTOME ACYL CHAIN REMODELLING OF PE | 24 | 2.26e-01 | -0.143000 | 3.04e-01 |
REACTOME GLYCEROPHOSPHOLIPID CATABOLISM | 7 | 5.13e-01 | 0.143000 | 5.91e-01 |
REACTOME PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 73 | 3.49e-02 | 0.143000 | 7.12e-02 |
REACTOME DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 20 | 2.69e-01 | 0.143000 | 3.50e-01 |
REACTOME P2Y RECEPTORS | 9 | 4.60e-01 | 0.142000 | 5.43e-01 |
REACTOME INFECTIOUS DISEASE | 889 | 4.22e-13 | 0.142000 | 1.91e-11 |
REACTOME CD209 DC SIGN SIGNALING | 20 | 2.71e-01 | 0.142000 | 3.52e-01 |
REACTOME HYDROLYSIS OF LPC | 9 | 4.61e-01 | -0.142000 | 5.43e-01 |
REACTOME ACYL CHAIN REMODELLING OF PC | 26 | 2.10e-01 | -0.142000 | 2.88e-01 |
REACTOME TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 20 | 2.72e-01 | 0.142000 | 3.53e-01 |
REACTOME GLUTATHIONE CONJUGATION | 35 | 1.47e-01 | 0.142000 | 2.20e-01 |
REACTOME UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 19 | 2.86e-01 | 0.141000 | 3.68e-01 |
REACTOME SIGNALING BY GPCR | 656 | 5.33e-10 | 0.141000 | 1.52e-08 |
REACTOME CA DEPENDENT EVENTS | 35 | 1.48e-01 | 0.141000 | 2.21e-01 |
REACTOME SODIUM CALCIUM EXCHANGERS | 10 | 4.40e-01 | 0.141000 | 5.23e-01 |
REACTOME FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 28 | 1.98e-01 | 0.140000 | 2.76e-01 |
REACTOME SODIUM PROTON EXCHANGERS | 7 | 5.21e-01 | 0.140000 | 5.99e-01 |
REACTOME SARS COV 2 HOST INTERACTIONS | 186 | 9.72e-04 | 0.140000 | 4.12e-03 |
REACTOME TCR SIGNALING | 114 | 9.92e-03 | 0.140000 | 2.65e-02 |
REACTOME NRCAM INTERACTIONS | 6 | 5.55e-01 | 0.139000 | 6.31e-01 |
REACTOME PIWI INTERACTING RNA PIRNA BIOGENESIS | 29 | 1.95e-01 | 0.139000 | 2.73e-01 |
REACTOME CHYLOMICRON REMODELING | 10 | 4.48e-01 | -0.139000 | 5.31e-01 |
REACTOME INTERFERON ALPHA BETA SIGNALING | 72 | 4.19e-02 | 0.139000 | 8.21e-02 |
REACTOME CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 25 | 2.34e-01 | 0.138000 | 3.13e-01 |
REACTOME DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 12 | 4.09e-01 | -0.138000 | 4.93e-01 |
REACTOME VLDL ASSEMBLY | 5 | 5.98e-01 | -0.136000 | 6.69e-01 |
REACTOME INTEGRATION OF PROVIRUS | 9 | 4.80e-01 | 0.136000 | 5.62e-01 |
REACTOME ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 124 | 9.16e-03 | -0.135000 | 2.48e-02 |
REACTOME THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 23 | 2.62e-01 | -0.135000 | 3.42e-01 |
REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 48 | 1.06e-01 | 0.135000 | 1.70e-01 |
REACTOME EXTRACELLULAR MATRIX ORGANIZATION | 281 | 1.10e-04 | 0.134000 | 7.25e-04 |
REACTOME GROWTH HORMONE RECEPTOR SIGNALING | 24 | 2.57e-01 | 0.134000 | 3.39e-01 |
REACTOME ERBB2 REGULATES CELL MOTILITY | 15 | 3.71e-01 | 0.134000 | 4.54e-01 |
REACTOME EUKARYOTIC TRANSLATION INITIATION | 112 | 1.46e-02 | 0.133000 | 3.58e-02 |
REACTOME RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 19 | 3.14e-01 | 0.133000 | 3.97e-01 |
REACTOME AMYLOID FIBER FORMATION | 50 | 1.03e-01 | 0.133000 | 1.66e-01 |
REACTOME GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 36 | 1.67e-01 | 0.133000 | 2.42e-01 |
REACTOME ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 23 | 2.70e-01 | 0.133000 | 3.51e-01 |
REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 11 | 4.46e-01 | 0.133000 | 5.29e-01 |
REACTOME INTERLEUKIN 12 FAMILY SIGNALING | 54 | 9.16e-02 | 0.133000 | 1.52e-01 |
REACTOME O LINKED GLYCOSYLATION OF MUCINS | 57 | 8.39e-02 | -0.132000 | 1.42e-01 |
REACTOME INFLAMMASOMES | 21 | 2.94e-01 | 0.132000 | 3.77e-01 |
REACTOME ACYL CHAIN REMODELLING OF PS | 21 | 2.95e-01 | -0.132000 | 3.78e-01 |
REACTOME LIPOPHAGY | 9 | 4.94e-01 | 0.132000 | 5.74e-01 |
REACTOME EFFECTS OF PIP2 HYDROLYSIS | 26 | 2.45e-01 | 0.132000 | 3.26e-01 |
REACTOME TYSND1 CLEAVES PEROXISOMAL PROTEINS | 7 | 5.49e-01 | 0.131000 | 6.26e-01 |
REACTOME ACYL CHAIN REMODELING OF CL | 5 | 6.13e-01 | 0.131000 | 6.83e-01 |
REACTOME ACTIVATION OF NIMA KINASES NEK9 NEK6 NEK7 | 7 | 5.50e-01 | 0.130000 | 6.27e-01 |
REACTOME RHO GTPASES ACTIVATE RHOTEKIN AND RHOPHILINS | 9 | 4.99e-01 | 0.130000 | 5.79e-01 |
REACTOME THYROXINE BIOSYNTHESIS | 10 | 4.77e-01 | 0.130000 | 5.60e-01 |
REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | 677 | 7.17e-09 | 0.130000 | 1.58e-07 |
REACTOME MATURATION OF SARS COV 1 SPIKE PROTEIN | 5 | 6.17e-01 | 0.129000 | 6.86e-01 |
REACTOME SYNDECAN INTERACTIONS | 26 | 2.54e-01 | 0.129000 | 3.35e-01 |
REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | 25 | 2.64e-01 | 0.129000 | 3.44e-01 |
REACTOME PI3K EVENTS IN ERBB4 SIGNALING | 10 | 4.80e-01 | 0.129000 | 5.62e-01 |
REACTOME PEPTIDE HORMONE METABOLISM | 80 | 4.61e-02 | 0.129000 | 8.77e-02 |
REACTOME LONG TERM POTENTIATION | 22 | 2.97e-01 | 0.128000 | 3.80e-01 |
REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | 338 | 4.78e-05 | 0.128000 | 3.54e-04 |
REACTOME PHENYLALANINE AND TYROSINE METABOLISM | 10 | 4.84e-01 | 0.128000 | 5.65e-01 |
REACTOME DEFECTIVE FACTOR IX CAUSES HEMOPHILIA B | 7 | 5.58e-01 | 0.128000 | 6.34e-01 |
REACTOME GPCR LIGAND BINDING | 428 | 5.44e-06 | 0.128000 | 5.58e-05 |
REACTOME SYNTHESIS OF 5 EICOSATETRAENOIC ACIDS | 9 | 5.08e-01 | 0.127000 | 5.88e-01 |
REACTOME SARS COV 2 ACTIVATES MODULATES INNATE AND ADAPTIVE IMMUNE RESPONSES | 114 | 1.91e-02 | 0.127000 | 4.45e-02 |
REACTOME VASOPRESSIN LIKE RECEPTORS | 5 | 6.25e-01 | 0.126000 | 6.94e-01 |
REACTOME PHOSPHOLIPID METABOLISM | 190 | 2.85e-03 | 0.125000 | 9.88e-03 |
REACTOME L1CAM INTERACTIONS | 111 | 2.26e-02 | 0.125000 | 5.04e-02 |
REACTOME INSULIN RECEPTOR RECYCLING | 29 | 2.44e-01 | 0.125000 | 3.24e-01 |
REACTOME EGFR INTERACTS WITH PHOSPHOLIPASE C GAMMA | 9 | 5.18e-01 | -0.124000 | 5.97e-01 |
REACTOME ACYL CHAIN REMODELLING OF PG | 18 | 3.62e-01 | -0.124000 | 4.45e-01 |
REACTOME NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY DVL INTERACTING PROTEINS | 5 | 6.32e-01 | 0.124000 | 7.00e-01 |
REACTOME SYNTHESIS OF LIPOXINS LX | 6 | 6.00e-01 | 0.124000 | 6.69e-01 |
REACTOME RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 94 | 3.82e-02 | 0.124000 | 7.64e-02 |
REACTOME EUKARYOTIC TRANSLATION ELONGATION | 88 | 4.56e-02 | 0.123000 | 8.71e-02 |
REACTOME SARS COV 2 INFECTION | 275 | 4.35e-04 | 0.123000 | 2.15e-03 |
REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 30 | 2.44e-01 | 0.123000 | 3.24e-01 |
REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 55 | 1.17e-01 | 0.122000 | 1.83e-01 |
REACTOME REGULATED NECROSIS | 55 | 1.17e-01 | 0.122000 | 1.83e-01 |
REACTOME ALK MUTANTS BIND TKIS | 12 | 4.64e-01 | 0.122000 | 5.47e-01 |
REACTOME UNWINDING OF DNA | 12 | 4.70e-01 | 0.120000 | 5.54e-01 |
REACTOME P75NTR REGULATES AXONOGENESIS | 9 | 5.32e-01 | 0.120000 | 6.10e-01 |
REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 23 | 3.18e-01 | 0.120000 | 4.00e-01 |
REACTOME MET ACTIVATES PTPN11 | 5 | 6.42e-01 | 0.120000 | 7.07e-01 |
REACTOME INTERFERON GAMMA SIGNALING | 89 | 5.07e-02 | 0.120000 | 9.48e-02 |
REACTOME MRNA EDITING | 10 | 5.13e-01 | -0.119000 | 5.91e-01 |
REACTOME EARLY SARS COV 2 INFECTION EVENTS | 33 | 2.40e-01 | 0.118000 | 3.21e-01 |
REACTOME KINESINS | 59 | 1.18e-01 | 0.118000 | 1.84e-01 |
REACTOME DNA DAMAGE REVERSAL | 8 | 5.67e-01 | 0.117000 | 6.41e-01 |
REACTOME LATE SARS COV 2 INFECTION EVENTS | 67 | 9.79e-02 | 0.117000 | 1.59e-01 |
REACTOME ACTIVATION OF RAS IN B CELLS | 5 | 6.51e-01 | 0.117000 | 7.14e-01 |
REACTOME CHYLOMICRON CLEARANCE | 5 | 6.54e-01 | 0.116000 | 7.17e-01 |
REACTOME COENZYME A BIOSYNTHESIS | 8 | 5.72e-01 | 0.115000 | 6.46e-01 |
REACTOME OAS ANTIVIRAL RESPONSE | 7 | 5.99e-01 | -0.115000 | 6.69e-01 |
REACTOME RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN BCR SIGNALING | 6 | 6.27e-01 | 0.115000 | 6.95e-01 |
REACTOME STRIATED MUSCLE CONTRACTION | 35 | 2.42e-01 | 0.114000 | 3.23e-01 |
REACTOME LDL REMODELING | 6 | 6.30e-01 | -0.114000 | 6.98e-01 |
REACTOME G ALPHA S SIGNALLING EVENTS | 152 | 1.58e-02 | 0.113000 | 3.84e-02 |
REACTOME MUSCLE CONTRACTION | 194 | 6.46e-03 | 0.113000 | 1.89e-02 |
REACTOME ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 28 | 3.00e-01 | 0.113000 | 3.83e-01 |
REACTOME DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 17 | 4.20e-01 | 0.113000 | 5.02e-01 |
REACTOME HDL CLEARANCE | 5 | 6.62e-01 | 0.113000 | 7.25e-01 |
REACTOME SELENOAMINO ACID METABOLISM | 103 | 4.80e-02 | 0.113000 | 9.07e-02 |
REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 17 | 4.21e-01 | 0.113000 | 5.04e-01 |
REACTOME MUSCARINIC ACETYLCHOLINE RECEPTORS | 5 | 6.63e-01 | -0.113000 | 7.25e-01 |
REACTOME CLASS A 1 RHODOPSIN LIKE RECEPTORS | 300 | 8.25e-04 | 0.112000 | 3.64e-03 |
REACTOME TRANSPORT OF FATTY ACIDS | 8 | 5.85e-01 | 0.112000 | 6.57e-01 |
REACTOME IRS ACTIVATION | 5 | 6.66e-01 | 0.111000 | 7.28e-01 |
REACTOME RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF KERATINOCYTES | 6 | 6.37e-01 | 0.111000 | 7.04e-01 |
REACTOME INTERLEUKIN 37 SIGNALING | 20 | 3.90e-01 | 0.111000 | 4.74e-01 |
REACTOME PEPTIDE HORMONE BIOSYNTHESIS | 12 | 5.07e-01 | 0.111000 | 5.86e-01 |
REACTOME DEFECTIVE F9 ACTIVATION | 5 | 6.69e-01 | 0.110000 | 7.30e-01 |
REACTOME SLC TRANSPORTER DISORDERS | 91 | 6.88e-02 | 0.110000 | 1.22e-01 |
REACTOME MET PROMOTES CELL MOTILITY | 41 | 2.22e-01 | 0.110000 | 3.00e-01 |
REACTOME SYNTHESIS OF PG | 8 | 5.90e-01 | 0.110000 | 6.62e-01 |
REACTOME SUPPRESSION OF PHAGOSOMAL MATURATION | 13 | 4.94e-01 | 0.110000 | 5.74e-01 |
REACTOME TRNA MODIFICATION IN THE MITOCHONDRION | 6 | 6.42e-01 | 0.109000 | 7.07e-01 |
REACTOME TRANSPORT OF SMALL MOLECULES | 685 | 9.32e-07 | 0.109000 | 1.23e-05 |
REACTOME CA2 ACTIVATED K CHANNELS | 9 | 5.71e-01 | -0.109000 | 6.46e-01 |
REACTOME ARYL HYDROCARBON RECEPTOR SIGNALLING | 6 | 6.45e-01 | 0.109000 | 7.10e-01 |
REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 4.19e-01 | 0.107000 | 5.02e-01 |
REACTOME ACROSOME REACTION AND SPERM OOCYTE MEMBRANE BINDING | 6 | 6.50e-01 | -0.107000 | 7.13e-01 |
REACTOME NICOTINAMIDE SALVAGING | 16 | 4.59e-01 | 0.107000 | 5.42e-01 |
REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 18 | 4.35e-01 | 0.106000 | 5.18e-01 |
REACTOME FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 131 | 3.62e-02 | -0.106000 | 7.35e-02 |
REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 149 | 2.56e-02 | 0.106000 | 5.58e-02 |
REACTOME METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 32 | 3.04e-01 | 0.105000 | 3.87e-01 |
REACTOME CROSS PRESENTATION OF PARTICULATE EXOGENOUS ANTIGENS PHAGOSOMES | 7 | 6.35e-01 | -0.104000 | 7.02e-01 |
REACTOME DAP12 SIGNALING | 28 | 3.43e-01 | 0.103000 | 4.26e-01 |
REACTOME SYNTHESIS OF 16 20 HYDROXYEICOSATETRAENOIC ACIDS HETE | 9 | 5.91e-01 | -0.103000 | 6.62e-01 |
REACTOME NICOTINATE METABOLISM | 25 | 3.71e-01 | 0.103000 | 4.54e-01 |
REACTOME PLASMA LIPOPROTEIN ASSEMBLY | 19 | 4.36e-01 | -0.103000 | 5.18e-01 |
REACTOME REGULATION OF SIGNALING BY NODAL | 11 | 5.53e-01 | 0.103000 | 6.30e-01 |
REACTOME VITAMIN D CALCIFEROL METABOLISM | 12 | 5.38e-01 | 0.103000 | 6.15e-01 |
REACTOME CHYLOMICRON ASSEMBLY | 10 | 5.76e-01 | -0.102000 | 6.50e-01 |
REACTOME SIGNALLING TO P38 VIA RIT AND RIN | 5 | 6.95e-01 | 0.101000 | 7.50e-01 |
REACTOME INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 105 | 7.24e-02 | 0.101000 | 1.26e-01 |
REACTOME INTERLEUKIN 20 FAMILY SIGNALING | 22 | 4.13e-01 | 0.101000 | 4.96e-01 |
REACTOME CD28 DEPENDENT VAV1 PATHWAY | 11 | 5.66e-01 | -0.099900 | 6.41e-01 |
REACTOME METABOLISM OF AMINE DERIVED HORMONES | 17 | 4.79e-01 | -0.099200 | 5.61e-01 |
REACTOME SARS COV 2 MODULATES HOST TRANSLATION MACHINERY | 47 | 2.48e-01 | 0.097400 | 3.28e-01 |
REACTOME TRANSPORT OF RCBL WITHIN THE BODY | 8 | 6.33e-01 | 0.097400 | 7.01e-01 |
REACTOME METABOLISM OF NUCLEOTIDES | 86 | 1.20e-01 | 0.096900 | 1.87e-01 |
REACTOME SENSORY PROCESSING OF SOUND | 69 | 1.64e-01 | 0.096800 | 2.40e-01 |
REACTOME CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 44 | 2.68e-01 | 0.096500 | 3.49e-01 |
REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 113 | 7.62e-02 | 0.096500 | 1.31e-01 |
REACTOME CARDIAC CONDUCTION | 125 | 6.44e-02 | 0.095700 | 1.15e-01 |
REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | 14 | 5.43e-01 | 0.093900 | 6.20e-01 |
REACTOME AFLATOXIN ACTIVATION AND DETOXIFICATION | 19 | 4.81e-01 | 0.093500 | 5.62e-01 |
REACTOME PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 77 | 1.57e-01 | 0.093200 | 2.31e-01 |
REACTOME REMOVAL OF AMINOTERMINAL PROPEPTIDES FROM GAMMA CARBOXYLATED PROTEINS | 8 | 6.48e-01 | -0.093100 | 7.12e-01 |
REACTOME PYRIMIDINE CATABOLISM | 11 | 5.94e-01 | -0.092900 | 6.64e-01 |
REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 20 | 4.73e-01 | 0.092700 | 5.56e-01 |
REACTOME PROTON COUPLED MONOCARBOXYLATE TRANSPORT | 6 | 6.96e-01 | -0.092200 | 7.50e-01 |
REACTOME POLO LIKE KINASE MEDIATED EVENTS | 16 | 5.27e-01 | 0.091300 | 6.05e-01 |
REACTOME PROTEIN REPAIR | 6 | 6.99e-01 | -0.091000 | 7.54e-01 |
REACTOME C TYPE LECTIN RECEPTORS CLRS | 135 | 6.88e-02 | 0.090600 | 1.22e-01 |
REACTOME PHOSPHORYLATION OF EMI1 | 6 | 7.09e-01 | -0.087900 | 7.63e-01 |
REACTOME PASSIVE TRANSPORT BY AQUAPORINS | 13 | 5.86e-01 | -0.087200 | 6.58e-01 |
REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 20 | 5.01e-01 | 0.087000 | 5.80e-01 |
REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT | 234 | 2.24e-02 | 0.086500 | 5.01e-02 |
REACTOME PHASE I FUNCTIONALIZATION OF COMPOUNDS | 98 | 1.41e-01 | 0.086000 | 2.13e-01 |
REACTOME DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 77 | 1.92e-01 | 0.085900 | 2.70e-01 |
REACTOME SARS COV 1 MODULATES HOST TRANSLATION MACHINERY | 34 | 3.87e-01 | 0.085800 | 4.71e-01 |
REACTOME RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 14 | 5.81e-01 | 0.085100 | 6.54e-01 |
REACTOME TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 82 | 1.83e-01 | 0.084900 | 2.61e-01 |
REACTOME TRP CHANNELS | 27 | 4.53e-01 | 0.083400 | 5.36e-01 |
REACTOME PROLACTIN RECEPTOR SIGNALING | 15 | 5.79e-01 | 0.082800 | 6.52e-01 |
REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 15 | 5.79e-01 | 0.082700 | 6.52e-01 |
REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | 34 | 4.08e-01 | 0.082000 | 4.91e-01 |
REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 17 | 5.60e-01 | 0.081600 | 6.35e-01 |
REACTOME PHOSPHORYLATION OF THE APC C | 19 | 5.38e-01 | 0.081500 | 6.15e-01 |
REACTOME ADAPTIVE IMMUNE SYSTEM | 771 | 1.10e-04 | 0.081300 | 7.25e-04 |
REACTOME RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN INTERLEUKIN SIGNALING | 5 | 7.53e-01 | -0.081100 | 8.05e-01 |
REACTOME REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 6.42e-01 | 0.080900 | 7.07e-01 |
REACTOME METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 114 | 1.38e-01 | 0.080400 | 2.09e-01 |
REACTOME ARACHIDONIC ACID METABOLISM | 56 | 2.98e-01 | 0.080300 | 3.81e-01 |
REACTOME GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 30 | 4.48e-01 | 0.080000 | 5.31e-01 |
REACTOME SARS COV INFECTIONS | 434 | 4.21e-03 | 0.079800 | 1.35e-02 |
REACTOME HEMOSTASIS | 622 | 6.43e-04 | 0.079700 | 2.93e-03 |
REACTOME REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 5 | 7.58e-01 | 0.079500 | 8.08e-01 |
REACTOME ACTIVATION OF THE PHOTOTRANSDUCTION CASCADE | 11 | 6.48e-01 | 0.079500 | 7.12e-01 |
REACTOME RSK ACTIVATION | 5 | 7.59e-01 | 0.079300 | 8.08e-01 |
REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 37 | 4.07e-01 | 0.078700 | 4.91e-01 |
REACTOME ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY | 10 | 6.68e-01 | 0.078400 | 7.29e-01 |
REACTOME INTERLEUKIN 23 SIGNALING | 9 | 6.84e-01 | -0.078300 | 7.43e-01 |
REACTOME NEUREXINS AND NEUROLIGINS | 51 | 3.34e-01 | 0.078100 | 4.18e-01 |
REACTOME BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 19 | 5.59e-01 | 0.077500 | 6.34e-01 |
REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 16 | 5.92e-01 | 0.077400 | 6.63e-01 |
REACTOME INTERLEUKIN 2 FAMILY SIGNALING | 40 | 4.05e-01 | 0.076000 | 4.89e-01 |
REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 27 HYDROXYCHOLESTEROL | 15 | 6.11e-01 | -0.075800 | 6.81e-01 |
REACTOME COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 59 | 3.15e-01 | 0.075600 | 3.97e-01 |
REACTOME DISSOLUTION OF FIBRIN CLOT | 13 | 6.39e-01 | 0.075200 | 7.05e-01 |
REACTOME DRUG ADME | 107 | 1.80e-01 | -0.074900 | 2.57e-01 |
REACTOME KETONE BODY METABOLISM | 10 | 6.82e-01 | 0.074900 | 7.41e-01 |
REACTOME BIOLOGICAL OXIDATIONS | 211 | 6.09e-02 | 0.074700 | 1.11e-01 |
REACTOME SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 49 | 3.66e-01 | 0.074600 | 4.49e-01 |
REACTOME RUNX3 REGULATES IMMUNE RESPONSE AND CELL MIGRATION | 6 | 7.53e-01 | 0.074200 | 8.05e-01 |
REACTOME INTERLEUKIN RECEPTOR SHC SIGNALING | 24 | 5.31e-01 | 0.073900 | 6.09e-01 |
REACTOME TFAP2A ACTS AS A TRANSCRIPTIONAL REPRESSOR DURING RETINOIC ACID INDUCED CELL DIFFERENTIATION | 5 | 7.75e-01 | 0.073800 | 8.24e-01 |
REACTOME GLUCURONIDATION | 24 | 5.35e-01 | -0.073200 | 6.12e-01 |
REACTOME OTHER SEMAPHORIN INTERACTIONS | 18 | 5.91e-01 | 0.073200 | 6.62e-01 |
REACTOME ORGANIC CATION TRANSPORT | 10 | 6.89e-01 | 0.073200 | 7.46e-01 |
REACTOME MET ACTIVATES PTK2 SIGNALING | 30 | 4.95e-01 | 0.072000 | 5.75e-01 |
REACTOME METABOLISM OF VITAMINS AND COFACTORS | 176 | 9.98e-02 | 0.071800 | 1.62e-01 |
REACTOME ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 17 | 6.12e-01 | -0.071000 | 6.82e-01 |
REACTOME FCERI MEDIATED NF KB ACTIVATION | 124 | 1.73e-01 | -0.070800 | 2.49e-01 |
REACTOME SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 16 | 6.27e-01 | 0.070200 | 6.95e-01 |
REACTOME SYNAPTIC ADHESION LIKE MOLECULES | 19 | 5.96e-01 | 0.070200 | 6.67e-01 |
REACTOME LTC4 CYSLTR MEDIATED IL4 PRODUCTION | 6 | 7.70e-01 | -0.068900 | 8.19e-01 |
REACTOME G ALPHA I SIGNALLING EVENTS | 302 | 4.09e-02 | 0.068200 | 8.06e-02 |
REACTOME DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 61 | 3.61e-01 | 0.067600 | 4.45e-01 |
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | 52 | 4.04e-01 | -0.066800 | 4.88e-01 |
REACTOME COSTIMULATION BY THE CD28 FAMILY | 68 | 3.41e-01 | 0.066700 | 4.25e-01 |
REACTOME ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 6 | 7.79e-01 | 0.066300 | 8.27e-01 |
REACTOME INTESTINAL ABSORPTION | 5 | 8.03e-01 | 0.064600 | 8.48e-01 |
REACTOME SIGNALING BY MST1 | 5 | 8.05e-01 | -0.063700 | 8.49e-01 |
REACTOME NFE2L2 REGULATING ANTI OXIDANT DETOXIFICATION ENZYMES | 17 | 6.50e-01 | 0.063600 | 7.13e-01 |
REACTOME NEUTROPHIL DEGRANULATION | 448 | 2.12e-02 | 0.063300 | 4.82e-02 |
REACTOME STIMULI SENSING CHANNELS | 100 | 2.80e-01 | 0.062500 | 3.61e-01 |
REACTOME HS GAG DEGRADATION | 19 | 6.40e-01 | 0.061900 | 7.07e-01 |
REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | 153 | 1.89e-01 | -0.061400 | 2.67e-01 |
REACTOME HDL ASSEMBLY | 8 | 7.64e-01 | -0.061300 | 8.13e-01 |
REACTOME MATURATION OF SARS COV 2 SPIKE PROTEIN | 35 | 5.32e-01 | 0.061000 | 6.10e-01 |
REACTOME RUNX1 AND FOXP3 CONTROL THE DEVELOPMENT OF REGULATORY T LYMPHOCYTES TREGS | 9 | 7.57e-01 | -0.059500 | 8.08e-01 |
REACTOME PYRIMIDINE SALVAGE | 10 | 7.48e-01 | 0.058800 | 8.00e-01 |
REACTOME METABOLISM OF FOLATE AND PTERINES | 16 | 6.87e-01 | 0.058200 | 7.45e-01 |
REACTOME GLUTATHIONE SYNTHESIS AND RECYCLING | 12 | 7.29e-01 | -0.057700 | 7.83e-01 |
REACTOME NR1H2 NR1H3 REGULATE GENE EXPRESSION LINKED TO GLUCONEOGENESIS | 5 | 8.23e-01 | 0.057700 | 8.64e-01 |
REACTOME ENDOGENOUS STEROLS | 25 | 6.20e-01 | 0.057300 | 6.89e-01 |
REACTOME SCAVENGING BY CLASS A RECEPTORS | 19 | 6.67e-01 | 0.057100 | 7.28e-01 |
REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | 16 | 6.95e-01 | -0.056700 | 7.50e-01 |
REACTOME METABOLISM OF STEROID HORMONES | 33 | 5.74e-01 | 0.056600 | 6.47e-01 |
REACTOME ION TRANSPORT BY P TYPE ATPASES | 51 | 4.86e-01 | -0.056300 | 5.67e-01 |
REACTOME VISUAL PHOTOTRANSDUCTION | 92 | 3.51e-01 | -0.056300 | 4.34e-01 |
REACTOME INTERLEUKIN 18 SIGNALING | 8 | 7.83e-01 | -0.056200 | 8.31e-01 |
REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | 16 | 7.02e-01 | 0.055300 | 7.56e-01 |
REACTOME GENERATION OF SECOND MESSENGER MOLECULES | 32 | 5.89e-01 | -0.055200 | 6.61e-01 |
REACTOME ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 17 | 6.93e-01 | -0.055200 | 7.50e-01 |
REACTOME UPTAKE AND FUNCTION OF DIPHTHERIA TOXIN | 6 | 8.15e-01 | 0.055000 | 8.58e-01 |
REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | 62 | 4.72e-01 | 0.052800 | 5.56e-01 |
REACTOME SYNTHESIS OF KETONE BODIES | 8 | 7.99e-01 | 0.052100 | 8.44e-01 |
REACTOME FIBRONECTIN MATRIX FORMATION | 6 | 8.29e-01 | 0.050900 | 8.69e-01 |
REACTOME ABACAVIR ADME | 9 | 7.92e-01 | 0.050700 | 8.39e-01 |
REACTOME CREB PHOSPHORYLATION | 6 | 8.30e-01 | 0.050600 | 8.69e-01 |
REACTOME INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 21 | 6.89e-01 | 0.050500 | 7.46e-01 |
REACTOME N GLYCAN ANTENNAE ELONGATION | 15 | 7.35e-01 | 0.050500 | 7.89e-01 |
REACTOME INTERLEUKIN 10 SIGNALING | 43 | 5.67e-01 | -0.050400 | 6.41e-01 |
REACTOME RHO GTPASES ACTIVATE NADPH OXIDASES | 22 | 6.89e-01 | -0.049300 | 7.46e-01 |
REACTOME COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 20 | 7.12e-01 | 0.047700 | 7.66e-01 |
REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | 14 | 7.59e-01 | -0.047400 | 8.08e-01 |
REACTOME FRUCTOSE METABOLISM | 6 | 8.41e-01 | 0.047300 | 8.78e-01 |
REACTOME NEF AND SIGNAL TRANSDUCTION | 8 | 8.23e-01 | 0.045800 | 8.63e-01 |
REACTOME RIBAVIRIN ADME | 11 | 7.95e-01 | 0.045300 | 8.41e-01 |
REACTOME GPVI MEDIATED ACTIVATION CASCADE | 34 | 6.48e-01 | 0.045200 | 7.12e-01 |
REACTOME COLLAGEN FORMATION | 80 | 4.97e-01 | 0.043900 | 5.77e-01 |
REACTOME ION CHANNEL TRANSPORT | 172 | 3.25e-01 | 0.043500 | 4.07e-01 |
REACTOME FORMATION OF XYLULOSE 5 PHOSPHATE | 5 | 8.67e-01 | 0.043200 | 8.99e-01 |
REACTOME GLUCONEOGENESIS | 32 | 6.72e-01 | 0.043200 | 7.32e-01 |
REACTOME THE PHOTOTRANSDUCTION CASCADE | 32 | 6.73e-01 | 0.043200 | 7.32e-01 |
REACTOME ACETYLCHOLINE INHIBITS CONTRACTION OF OUTER HAIR CELLS | 5 | 8.69e-01 | 0.042700 | 8.99e-01 |
REACTOME BIOTIN TRANSPORT AND METABOLISM | 10 | 8.16e-01 | -0.042500 | 8.58e-01 |
REACTOME OREXIN AND NEUROPEPTIDES FF AND QRFP BIND TO THEIR RESPECTIVE RECEPTORS | 8 | 8.35e-01 | 0.042500 | 8.74e-01 |
REACTOME SHC1 EVENTS IN EGFR SIGNALING | 14 | 7.84e-01 | -0.042300 | 8.31e-01 |
REACTOME HISTIDINE CATABOLISM | 7 | 8.46e-01 | 0.042300 | 8.81e-01 |
REACTOME CLEC7A INFLAMMASOME PATHWAY | 6 | 8.59e-01 | -0.041900 | 8.91e-01 |
REACTOME TRYPTOPHAN CATABOLISM | 12 | 8.05e-01 | 0.041200 | 8.49e-01 |
REACTOME ION HOMEOSTASIS | 52 | 6.14e-01 | 0.040500 | 6.83e-01 |
REACTOME NUCLEOTIDE CATABOLISM | 32 | 6.93e-01 | 0.040300 | 7.50e-01 |
REACTOME RUNX2 REGULATES GENES INVOLVED IN CELL MIGRATION | 8 | 8.44e-01 | -0.040000 | 8.80e-01 |
REACTOME METABOLISM OF PORPHYRINS | 26 | 7.32e-01 | 0.038900 | 7.86e-01 |
REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 38 | 6.87e-01 | -0.037800 | 7.45e-01 |
REACTOME DAP12 INTERACTIONS | 39 | 6.86e-01 | -0.037400 | 7.45e-01 |
REACTOME GAB1 SIGNALOSOME | 17 | 7.92e-01 | 0.037000 | 8.39e-01 |
REACTOME PURINE SALVAGE | 12 | 8.26e-01 | -0.036600 | 8.66e-01 |
REACTOME PHASE II CONJUGATION OF COMPOUNDS | 106 | 5.15e-01 | 0.036600 | 5.93e-01 |
REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 26 | 7.47e-01 | 0.036600 | 8.00e-01 |
REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | 15 | 8.07e-01 | -0.036500 | 8.51e-01 |
REACTOME PENTOSE PHOSPHATE PATHWAY | 11 | 8.40e-01 | 0.035100 | 8.78e-01 |
REACTOME PHASE 0 RAPID DEPOLARISATION | 31 | 7.37e-01 | -0.034800 | 7.90e-01 |
REACTOME ANCHORING FIBRIL FORMATION | 13 | 8.36e-01 | 0.033100 | 8.75e-01 |
REACTOME G2 M DNA REPLICATION CHECKPOINT | 5 | 8.99e-01 | -0.032900 | 9.25e-01 |
REACTOME COLLAGEN DEGRADATION | 58 | 6.65e-01 | 0.032900 | 7.27e-01 |
REACTOME TRIGLYCERIDE BIOSYNTHESIS | 12 | 8.53e-01 | -0.030900 | 8.87e-01 |
REACTOME SYNTHESIS OF EPOXY EET AND DIHYDROXYEICOSATRIENOIC ACIDS DHET | 8 | 8.88e-01 | 0.028700 | 9.17e-01 |
REACTOME PLASMA LIPOPROTEIN REMODELING | 32 | 7.80e-01 | 0.028600 | 8.28e-01 |
REACTOME N GLYCAN TRIMMING AND ELONGATION IN THE CIS GOLGI | 5 | 9.15e-01 | 0.027400 | 9.38e-01 |
REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 24 | 8.19e-01 | 0.027000 | 8.60e-01 |
REACTOME IRF3 MEDIATED ACTIVATION OF TYPE 1 IFN | 5 | 9.17e-01 | -0.026900 | 9.39e-01 |
REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 9 | 8.95e-01 | 0.025500 | 9.23e-01 |
REACTOME DISEASES OF IMMUNE SYSTEM | 29 | 8.12e-01 | -0.025500 | 8.55e-01 |
REACTOME PHOSPHATE BOND HYDROLYSIS BY NTPDASE PROTEINS | 8 | 9.02e-01 | 0.025300 | 9.26e-01 |
REACTOME SPERM MOTILITY AND TAXES | 9 | 8.97e-01 | 0.025000 | 9.24e-01 |
REACTOME ATTACHMENT AND ENTRY | 15 | 8.70e-01 | 0.024500 | 9.00e-01 |
REACTOME O LINKED GLYCOSYLATION | 97 | 6.78e-01 | 0.024400 | 7.38e-01 |
REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | 9 | 9.02e-01 | -0.023800 | 9.26e-01 |
REACTOME REACTIONS SPECIFIC TO THE COMPLEX N GLYCAN SYNTHESIS PATHWAY | 10 | 9.00e-01 | 0.023000 | 9.26e-01 |
REACTOME COMMON PATHWAY OF FIBRIN CLOT FORMATION | 21 | 8.56e-01 | 0.022800 | 8.89e-01 |
REACTOME RETINOID CYCLE DISEASE EVENTS | 11 | 8.96e-01 | 0.022800 | 9.24e-01 |
REACTOME MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 22 | 8.55e-01 | -0.022500 | 8.89e-01 |
REACTOME LEISHMANIA INFECTION | 206 | 5.80e-01 | -0.022300 | 6.53e-01 |
REACTOME TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 26 | 8.44e-01 | -0.022300 | 8.80e-01 |
REACTOME SYNTHESIS OF PA | 35 | 8.21e-01 | -0.022100 | 8.63e-01 |
REACTOME COLLAGEN CHAIN TRIMERIZATION | 41 | 8.10e-01 | -0.021700 | 8.54e-01 |
REACTOME PYROPTOSIS | 26 | 8.52e-01 | 0.021200 | 8.87e-01 |
REACTOME METHIONINE SALVAGE PATHWAY | 6 | 9.33e-01 | 0.019800 | 9.51e-01 |
REACTOME MET INTERACTS WITH TNS PROTEINS | 5 | 9.40e-01 | 0.019500 | 9.56e-01 |
REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 85 | 7.56e-01 | 0.019500 | 8.07e-01 |
REACTOME DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 34 | 8.44e-01 | 0.019500 | 8.80e-01 |
REACTOME CELLULAR HEXOSE TRANSPORT | 20 | 8.85e-01 | -0.018600 | 9.15e-01 |
REACTOME POTENTIAL THERAPEUTICS FOR SARS | 140 | 7.05e-01 | -0.018500 | 7.59e-01 |
REACTOME VLDL CLEARANCE | 6 | 9.37e-01 | 0.018500 | 9.54e-01 |
REACTOME UREA CYCLE | 9 | 9.26e-01 | 0.018000 | 9.45e-01 |
REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 15 | 9.04e-01 | 0.018000 | 9.28e-01 |
REACTOME ABACAVIR TRANSMEMBRANE TRANSPORT | 5 | 9.45e-01 | 0.017900 | 9.61e-01 |
REACTOME EGFR TRANSACTIVATION BY GASTRIN | 9 | 9.29e-01 | 0.017300 | 9.47e-01 |
REACTOME DNA METHYLATION | 5 | 9.48e-01 | 0.016800 | 9.63e-01 |
REACTOME PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 9.24e-01 | 0.016700 | 9.44e-01 |
REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | 130 | 7.46e-01 | 0.016500 | 7.99e-01 |
REACTOME TRANSPORT OF NUCLEOSIDES AND FREE PURINE AND PYRIMIDINE BASES ACROSS THE PLASMA MEMBRANE | 10 | 9.28e-01 | -0.016400 | 9.47e-01 |
REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 9.19e-01 | 0.016300 | 9.41e-01 |
REACTOME ERBB2 ACTIVATES PTK6 SIGNALING | 13 | 9.23e-01 | 0.015500 | 9.44e-01 |
REACTOME METABOLISM OF FAT SOLUBLE VITAMINS | 45 | 8.59e-01 | -0.015300 | 8.91e-01 |
REACTOME NFE2L2 REGULATES PENTOSE PHOSPHATE PATHWAY GENES | 7 | 9.50e-01 | -0.013800 | 9.64e-01 |
REACTOME BLOOD GROUP SYSTEMS BIOSYNTHESIS | 21 | 9.15e-01 | -0.013400 | 9.38e-01 |
REACTOME ROS AND RNS PRODUCTION IN PHAGOCYTES | 35 | 8.92e-01 | 0.013200 | 9.21e-01 |
REACTOME TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 16 | 9.32e-01 | -0.012400 | 9.50e-01 |
REACTOME TRIGLYCERIDE METABOLISM | 35 | 9.01e-01 | -0.012100 | 9.26e-01 |
REACTOME MATURATION OF PROTEIN 3A | 9 | 9.50e-01 | 0.012000 | 9.65e-01 |
REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 63 | 8.78e-01 | -0.011200 | 9.08e-01 |
REACTOME BICARBONATE TRANSPORTERS | 10 | 9.56e-01 | 0.010100 | 9.70e-01 |
REACTOME SYNTHESIS OF PIPS AT THE ER MEMBRANE | 5 | 9.72e-01 | -0.009010 | 9.82e-01 |
REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 9 | 9.65e-01 | 0.008450 | 9.77e-01 |
REACTOME SYNTHESIS OF PI | 5 | 9.74e-01 | -0.008340 | 9.83e-01 |
REACTOME INDUCTION OF CELL CELL FUSION | 12 | 9.61e-01 | -0.008210 | 9.74e-01 |
REACTOME NEUROTRANSMITTER CLEARANCE | 9 | 9.67e-01 | 0.008080 | 9.77e-01 |
REACTOME SCAVENGING BY CLASS B RECEPTORS | 6 | 9.74e-01 | 0.007760 | 9.83e-01 |
REACTOME ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 57 | 9.21e-01 | -0.007560 | 9.43e-01 |
REACTOME FC EPSILON RECEPTOR FCERI SIGNALING | 173 | 8.65e-01 | -0.007500 | 8.97e-01 |
REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | 14 | 9.66e-01 | -0.006550 | 9.77e-01 |
REACTOME DEFECTS IN BIOTIN BTN METABOLISM | 8 | 9.76e-01 | -0.006210 | 9.84e-01 |
REACTOME TNFR1 MEDIATED CERAMIDE PRODUCTION | 5 | 9.82e-01 | 0.005760 | 9.88e-01 |
REACTOME ARACHIDONATE PRODUCTION FROM DAG | 5 | 9.84e-01 | -0.005240 | 9.89e-01 |
REACTOME VITAMIN B2 RIBOFLAVIN METABOLISM | 7 | 9.82e-01 | -0.005030 | 9.88e-01 |
REACTOME PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 26 | 9.67e-01 | 0.004740 | 9.77e-01 |
REACTOME INNATE IMMUNE SYSTEM | 1044 | 7.99e-01 | -0.004630 | 8.44e-01 |
REACTOME CGMP EFFECTS | 15 | 9.80e-01 | -0.003810 | 9.86e-01 |
REACTOME NUCLEOTIDE SALVAGE | 21 | 9.78e-01 | -0.003430 | 9.86e-01 |
REACTOME TYROSINE CATABOLISM | 5 | 9.90e-01 | -0.003250 | 9.92e-01 |
REACTOME ANDROGEN BIOSYNTHESIS | 11 | 9.88e-01 | -0.002720 | 9.91e-01 |
REACTOME TRIGLYCERIDE CATABOLISM | 23 | 9.85e-01 | -0.002310 | 9.89e-01 |
REACTOME BILE ACID AND BILE SALT METABOLISM | 43 | 9.79e-01 | 0.002300 | 9.86e-01 |
REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 19 | 9.88e-01 | 0.002050 | 9.91e-01 |
REACTOME SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 21 | 9.91e-01 | 0.001350 | 9.93e-01 |
REACTOME SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 15 | 9.94e-01 | -0.001090 | 9.95e-01 |
REACTOME PARACETAMOL ADME | 29 | 9.98e-01 | 0.000262 | 9.98e-01 |
REACTOME NCAM1 INTERACTIONS | 41 | 9.98e-01 | 0.000191 | 9.98e-01 |
REACTOME_FORMATION_OF_LATERAL_PLATE_MESODERM
1602 | |
---|---|
set | REACTOME_FORMATION_OF_LATERAL_PLATE_MESODERM |
setSize | 5 |
pANOVA | 0.00047 |
s.dist | 0.903 |
p.adjustANOVA | 0.0023 |
Top enriched genes
GeneID | Gene Rank |
---|---|
SHH | 6252 |
FOXF1 | 5408 |
BMP4 | 5031 |
GATA4 | 4914 |
IHH | 4421 |
GeneID | Gene Rank |
---|---|
SHH | 6252 |
FOXF1 | 5408 |
BMP4 | 5031 |
GATA4 | 4914 |
IHH | 4421 |
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS
421 | |
---|---|
set | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS |
setSize | 8 |
pANOVA | 1.27e-05 |
s.dist | 0.891 |
p.adjustANOVA | 0.000116 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PTF1A | 6709 |
NKX6-1 | 6466 |
ONECUT1 | 6430 |
FGF10 | 6416 |
PDX1 | 6317 |
ONECUT3 | 5631 |
HNF1B | 4885 |
NR5A2 | -2832 |
GeneID | Gene Rank |
---|---|
PTF1A | 6709 |
NKX6-1 | 6466 |
ONECUT1 | 6430 |
FGF10 | 6416 |
PDX1 | 6317 |
ONECUT3 | 5631 |
HNF1B | 4885 |
NR5A2 | -2832 |
REACTOME_OLFACTORY_SIGNALING_PATHWAY
626 | |
---|---|
set | REACTOME_OLFACTORY_SIGNALING_PATHWAY |
setSize | 373 |
pANOVA | 2.54e-141 |
s.dist | -0.757 |
p.adjustANOVA | 4.14e-138 |
Top enriched genes
GeneID | Gene Rank |
---|---|
OR6Q1 | -27075 |
OR9I1 | -27072 |
OR1S2 | -27041 |
OR51I1 | -27031 |
OR2T29 | -27025 |
OR10W1 | -27007 |
OR5H6 | -27002 |
OR5H1 | -26981 |
OR10K2 | -26949 |
OR10J3 | -26927 |
OR52D1 | -26926 |
OR2M7 | -26892 |
OR2M4 | -26891 |
OR4C3 | -26890 |
OR10Z1 | -26873 |
OR52A5 | -26870 |
OR5AC2 | -26867 |
OR10G9 | -26861 |
OR5H14 | -26853 |
OR6P1 | -26791 |
GeneID | Gene Rank |
---|---|
OR6Q1 | -27075 |
OR9I1 | -27072 |
OR1S2 | -27041 |
OR51I1 | -27031 |
OR2T29 | -27025 |
OR10W1 | -27007 |
OR5H6 | -27002 |
OR5H1 | -26981 |
OR10K2 | -26949 |
OR10J3 | -26927 |
OR52D1 | -26926 |
OR2M7 | -26892 |
OR2M4 | -26891 |
OR4C3 | -26890 |
OR10Z1 | -26873 |
OR52A5 | -26870 |
OR5AC2 | -26867 |
OR10G9 | -26861 |
OR5H14 | -26853 |
OR6P1 | -26791 |
OR10J1 | -26778 |
OR2L5 | -26767 |
OR6Y1 | -26756 |
OR4D1 | -26737 |
OR1B1 | -26699 |
OR56A1 | -26691 |
OR8B8 | -26689 |
OR6K2 | -26687 |
OR5W2 | -26655 |
OR5J2 | -26648 |
OR2T5 | -26641 |
OR56B1 | -26639 |
OR1S1 | -26635 |
OR8H2 | -26633 |
OR5B17 | -26614 |
OR14I1 | -26595 |
OR4C46 | -26594 |
OR51F1 | -26587 |
OR2M5 | -26579 |
OR14J1 | -26576 |
OR52E2 | -26553 |
OR1L1 | -26548 |
OR1N1 | -26544 |
OR8U1 | -26518 |
OR13G1 | -26513 |
OR14A2 | -26512 |
OR2AP1 | -26510 |
OR14K1 | -26497 |
OR8B12 | -26492 |
OR4D11 | -26491 |
OR5I1 | -26481 |
OR5B2 | -26474 |
OR10J5 | -26471 |
OR5B21 | -26467 |
OR5AS1 | -26464 |
OR2B11 | -26463 |
OR6N1 | -26451 |
OR2G2 | -26428 |
OR4D9 | -26393 |
OR8B4 | -26387 |
OR8K3 | -26383 |
OR3A2 | -26381 |
OR52E6 | -26372 |
OR52N4 | -26355 |
OR10G8 | -26345 |
OR2T34 | -26340 |
OR5T3 | -26329 |
OR4D10 | -26322 |
OR6F1 | -26309 |
OR51J1 | -26302 |
OR8K5 | -26278 |
OR51B6 | -26274 |
OR4A16 | -26270 |
OR51B5 | -26216 |
OR5B3 | -26211 |
OR5T2 | -26199 |
OR52R1 | -26167 |
OR2F1 | -26162 |
OR2T6 | -26133 |
OR10AG1 | -26132 |
OR51F2 | -26110 |
OR5B12 | -26091 |
OR4D6 | -26090 |
OR10G4 | -26076 |
OR4A47 | -26070 |
OR8H3 | -26065 |
OR10C1 | -26063 |
OR8J1 | -26059 |
OR5P2 | -26050 |
OR2A25 | -26047 |
OR51A7 | -26045 |
OR8A1 | -26043 |
OR4C16 | -26039 |
OR6B1 | -26030 |
OR6N2 | -26025 |
OR11H7 | -26024 |
OR5AU1 | -26016 |
OR51B2 | -26008 |
OR52E4 | -26003 |
OR5M8 | -25980 |
OR5AP2 | -25966 |
OR9G1 | -25965 |
OR11L1 | -25958 |
OR5M3 | -25955 |
OR8J3 | -25950 |
OR12D2 | -25903 |
OR10A5 | -25896 |
OR8D1 | -25889 |
OR4F15 | -25863 |
OR52J3 | -25827 |
OR52H1 | -25808 |
OR9Q2 | -25789 |
OR5AR1 | -25784 |
OR2G3 | -25774 |
OR2T12 | -25771 |
OR2A2 | -25748 |
OR2A4 | -25735 |
OR5F1 | -25728 |
OR52L1 | -25709 |
OR2L8 | -25693 |
OR51T1 | -25681 |
OR4F4 | -25666 |
OR1C1 | -25646 |
OR2AG2 | -25645 |
OR2M3 | -25628 |
OR51I2 | -25624 |
OR10K1 | -25600 |
OR5L1 | -25584 |
OR4A15 | -25565 |
OR2G6 | -25557 |
OR51B4 | -25553 |
OR2W1 | -25547 |
OR2T3 | -25531 |
OR5H15 | -25522 |
OR2T33 | -25513 |
OR6C75 | -25511 |
OR10X1 | -25493 |
OR9G4 | -25490 |
OR6K6 | -25483 |
OR51Q1 | -25479 |
OR52N1 | -25470 |
OR10T2 | -25467 |
OR8B2 | -25455 |
OR4E2 | -25445 |
OR51G2 | -25404 |
OR4C15 | -25380 |
OR5D13 | -25372 |
OR2M2 | -25363 |
OR9A2 | -25348 |
OR14C36 | -25346 |
OR4X2 | -25342 |
OR2W3 | -25327 |
OR51A2 | -25317 |
OR52A1 | -25223 |
OR10S1 | -25208 |
OR14A16 | -25197 |
OR4D5 | -25172 |
OR2B3 | -25161 |
OR2T35 | -25160 |
OR5AK2 | -25154 |
OR10A4 | -25147 |
OR10D3 | -25137 |
OR7G3 | -25121 |
OR10Q1 | -25054 |
OR3A3 | -25044 |
OR52B2 | -25043 |
OR2D2 | -25015 |
OR2J2 | -25008 |
OR52E8 | -24969 |
OR1L6 | -24949 |
OR10R2 | -24927 |
OR5T1 | -24925 |
OR51G1 | -24906 |
OR8K1 | -24884 |
OR5V1 | -24874 |
OR5M9 | -24862 |
OR4C12 | -24830 |
OR1L4 | -24822 |
OR8B3 | -24811 |
OR5L2 | -24802 |
OR51D1 | -24757 |
OR2AT4 | -24742 |
OR4C6 | -24737 |
OR2AE1 | -24729 |
OR5D14 | -24686 |
OR1J2 | -24649 |
OR4S1 | -24591 |
OR9Q1 | -24586 |
OR51E1 | -24583 |
OR52N2 | -24577 |
OR2Z1 | -24527 |
OR5A1 | -24509 |
OR2A12 | -24485 |
OR52B6 | -24482 |
OR12D3 | -24430 |
OR56A4 | -24423 |
OR1K1 | -24422 |
OR8D2 | -24418 |
OR2L2 | -24412 |
OR8I2 | -24396 |
OR56A3 | -24384 |
OR9K2 | -24369 |
OR2J3 | -24364 |
OR5M1 | -24348 |
OR2T2 | -24325 |
OR2T8 | -24315 |
OR4B1 | -24302 |
OR5H2 | -24301 |
ANO2 | -24251 |
OR1L8 | -24179 |
OR5A2 | -24172 |
OR5AN1 | -24159 |
OR4K5 | -24157 |
OR2T1 | -24141 |
OR11A1 | -24082 |
OR2S2 | -24078 |
OR56B4 | -24073 |
OR2Y1 | -24055 |
OR1Q1 | -24052 |
OR4K13 | -24050 |
OR51S1 | -24030 |
OR4F6 | -24022 |
OR5D18 | -23989 |
OR2AJ1 | -23942 |
OR6X1 | -23891 |
OR52I2 | -23861 |
OR52K1 | -23825 |
OR4C5 | -23811 |
OR13D1 | -23794 |
OR1A2 | -23769 |
OR51L1 | -23730 |
OR10A3 | -23706 |
OR10A7 | -23683 |
OR6B2 | -23678 |
OR1M1 | -23656 |
OR6C6 | -23592 |
OR6C74 | -23558 |
OR2T27 | -23542 |
OR4N4 | -23484 |
OR5M11 | -23459 |
OR2K2 | -23451 |
OR51V1 | -23432 |
OR2J1 | -23357 |
OR7C2 | -23324 |
OR4D2 | -23304 |
OR10G7 | -23299 |
OR6C65 | -23279 |
OR5C1 | -23263 |
OR7D4 | -23255 |
OR2H1 | -23125 |
OR6T1 | -23103 |
OR8D4 | -23072 |
OR4K15 | -23036 |
OR2V1 | -23029 |
OR1E2 | -22991 |
OR6C2 | -22933 |
OR1J4 | -22923 |
OR6C1 | -22890 |
OR7G2 | -22886 |
OR5D16 | -22863 |
OR1L3 | -22860 |
OR51M1 | -22856 |
OR2L13 | -22832 |
OR10V1 | -22821 |
OR2D3 | -22709 |
OR10H5 | -22698 |
OR52K2 | -22693 |
OR2AG1 | -22630 |
OR1N2 | -22604 |
OR6K3 | -22553 |
OR2A5 | -22532 |
OR2F2 | -22463 |
OR10G2 | -22462 |
OR51E2 | -22440 |
OR10H3 | -22434 |
OR2AK2 | -22422 |
OR4F5 | -22417 |
OR1D5 | -22397 |
OR52W1 | -22296 |
OR8H1 | -22207 |
OR5P3 | -22206 |
OR7G1 | -22137 |
OR4X1 | -22113 |
OR7A17 | -22069 |
OR6C4 | -22031 |
OR2T4 | -22015 |
OR4M1 | -21987 |
OR13C2 | -21981 |
OR52I1 | -21746 |
OR7E24 | -21701 |
OR6J1 | -21535 |
OR10H4 | -21498 |
OR10H2 | -21152 |
OR52N5 | -21021 |
OR1D2 | -20978 |
OR7D2 | -20975 |
RTP2 | -20915 |
OR10A6 | -20823 |
OR4A5 | -20652 |
OR10P1 | -20584 |
OR2A14 | -20581 |
OR4N2 | -20579 |
OR52M1 | -20507 |
OR10H1 | -20346 |
OR2V2 | -20281 |
OR6A2 | -20122 |
OR1E1 | -19980 |
OR13A1 | -19947 |
OR2L3 | -19931 |
OR11G2 | -19918 |
OR10A2 | -19859 |
OR6C70 | -19711 |
OR4Q3 | -19699 |
OR1J1 | -19569 |
OR6V1 | -19505 |
OR5K3 | -19501 |
OR1F1 | -19173 |
OR4C13 | -19153 |
OR6C3 | -19009 |
OR6C68 | -18942 |
OR13C9 | -18921 |
OR9A4 | -18768 |
OR13J1 | -18720 |
OR5K2 | -18542 |
OR2H2 | -18442 |
OR2C1 | -18375 |
OR4K1 | -18347 |
OR13C3 | -18264 |
OR5M10 | -17966 |
OR5K4 | -17914 |
OR13F1 | -17538 |
REEP1 | -17480 |
OR4L1 | -17403 |
OR6B3 | -17400 |
OR2B6 | -17314 |
ADCY3 | -17130 |
OR6M1 | -17083 |
OR5K1 | -17015 |
OR8S1 | -16954 |
OR4K17 | -16924 |
EBF1 | -16910 |
OR2B2 | -16491 |
OR6S1 | -16034 |
OR13C8 | -15760 |
OR4M2 | -15571 |
OR1A1 | -15376 |
OR1G1 | -15049 |
OR10AD1 | -14878 |
OR10G3 | -14801 |
CNGB1 | -14776 |
OR3A1 | -14732 |
OR2T11 | -14600 |
OR4Q2 | -13368 |
CNGA4 | -12546 |
OR13C4 | -12351 |
OR4K2 | -12287 |
OR1I1 | -11628 |
OR4K14 | -10846 |
OR11H4 | -10012 |
RTP1 | -9900 |
OR2C3 | -8616 |
OR7C1 | -7784 |
GNAL | -5571 |
OR11H6 | -2410 |
OR2A1 | -2197 |
OR4N5 | -2180 |
OR7A10 | -1468 |
GNG13 | 702 |
GNB1 | 3998 |
LDB1 | 4099 |
OR7A5 | 5213 |
OR6C76 | 5608 |
LHX2 | 6452 |
REACTOME_BETA_DEFENSINS
110 | |
---|---|
set | REACTOME_BETA_DEFENSINS |
setSize | 36 |
pANOVA | 3.73e-14 |
s.dist | -0.729 |
p.adjustANOVA | 2.17e-12 |
Top enriched genes
GeneID | Gene Rank |
---|---|
DEFB107B | -26858 |
DEFB105B | -26590 |
DEFB105A | -26568 |
DEFB106B | -26101 |
DEFB118 | -26036 |
DEFB135 | -25882 |
DEFB119 | -25851 |
DEFB115 | -25770 |
DEFB116 | -25749 |
DEFB126 | -25587 |
DEFB106A | -25566 |
DEFB114 | -25545 |
DEFB103A | -25521 |
DEFB121 | -25229 |
DEFB104B | -25192 |
DEFB127 | -24557 |
DEFB110 | -24236 |
DEFB125 | -24152 |
DEFB4A | -24047 |
DEFB108B | -23922 |
GeneID | Gene Rank |
---|---|
DEFB107B | -26858 |
DEFB105B | -26590 |
DEFB105A | -26568 |
DEFB106B | -26101 |
DEFB118 | -26036 |
DEFB135 | -25882 |
DEFB119 | -25851 |
DEFB115 | -25770 |
DEFB116 | -25749 |
DEFB126 | -25587 |
DEFB106A | -25566 |
DEFB114 | -25545 |
DEFB103A | -25521 |
DEFB121 | -25229 |
DEFB104B | -25192 |
DEFB127 | -24557 |
DEFB110 | -24236 |
DEFB125 | -24152 |
DEFB4A | -24047 |
DEFB108B | -23922 |
DEFB128 | -23827 |
DEFB129 | -23112 |
DEFB123 | -22494 |
DEFB104A | -22488 |
DEFB113 | -22004 |
CCR2 | -21824 |
CCR6 | -21719 |
DEFB134 | -21632 |
DEFB4B | -21426 |
DEFB133 | -20848 |
DEFB136 | -20746 |
TLR1 | -20006 |
DEFB132 | -18419 |
TLR2 | -14967 |
DEFB1 | -2305 |
DEFB124 | -1751 |
REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS
1048 | |
---|---|
set | REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS |
setSize | 6 |
pANOVA | 0.00218 |
s.dist | -0.722 |
p.adjustANOVA | 0.00796 |
Top enriched genes
GeneID | Gene Rank |
---|---|
S100A8 | -26301 |
S100A7 | -23228 |
S100A7A | -23210 |
LCN2 | -22910 |
S100A9 | -19879 |
LTF | -18655 |
GeneID | Gene Rank |
---|---|
S100A8 | -26301 |
S100A7 | -23228 |
S100A7A | -23210 |
LCN2 | -22910 |
S100A9 | -19879 |
LTF | -18655 |
REACTOME_VITAMINS
428 | |
---|---|
set | REACTOME_VITAMINS |
setSize | 6 |
pANOVA | 0.00286 |
s.dist | 0.703 |
p.adjustANOVA | 0.00989 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CYP26C1 | 5725 |
CYP26A1 | 4761 |
CYP26B1 | 2903 |
CYP24A1 | 2112 |
CYP27B1 | 809 |
CYP2R1 | -5436 |
GeneID | Gene Rank |
---|---|
CYP26C1 | 5725 |
CYP26A1 | 4761 |
CYP26B1 | 2903 |
CYP24A1 | 2112 |
CYP27B1 | 809 |
CYP2R1 | -5436 |
REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION
523 | |
---|---|
set | REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION |
setSize | 10 |
pANOVA | 0.00019 |
s.dist | 0.681 |
p.adjustANOVA | 0.00112 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CDX2 | 6692 |
GSC | 6253 |
EOMES | 6219 |
GATA6 | 5754 |
HHEX | 2028 |
DKK1 | 1310 |
NANOG | 784 |
POU5F1 | 725 |
TSC22D1 | -2544 |
SOX2 | -12792 |
GeneID | Gene Rank |
---|---|
CDX2 | 6692 |
GSC | 6253 |
EOMES | 6219 |
GATA6 | 5754 |
HHEX | 2028 |
DKK1 | 1310 |
NANOG | 784 |
POU5F1 | 725 |
TSC22D1 | -2544 |
SOX2 | -12792 |
REACTOME_DEFENSINS
111 | |
---|---|
set | REACTOME_DEFENSINS |
setSize | 45 |
pANOVA | 8.4e-15 |
s.dist | -0.668 |
p.adjustANOVA | 5.26e-13 |
Top enriched genes
GeneID | Gene Rank |
---|---|
DEFB107B | -26858 |
DEFB105B | -26590 |
DEFB105A | -26568 |
DEFA1 | -26339 |
DEFB106B | -26101 |
DEFB118 | -26036 |
DEFB135 | -25882 |
DEFB119 | -25851 |
DEFB115 | -25770 |
DEFB116 | -25749 |
DEFB126 | -25587 |
DEFB106A | -25566 |
DEFB114 | -25545 |
DEFB103A | -25521 |
DEFB121 | -25229 |
DEFB104B | -25192 |
DEFB127 | -24557 |
DEFB110 | -24236 |
DEFB125 | -24152 |
DEFB4A | -24047 |
GeneID | Gene Rank |
---|---|
DEFB107B | -26858 |
DEFB105B | -26590 |
DEFB105A | -26568 |
DEFA1 | -26339 |
DEFB106B | -26101 |
DEFB118 | -26036 |
DEFB135 | -25882 |
DEFB119 | -25851 |
DEFB115 | -25770 |
DEFB116 | -25749 |
DEFB126 | -25587 |
DEFB106A | -25566 |
DEFB114 | -25545 |
DEFB103A | -25521 |
DEFB121 | -25229 |
DEFB104B | -25192 |
DEFB127 | -24557 |
DEFB110 | -24236 |
DEFB125 | -24152 |
DEFB4A | -24047 |
DEFB108B | -23922 |
DEFA4 | -23901 |
DEFB128 | -23827 |
DEFB129 | -23112 |
DEFA1B | -23034 |
DEFB123 | -22494 |
DEFB104A | -22488 |
DEFB113 | -22004 |
DEFA5 | -21886 |
DEFA3 | -21840 |
CCR2 | -21824 |
CCR6 | -21719 |
DEFB134 | -21632 |
DEFB4B | -21426 |
DEFB133 | -20848 |
DEFB136 | -20746 |
TLR1 | -20006 |
DEFB132 | -18419 |
ART1 | -17476 |
TLR2 | -14967 |
DEFA6 | -13351 |
CD4 | -8684 |
DEFB1 | -2305 |
DEFB124 | -1751 |
PRSS3 | 555 |
REACTOME_ADRENOCEPTORS
655 | |
---|---|
set | REACTOME_ADRENOCEPTORS |
setSize | 9 |
pANOVA | 0.000625 |
s.dist | 0.658 |
p.adjustANOVA | 0.00287 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ADRB3 | 6307 |
ADRB1 | 5506 |
ADRA1D | 5230 |
ADRA2A | 5166 |
ADRA2C | 4576 |
ADRB2 | 4198 |
ADRA1A | 1930 |
ADRA2B | -11225 |
ADRA1B | -12211 |
GeneID | Gene Rank |
---|---|
ADRB3 | 6307 |
ADRB1 | 5506 |
ADRA1D | 5230 |
ADRA2A | 5166 |
ADRA2C | 4576 |
ADRB2 | 4198 |
ADRA1A | 1930 |
ADRA2B | -11225 |
ADRA1B | -12211 |
REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER
510 | |
---|---|
set | REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER |
setSize | 5 |
pANOVA | 0.0123 |
s.dist | 0.647 |
p.adjustANOVA | 0.0313 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RBX1 | 2738 |
NOTCH1 | 2659 |
FBXW7 | 911 |
CUL1 | -389 |
SKP1 | -1635 |
GeneID | Gene Rank |
---|---|
RBX1 | 2738 |
NOTCH1 | 2659 |
FBXW7 | 911 |
CUL1 | -389 |
SKP1 | -1635 |
REACTOME_G2_PHASE
1090 | |
---|---|
set | REACTOME_G2_PHASE |
setSize | 5 |
pANOVA | 0.0144 |
s.dist | 0.632 |
p.adjustANOVA | 0.0353 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CCNA1 | 5553 |
CDK2 | 1941 |
CCNA2 | 87 |
E2F1 | -2166 |
E2F3 | -2366 |
GeneID | Gene Rank |
---|---|
CCNA1 | 5553 |
CDK2 | 1941 |
CCNA2 | 87 |
E2F1 | -2166 |
E2F3 | -2366 |
REACTOME_INTERLEUKIN_9_SIGNALING
1339 | |
---|---|
set | REACTOME_INTERLEUKIN_9_SIGNALING |
setSize | 7 |
pANOVA | 0.00546 |
s.dist | 0.606 |
p.adjustANOVA | 0.0165 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IL9 | 5988 |
JAK1 | 3361 |
STAT5B | 2575 |
JAK3 | 1322 |
STAT5A | -349 |
STAT3 | -1684 |
STAT1 | -10001 |
GeneID | Gene Rank |
---|---|
IL9 | 5988 |
JAK1 | 3361 |
STAT5B | 2575 |
JAK3 | 1322 |
STAT5A | -349 |
STAT3 | -1684 |
STAT1 | -10001 |
REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD
582 | |
---|---|
set | REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD |
setSize | 7 |
pANOVA | 0.00551 |
s.dist | 0.606 |
p.adjustANOVA | 0.0166 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CHST3 | 5771 |
BCAN | 4936 |
CSPG5 | 2240 |
NCAN | -886 |
CSPG4 | -1040 |
DCN | -2673 |
VCAN | -7220 |
GeneID | Gene Rank |
---|---|
CHST3 | 5771 |
BCAN | 4936 |
CSPG5 | 2240 |
NCAN | -886 |
CSPG4 | -1040 |
DCN | -2673 |
VCAN | -7220 |
REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE
300 | |
---|---|
set | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE |
setSize | 8 |
pANOVA | 0.00329 |
s.dist | -0.6 |
p.adjustANOVA | 0.0112 |
Top enriched genes
GeneID | Gene Rank |
---|---|
AMY1B | -26667 |
AMY2A | -23859 |
CHIA | -22162 |
MGAM | -21016 |
AMY2B | -18722 |
LCT | -18273 |
CHIT1 | -16260 |
TREH | -15362 |
GeneID | Gene Rank |
---|---|
AMY1B | -26667 |
AMY2A | -23859 |
CHIA | -22162 |
MGAM | -21016 |
AMY2B | -18722 |
LCT | -18273 |
CHIT1 | -16260 |
TREH | -15362 |
REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS
584 | |
---|---|
set | REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS |
setSize | 7 |
pANOVA | 0.00607 |
s.dist | 0.599 |
p.adjustANOVA | 0.018 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CHSY1 | 4957 |
BCAN | 4936 |
CSPG5 | 2240 |
NCAN | -886 |
CSPG4 | -1040 |
DCN | -2673 |
VCAN | -7220 |
GeneID | Gene Rank |
---|---|
CHSY1 | 4957 |
BCAN | 4936 |
CSPG5 | 2240 |
NCAN | -886 |
CSPG4 | -1040 |
DCN | -2673 |
VCAN | -7220 |
REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY
65 | |
---|---|
set | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY |
setSize | 9 |
pANOVA | 0.00187 |
s.dist | 0.599 |
p.adjustANOVA | 0.00703 |
Top enriched genes
GeneID | Gene Rank |
---|---|
HLA-B | 5142 |
HLA-G | 4549 |
HLA-C | 4343 |
B2M | 3510 |
HLA-E | 3411 |
HLA-F | 1668 |
HLA-A | -513 |
LNPEP | -7373 |
CTSS | -14370 |
GeneID | Gene Rank |
---|---|
HLA-B | 5142 |
HLA-G | 4549 |
HLA-C | 4343 |
B2M | 3510 |
HLA-E | 3411 |
HLA-F | 1668 |
HLA-A | -513 |
LNPEP | -7373 |
CTSS | -14370 |
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS
810 | |
---|---|
set | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS |
setSize | 30 |
pANOVA | 1.68e-08 |
s.dist | 0.595 |
p.adjustANOVA | 3.25e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CDX2 | 6692 |
PRDM14 | 6621 |
GSC | 6253 |
EOMES | 6219 |
LIN28A | 6053 |
SALL1 | 6037 |
EPAS1 | 5944 |
FOXD3 | 5924 |
GATA6 | 5754 |
KLF4 | 5020 |
HIF3A | 3979 |
FGF2 | 2764 |
EPHA1 | 2500 |
HHEX | 2028 |
DKK1 | 1310 |
SALL4 | 851 |
NANOG | 784 |
POU5F1 | 725 |
ZSCAN10 | 132 |
STAT3 | -1684 |
GeneID | Gene Rank |
---|---|
CDX2 | 6692 |
PRDM14 | 6621 |
GSC | 6253 |
EOMES | 6219 |
LIN28A | 6053 |
SALL1 | 6037 |
EPAS1 | 5944 |
FOXD3 | 5924 |
GATA6 | 5754 |
KLF4 | 5020 |
HIF3A | 3979 |
FGF2 | 2764 |
EPHA1 | 2500 |
HHEX | 2028 |
DKK1 | 1310 |
SALL4 | 851 |
NANOG | 784 |
POU5F1 | 725 |
ZSCAN10 | 132 |
STAT3 | -1684 |
SMAD4 | -1697 |
TSC22D1 | -2544 |
NR5A1 | -4377 |
PBX1 | -5965 |
TDGF1 | -7645 |
FOXP1 | -8193 |
NR6A1 | -9358 |
SMAD2 | -10296 |
DPPA4 | -11902 |
SOX2 | -12792 |
REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS
1404 | |
---|---|
set | REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS |
setSize | 6 |
pANOVA | 0.0117 |
s.dist | -0.594 |
p.adjustANOVA | 0.0302 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CYP1A2 | -23705 |
CYP2C8 | -22947 |
CYP3A4 | -22664 |
CYP2C9 | -22485 |
CYP2D6 | -15188 |
CYP2E1 | -14142 |
GeneID | Gene Rank |
---|---|
CYP1A2 | -23705 |
CYP2C8 | -22947 |
CYP3A4 | -22664 |
CYP2C9 | -22485 |
CYP2D6 | -15188 |
CYP2E1 | -14142 |
REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS
1386 | |
---|---|
set | REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS |
setSize | 6 |
pANOVA | 0.0123 |
s.dist | 0.59 |
p.adjustANOVA | 0.0313 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ALOX15 | 4922 |
PTGS2 | 2911 |
HPGD | 2214 |
ALOX5 | -2315 |
LTA4H | -3187 |
GPX4 | -5139 |
GeneID | Gene Rank |
---|---|
ALOX15 | 4922 |
PTGS2 | 2911 |
HPGD | 2214 |
ALOX5 | -2315 |
LTA4H | -3187 |
GPX4 | -5139 |
REACTOME_ERKS_ARE_INACTIVATED
395 | |
---|---|
set | REACTOME_ERKS_ARE_INACTIVATED |
setSize | 13 |
pANOVA | 0.000277 |
s.dist | 0.582 |
p.adjustANOVA | 0.00148 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PPP2R1B | 5565 |
DUSP6 | 4183 |
MAPK3 | 3516 |
DUSP7 | 3119 |
PPP2R1A | 2355 |
DUSP4 | 2033 |
VRK3 | 47 |
MAPK7 | -188 |
PPP2CA | -1782 |
DUSP3 | -2562 |
PPP2CB | -4338 |
MAPK1 | -6631 |
PPP2R5D | -8395 |
GeneID | Gene Rank |
---|---|
PPP2R1B | 5565 |
DUSP6 | 4183 |
MAPK3 | 3516 |
DUSP7 | 3119 |
PPP2R1A | 2355 |
DUSP4 | 2033 |
VRK3 | 47 |
MAPK7 | -188 |
PPP2CA | -1782 |
DUSP3 | -2562 |
PPP2CB | -4338 |
MAPK1 | -6631 |
PPP2R5D | -8395 |
REACTOME_CD22_MEDIATED_BCR_REGULATION
1002 | |
---|---|
set | REACTOME_CD22_MEDIATED_BCR_REGULATION |
setSize | 53 |
pANOVA | 2.87e-13 |
s.dist | -0.579 |
p.adjustANOVA | 1.42e-11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IGKV4-1 | -27061 |
IGKV1D-12 | -26997 |
IGKV2D-30 | -26888 |
IGKV3-11 | -26835 |
IGKV1-17 | -26817 |
IGHV3-48 | -26559 |
IGKV1-16 | -26541 |
IGKV1D-16 | -26166 |
IGKV1-5 | -26146 |
IGLV3-25 | -25750 |
IGKV3-15 | -25710 |
IGKV5-2 | -25480 |
CD79A | -25457 |
IGHD | -25401 |
IGHV3-7 | -25379 |
IGHV4-39 | -25365 |
IGKV3-20 | -25355 |
IGHV3-11 | -25059 |
IGKV3D-20 | -24112 |
PTPN6 | -23359 |
GeneID | Gene Rank |
---|---|
IGKV4-1 | -27061.0 |
IGKV1D-12 | -26997.0 |
IGKV2D-30 | -26888.0 |
IGKV3-11 | -26835.0 |
IGKV1-17 | -26817.0 |
IGHV3-48 | -26559.0 |
IGKV1-16 | -26541.0 |
IGKV1D-16 | -26166.0 |
IGKV1-5 | -26146.0 |
IGLV3-25 | -25750.0 |
IGKV3-15 | -25710.0 |
IGKV5-2 | -25480.0 |
CD79A | -25457.0 |
IGHD | -25401.0 |
IGHV3-7 | -25379.0 |
IGHV4-39 | -25365.0 |
IGKV3-20 | -25355.0 |
IGHV3-11 | -25059.0 |
IGKV3D-20 | -24112.0 |
PTPN6 | -23359.0 |
IGKV2-30 | -22816.0 |
IGLV2-23 | -22624.0 |
IGLV3-1 | -22479.0 |
IGHV1-46 | -21726.0 |
IGLV3-27 | -21703.0 |
CD22 | -21433.0 |
IGHM | -21413.0 |
IGHV3-23 | -20814.0 |
CD79B | -20511.0 |
IGLV2-11 | -20488.5 |
IGHV3-13 | -20476.0 |
IGLV3-21 | -20443.0 |
IGHV2-70 | -19320.0 |
IGLV2-8 | -19236.5 |
IGLV3-19 | -19218.0 |
IGHV2-5 | -18846.0 |
IGLV7-43 | -18195.0 |
IGHV1-69 | -17835.0 |
IGHV4-59 | -17725.0 |
IGHV3-53 | -16945.0 |
IGHV1-2 | -16899.0 |
IGHV3-33 | -16165.0 |
LYN | -16115.0 |
IGHV4-34 | -14507.0 |
IGLC3 | -12965.0 |
IGLC2 | -12419.0 |
IGLV1-44 | -12247.0 |
IGLV1-47 | -10868.0 |
IGKV2-28 | -8472.0 |
IGLV6-57 | -6973.0 |
IGLV1-40 | -6371.0 |
IGLV1-51 | -797.0 |
IGLV2-14 | -443.5 |
REACTOME_ANTIMICROBIAL_PEPTIDES
1053 | |
---|---|
set | REACTOME_ANTIMICROBIAL_PEPTIDES |
setSize | 86 |
pANOVA | 1.94e-20 |
s.dist | -0.577 |
p.adjustANOVA | 2.11e-18 |
Top enriched genes
GeneID | Gene Rank |
---|---|
DEFB107B | -26858 |
RNASE6 | -26794 |
REG3A | -26597 |
DEFB105B | -26590 |
DEFB105A | -26568 |
DEFA1 | -26339 |
S100A8 | -26301 |
BPIFA1 | -26246 |
SEMG1 | -26187 |
RNASE3 | -26147 |
DEFB106B | -26101 |
DEFB118 | -26036 |
DEFB135 | -25882 |
DEFB119 | -25851 |
REG3G | -25847 |
DEFB115 | -25770 |
DEFB116 | -25749 |
DEFB126 | -25587 |
DEFB106A | -25566 |
DEFB114 | -25545 |
GeneID | Gene Rank |
---|---|
DEFB107B | -26858 |
RNASE6 | -26794 |
REG3A | -26597 |
DEFB105B | -26590 |
DEFB105A | -26568 |
DEFA1 | -26339 |
S100A8 | -26301 |
BPIFA1 | -26246 |
SEMG1 | -26187 |
RNASE3 | -26147 |
DEFB106B | -26101 |
DEFB118 | -26036 |
DEFB135 | -25882 |
DEFB119 | -25851 |
REG3G | -25847 |
DEFB115 | -25770 |
DEFB116 | -25749 |
DEFB126 | -25587 |
DEFB106A | -25566 |
DEFB114 | -25545 |
DEFB103A | -25521 |
DCD | -25442 |
DEFB121 | -25229 |
DEFB104B | -25192 |
PI3 | -24889 |
DEFB127 | -24557 |
DEFB110 | -24236 |
DEFB125 | -24152 |
DEFB4A | -24047 |
BPIFA2 | -23955 |
DEFB108B | -23922 |
DEFA4 | -23901 |
DEFB128 | -23827 |
BPIFB6 | -23796 |
HTN3 | -23273 |
S100A7 | -23228 |
S100A7A | -23210 |
DEFB129 | -23112 |
DEFA1B | -23034 |
BPIFB4 | -22988 |
LCN2 | -22910 |
DEFB123 | -22494 |
DEFB104A | -22488 |
BPIFB2 | -22317 |
DEFB113 | -22004 |
GNLY | -21970 |
DEFA5 | -21886 |
DEFA3 | -21840 |
CCR2 | -21824 |
CCR6 | -21719 |
DEFB134 | -21632 |
HTN1 | -21587 |
DEFB4B | -21426 |
DEFB133 | -20848 |
DEFB136 | -20746 |
CAMP | -20341 |
TLR1 | -20006 |
S100A9 | -19879 |
PLA2G2A | -19717 |
PRTN3 | -19268 |
LTF | -18655 |
LYZ | -18576 |
CTSG | -18486 |
DEFB132 | -18419 |
BPIFB1 | -18408 |
ART1 | -17476 |
RNASE7 | -17020 |
PGLYRP4 | -16608 |
ELANE | -16528 |
ITLN1 | -15590 |
SLC11A1 | -15158 |
TLR2 | -14967 |
PGLYRP3 | -13812 |
DEFA6 | -13351 |
RNASE8 | -13135 |
CHGA | -12800 |
BPI | -11532 |
CD4 | -8684 |
ATOX1 | -6610 |
PGLYRP2 | -3654 |
DEFB1 | -2305 |
DEFB124 | -1751 |
PRSS3 | 555 |
CLU | 3441 |
LEAP2 | 4783 |
PGLYRP1 | 5998 |
REACTOME_LIGAND_RECEPTOR_INTERACTIONS
919 | |
---|---|
set | REACTOME_LIGAND_RECEPTOR_INTERACTIONS |
setSize | 8 |
pANOVA | 0.00477 |
s.dist | 0.576 |
p.adjustANOVA | 0.0151 |
Top enriched genes
GeneID | Gene Rank |
---|---|
SHH | 6252 |
HHIP | 4791 |
DHH | 4430 |
IHH | 4421 |
GAS1 | 3497 |
PTCH1 | -1733 |
CDON | -12137 |
BOC | -12254 |
GeneID | Gene Rank |
---|---|
SHH | 6252 |
HHIP | 4791 |
DHH | 4430 |
IHH | 4421 |
GAS1 | 3497 |
PTCH1 | -1733 |
CDON | -12137 |
BOC | -12254 |
REACTOME_RESPONSE_TO_METAL_IONS
962 | |
---|---|
set | REACTOME_RESPONSE_TO_METAL_IONS |
setSize | 14 |
pANOVA | 0.000195 |
s.dist | 0.575 |
p.adjustANOVA | 0.00114 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MT1E | 6320 |
MT1M | 5899 |
MT2A | 5372 |
SNCB | 4983 |
CSRP1 | 4931 |
MT1G | 4918 |
MT3 | 4849 |
MT1A | 4843 |
MT1X | -1276 |
MT1H | -1408 |
MT1F | -4690 |
MTF1 | -5140 |
MT1B | -11434 |
MT4 | -23259 |
GeneID | Gene Rank |
---|---|
MT1E | 6320 |
MT1M | 5899 |
MT2A | 5372 |
SNCB | 4983 |
CSRP1 | 4931 |
MT1G | 4918 |
MT3 | 4849 |
MT1A | 4843 |
MT1X | -1276 |
MT1H | -1408 |
MT1F | -4690 |
MTF1 | -5140 |
MT1B | -11434 |
MT4 | -23259 |
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS
420 | |
---|---|
set | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS |
setSize | 5 |
pANOVA | 0.0278 |
s.dist | 0.568 |
p.adjustANOVA | 0.059 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NEUROD1 | 6354 |
INSM1 | 5130 |
NKX2-2 | 5125 |
NEUROG3 | 4586 |
PAX4 | -23583 |
GeneID | Gene Rank |
---|---|
NEUROD1 | 6354 |
INSM1 | 5130 |
NKX2-2 | 5125 |
NEUROG3 | 4586 |
PAX4 | -23583 |
REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR
59 | |
---|---|
set | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR |
setSize | 11 |
pANOVA | 0.0012 |
s.dist | 0.564 |
p.adjustANOVA | 0.00485 |
Top enriched genes
GeneID | Gene Rank |
---|---|
EPAS1 | 5944 |
EPO | 5714 |
HIGD1A | 4231 |
HIF3A | 3979 |
VEGFA | 2308 |
CREBBP | 1997 |
CITED2 | 354 |
CA9 | -482 |
EP300 | -5855 |
ARNT | -6578 |
HIF1A | -17619 |
GeneID | Gene Rank |
---|---|
EPAS1 | 5944 |
EPO | 5714 |
HIGD1A | 4231 |
HIF3A | 3979 |
VEGFA | 2308 |
CREBBP | 1997 |
CITED2 | 354 |
CA9 | -482 |
EP300 | -5855 |
ARNT | -6578 |
HIF1A | -17619 |
REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS
896 | |
---|---|
set | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS |
setSize | 56 |
pANOVA | 3.61e-13 |
s.dist | 0.561 |
p.adjustANOVA | 1.68e-11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
HOXD4 | 6825 |
HOXB1 | 6778 |
HOXA2 | 6736 |
HOXA3 | 6707 |
HOXA4 | 6705 |
HOXD3 | 6689 |
HOXB4 | 6644 |
HOXB2 | 6565 |
PAX6 | 6549 |
HOXB3 | 6273 |
HOXC4 | 5820 |
RARA | 5679 |
MEIS1 | 5633 |
HOXD1 | 5591 |
RARG | 5305 |
POLR2C | 5112 |
MAFB | 4768 |
PCGF2 | 4086 |
POLR2L | 3674 |
AJUBA | 3579 |
GeneID | Gene Rank |
---|---|
HOXD4 | 6825 |
HOXB1 | 6778 |
HOXA2 | 6736 |
HOXA3 | 6707 |
HOXA4 | 6705 |
HOXD3 | 6689 |
HOXB4 | 6644 |
HOXB2 | 6565 |
PAX6 | 6549 |
HOXB3 | 6273 |
HOXC4 | 5820 |
RARA | 5679 |
MEIS1 | 5633 |
HOXD1 | 5591 |
RARG | 5305 |
POLR2C | 5112 |
MAFB | 4768 |
PCGF2 | 4086 |
POLR2L | 3674 |
AJUBA | 3579 |
POLR2A | 3132 |
CREBBP | 1997 |
YY1 | 1804 |
WDR5 | 1489 |
JUN | 24 |
POLR2I | -455 |
ASH2L | -594 |
RBBP5 | -806 |
NCOA3 | -1091 |
CTCF | -1092 |
RBBP4 | -1519 |
POLR2B | -1562 |
POLR2J | -1951 |
ZNF335 | -2357 |
POLR2E | -2394 |
CNOT6 | -2535 |
EED | -2816 |
HDAC3 | -2938 |
HOXA1 | -3243 |
PAXIP1 | -4474 |
POLR2K | -4581 |
POLR2H | -4998 |
POLR2D | -5773 |
EP300 | -5855 |
PBX1 | -5965 |
RARB | -7351 |
PKNOX1 | -7473 |
EGR2 | -7605 |
RXRA | -7948 |
SUZ12 | -8580 |
PIAS2 | -9001 |
POLR2G | -9254 |
NCOR1 | -9528 |
POLR2F | -10294 |
EZH2 | -11331 |
NCOA6 | -12893 |
REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5
1402 | |
---|---|
set | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 |
setSize | 7 |
pANOVA | 0.0106 |
s.dist | 0.558 |
p.adjustANOVA | 0.0278 |
Top enriched genes
GeneID | Gene Rank |
---|---|
EPO | 5714 |
EPOR | 4818 |
IRS2 | 2724 |
STAT5B | 2575 |
STAT5A | -349 |
JAK2 | -3906 |
LYN | -16115 |
GeneID | Gene Rank |
---|---|
EPO | 5714 |
EPOR | 4818 |
IRS2 | 2724 |
STAT5B | 2575 |
STAT5A | -349 |
JAK2 | -3906 |
LYN | -16115 |
REACTOME_CS_DS_DEGRADATION
392 | |
---|---|
set | REACTOME_CS_DS_DEGRADATION |
setSize | 12 |
pANOVA | 0.000867 |
s.dist | 0.555 |
p.adjustANOVA | 0.00376 |
Top enriched genes
GeneID | Gene Rank |
---|---|
BCAN | 4936 |
HYAL1 | 4834 |
CSPG5 | 2240 |
HYAL3 | 2124 |
ARSB | -340 |
NCAN | -886 |
CSPG4 | -1040 |
IDUA | -2382 |
DCN | -2673 |
HEXB | -3736 |
HEXA | -4232 |
VCAN | -7220 |
GeneID | Gene Rank |
---|---|
BCAN | 4936 |
HYAL1 | 4834 |
CSPG5 | 2240 |
HYAL3 | 2124 |
ARSB | -340 |
NCAN | -886 |
CSPG4 | -1040 |
IDUA | -2382 |
DCN | -2673 |
HEXB | -3736 |
HEXA | -4232 |
VCAN | -7220 |
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS
418 | |
---|---|
set | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS |
setSize | 15 |
pANOVA | 0.000211 |
s.dist | 0.552 |
p.adjustANOVA | 0.0012 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ONECUT1 | 6430 |
ONECUT3 | 5631 |
HNF1B | 4885 |
NEUROG3 | 4586 |
NOTCH1 | 2659 |
KAT2B | 2031 |
CREBBP | 1997 |
SNW1 | 1952 |
HES1 | -2088 |
MAML1 | -2390 |
KAT2A | -4799 |
EP300 | -5855 |
MAML2 | -6384 |
RBPJ | -6427 |
MAML3 | -13394 |
GeneID | Gene Rank |
---|---|
ONECUT1 | 6430 |
ONECUT3 | 5631 |
HNF1B | 4885 |
NEUROG3 | 4586 |
NOTCH1 | 2659 |
KAT2B | 2031 |
CREBBP | 1997 |
SNW1 | 1952 |
HES1 | -2088 |
MAML1 | -2390 |
KAT2A | -4799 |
EP300 | -5855 |
MAML2 | -6384 |
RBPJ | -6427 |
MAML3 | -13394 |
REACTOME_METALLOTHIONEINS_BIND_METALS
964 | |
---|---|
set | REACTOME_METALLOTHIONEINS_BIND_METALS |
setSize | 11 |
pANOVA | 0.0018 |
s.dist | 0.543 |
p.adjustANOVA | 0.00688 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MT1E | 6320 |
MT1M | 5899 |
MT2A | 5372 |
MT1G | 4918 |
MT3 | 4849 |
MT1A | 4843 |
MT1X | -1276 |
MT1H | -1408 |
MT1F | -4690 |
MT1B | -11434 |
MT4 | -23259 |
GeneID | Gene Rank |
---|---|
MT1E | 6320 |
MT1M | 5899 |
MT2A | 5372 |
MT1G | 4918 |
MT3 | 4849 |
MT1A | 4843 |
MT1X | -1276 |
MT1H | -1408 |
MT1F | -4690 |
MT1B | -11434 |
MT4 | -23259 |
REACTOME_RHO_GTPASES_ACTIVATE_ROCKS
916 | |
---|---|
set | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS |
setSize | 19 |
pANOVA | 4.34e-05 |
s.dist | 0.542 |
p.adjustANOVA | 0.000326 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RHOB | 5838 |
MYL9 | 4920 |
MYH9 | 4865 |
MYH14 | 3373 |
MYL6 | 2800 |
RHOC | 2405 |
ROCK2 | 2143 |
PPP1R12B | 867 |
ROCK1 | 674 |
CFL1 | -329 |
PPP1R12A | -765 |
LIMK2 | -1059 |
LIMK1 | -1102 |
MYH10 | -2740 |
RHOA | -5133 |
MYH11 | -6058 |
PPP1CB | -6414 |
MYL12B | -8034 |
PAK1 | -13890 |
GeneID | Gene Rank |
---|---|
RHOB | 5838 |
MYL9 | 4920 |
MYH9 | 4865 |
MYH14 | 3373 |
MYL6 | 2800 |
RHOC | 2405 |
ROCK2 | 2143 |
PPP1R12B | 867 |
ROCK1 | 674 |
CFL1 | -329 |
PPP1R12A | -765 |
LIMK2 | -1059 |
LIMK1 | -1102 |
MYH10 | -2740 |
RHOA | -5133 |
MYH11 | -6058 |
PPP1CB | -6414 |
MYL12B | -8034 |
PAK1 | -13890 |
REACTOME_SIGNALING_BY_RNF43_MUTANTS
857 | |
---|---|
set | REACTOME_SIGNALING_BY_RNF43_MUTANTS |
setSize | 8 |
pANOVA | 0.0089 |
s.dist | 0.534 |
p.adjustANOVA | 0.0242 |
Top enriched genes
GeneID | Gene Rank |
---|---|
WNT3A | 6309 |
FZD8 | 4600 |
FZD4 | 3508 |
FZD5 | 2762 |
LRP6 | 77 |
RNF43 | -3859 |
LRP5 | -9145 |
FZD6 | -12688 |
GeneID | Gene Rank |
---|---|
WNT3A | 6309 |
FZD8 | 4600 |
FZD4 | 3508 |
FZD5 | 2762 |
LRP6 | 77 |
RNF43 | -3859 |
LRP5 | -9145 |
FZD6 | -12688 |
REACTOME_LIPID_PARTICLE_ORGANIZATION
1329 | |
---|---|
set | REACTOME_LIPID_PARTICLE_ORGANIZATION |
setSize | 6 |
pANOVA | 0.0239 |
s.dist | 0.532 |
p.adjustANOVA | 0.0526 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CIDEA | 4150 |
FITM1 | 3826 |
HSD17B13 | 3639 |
HILPDA | 1989 |
FITM2 | -8028 |
CIDEC | -12062 |
GeneID | Gene Rank |
---|---|
CIDEA | 4150 |
FITM1 | 3826 |
HSD17B13 | 3639 |
HILPDA | 1989 |
FITM2 | -8028 |
CIDEC | -12062 |
REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION
821 | |
---|---|
set | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION |
setSize | 21 |
pANOVA | 2.96e-05 |
s.dist | 0.526 |
p.adjustANOVA | 0.000237 |
Top enriched genes
GeneID | Gene Rank |
---|---|
WNT3A | 6309 |
RSPO1 | 5942 |
RSPO4 | 5894 |
ZNRF3 | 5074 |
RSPO3 | 4723 |
FZD8 | 4600 |
UBB | 3591 |
FZD4 | 3508 |
FZD5 | 2762 |
RSPO2 | 1405 |
LRP6 | 77 |
RNF43 | -3859 |
UBC | -3961 |
USP8 | -4541 |
LGR5 | -5234 |
UBA52 | -6581 |
LGR6 | -7464 |
RPS27A | -7647 |
LGR4 | -7749 |
LRP5 | -9145 |
GeneID | Gene Rank |
---|---|
WNT3A | 6309 |
RSPO1 | 5942 |
RSPO4 | 5894 |
ZNRF3 | 5074 |
RSPO3 | 4723 |
FZD8 | 4600 |
UBB | 3591 |
FZD4 | 3508 |
FZD5 | 2762 |
RSPO2 | 1405 |
LRP6 | 77 |
RNF43 | -3859 |
UBC | -3961 |
USP8 | -4541 |
LGR5 | -5234 |
UBA52 | -6581 |
LGR6 | -7464 |
RPS27A | -7647 |
LGR4 | -7749 |
LRP5 | -9145 |
FZD6 | -12688 |
REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING
403 | |
---|---|
set | REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING |
setSize | 5 |
pANOVA | 0.0422 |
s.dist | 0.525 |
p.adjustANOVA | 0.0824 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CAV1 | 5224 |
DNM2 | 2630 |
NOSTRIN | 5 |
WASL | -5431 |
NOS3 | -8493 |
GeneID | Gene Rank |
---|---|
CAV1 | 5224 |
DNM2 | 2630 |
NOSTRIN | 5 |
WASL | -5431 |
NOS3 | -8493 |
REACTOME_FLT3_SIGNALING_BY_CBL_MUTANTS
1563 | |
---|---|
set | REACTOME_FLT3_SIGNALING_BY_CBL_MUTANTS |
setSize | 7 |
pANOVA | 0.0163 |
s.dist | 0.524 |
p.adjustANOVA | 0.0393 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CBL | 3851 |
UBB | 3591 |
FLT3LG | 3393 |
FLT3 | -1178 |
UBC | -3961 |
UBA52 | -6581 |
RPS27A | -7647 |
GeneID | Gene Rank |
---|---|
CBL | 3851 |
UBB | 3591 |
FLT3LG | 3393 |
FLT3 | -1178 |
UBC | -3961 |
UBA52 | -6581 |
RPS27A | -7647 |
REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION
401 | |
---|---|
set | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION |
setSize | 14 |
pANOVA | 0.000684 |
s.dist | 0.524 |
p.adjustANOVA | 0.00308 |
Top enriched genes
GeneID | Gene Rank |
---|---|
TBX5 | 6598 |
NKX2-5 | 6297 |
GATA4 | 4914 |
TEAD2 | 4351 |
KAT2B | 2031 |
HIPK1 | 1561 |
WWTR1 | -37 |
NPPA | -1588 |
TEAD3 | -3131 |
HIPK2 | -5597 |
YAP1 | -6203 |
RUNX2 | -6988 |
TEAD4 | -8233 |
TEAD1 | -11128 |
GeneID | Gene Rank |
---|---|
TBX5 | 6598 |
NKX2-5 | 6297 |
GATA4 | 4914 |
TEAD2 | 4351 |
KAT2B | 2031 |
HIPK1 | 1561 |
WWTR1 | -37 |
NPPA | -1588 |
TEAD3 | -3131 |
HIPK2 | -5597 |
YAP1 | -6203 |
RUNX2 | -6988 |
TEAD4 | -8233 |
TEAD1 | -11128 |
REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE
345 | |
---|---|
set | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE |
setSize | 16 |
pANOVA | 0.000289 |
s.dist | 0.523 |
p.adjustANOVA | 0.00154 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PPP2R1B | 5565 |
FRAT1 | 4087 |
PPP2R1A | 2355 |
PPP2R5A | 2217 |
PPP2R5B | 1681 |
CSNK1A1 | 1273 |
PPP2R5E | 729 |
APC | -1391 |
PPP2CA | -1782 |
PPP2R5C | -2475 |
FRAT2 | -2689 |
GSK3B | -3528 |
PPP2CB | -4338 |
CTNNB1 | -4457 |
PPP2R5D | -8395 |
AXIN1 | -8661 |
GeneID | Gene Rank |
---|---|
PPP2R1B | 5565 |
FRAT1 | 4087 |
PPP2R1A | 2355 |
PPP2R5A | 2217 |
PPP2R5B | 1681 |
CSNK1A1 | 1273 |
PPP2R5E | 729 |
APC | -1391 |
PPP2CA | -1782 |
PPP2R5C | -2475 |
FRAT2 | -2689 |
GSK3B | -3528 |
PPP2CB | -4338 |
CTNNB1 | -4457 |
PPP2R5D | -8395 |
AXIN1 | -8661 |
REACTOME_NADE_MODULATES_DEATH_SIGNALLING
410 | |
---|---|
set | REACTOME_NADE_MODULATES_DEATH_SIGNALLING |
setSize | 5 |
pANOVA | 0.0434 |
s.dist | 0.521 |
p.adjustANOVA | 0.084 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CASP3 | 4013 |
NGFR | 2426 |
YWHAE | 1788 |
CASP2 | -4812 |
NGF | -9752 |
GeneID | Gene Rank |
---|---|
CASP3 | 4013 |
NGFR | 2426 |
YWHAE | 1788 |
CASP2 | -4812 |
NGF | -9752 |
REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS
215 | |
---|---|
set | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS |
setSize | 63 |
pANOVA | 8.36e-13 |
s.dist | -0.521 |
p.adjustANOVA | 3.5e-11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IGKV4-1 | -27061 |
IGKV1D-12 | -26997 |
IGKV2D-30 | -26888 |
IGKV3-11 | -26835 |
IGKV1-17 | -26817 |
CRP | -26684 |
IGHV3-48 | -26559 |
IGKV1-16 | -26541 |
IGKV1D-16 | -26166 |
IGKV1-5 | -26146 |
FCN1 | -25844 |
IGLV3-25 | -25750 |
IGKV3-15 | -25710 |
IGHG4 | -25591 |
IGKV5-2 | -25480 |
IGHV3-7 | -25379 |
IGHV4-39 | -25365 |
IGKV3-20 | -25355 |
IGHV3-11 | -25059 |
IGHG2 | -24506 |
GeneID | Gene Rank |
---|---|
IGKV4-1 | -27061.0 |
IGKV1D-12 | -26997.0 |
IGKV2D-30 | -26888.0 |
IGKV3-11 | -26835.0 |
IGKV1-17 | -26817.0 |
CRP | -26684.0 |
IGHV3-48 | -26559.0 |
IGKV1-16 | -26541.0 |
IGKV1D-16 | -26166.0 |
IGKV1-5 | -26146.0 |
FCN1 | -25844.0 |
IGLV3-25 | -25750.0 |
IGKV3-15 | -25710.0 |
IGHG4 | -25591.0 |
IGKV5-2 | -25480.0 |
IGHV3-7 | -25379.0 |
IGHV4-39 | -25365.0 |
IGKV3-20 | -25355.0 |
IGHV3-11 | -25059.0 |
IGHG2 | -24506.0 |
MBL2 | -24444.0 |
IGKV3D-20 | -24112.0 |
IGHG1 | -23491.0 |
IGKV2-30 | -22816.0 |
IGLV2-23 | -22624.0 |
IGLV3-1 | -22479.0 |
C1QC | -22030.0 |
IGHV1-46 | -21726.0 |
IGLV3-27 | -21703.0 |
COLEC10 | -21696.0 |
IGHV3-23 | -20814.0 |
MASP2 | -20565.0 |
IGLV2-11 | -20488.5 |
IGHV3-13 | -20476.0 |
IGLV3-21 | -20443.0 |
C1QA | -20351.0 |
IGHV2-70 | -19320.0 |
IGLV2-8 | -19236.5 |
IGLV3-19 | -19218.0 |
IGHV2-5 | -18846.0 |
MASP1 | -18687.0 |
IGLV7-43 | -18195.0 |
IGHV1-69 | -17835.0 |
IGHV4-59 | -17725.0 |
IGHV3-53 | -16945.0 |
IGHV1-2 | -16899.0 |
C1QB | -16743.0 |
IGHV3-33 | -16165.0 |
IGHV4-34 | -14507.0 |
FCN2 | -14037.0 |
IGLC3 | -12965.0 |
IGLC2 | -12419.0 |
IGLV1-44 | -12247.0 |
IGLV1-47 | -10868.0 |
COLEC11 | -9643.0 |
IGKV2-28 | -8472.0 |
IGLV6-57 | -6973.0 |
IGLV1-40 | -6371.0 |
C1S | -4467.0 |
IGLV1-51 | -797.0 |
IGLV2-14 | -443.5 |
C1R | 2062.0 |
FCN3 | 6314.0 |
REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS
553 | |
---|---|
set | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS |
setSize | 20 |
pANOVA | 5.61e-05 |
s.dist | 0.52 |
p.adjustANOVA | 0.000407 |
Top enriched genes
GeneID | Gene Rank |
---|---|
TFAP2B | 6766 |
FOXL2 | 5473 |
CDKN2A | 5275 |
TFAP2C | 5055 |
TFAP2A | 4444 |
PIAS1 | 3447 |
PIAS4 | 1172 |
SUMO1 | -892 |
SP3 | -1179 |
MTA1 | -1387 |
PIAS3 | -1918 |
TP53BP1 | -2215 |
MDM2 | -2760 |
UBE2I | -3490 |
TP53 | -3641 |
HIC1 | -5035 |
SUMO3 | -5475 |
PIAS2 | -9001 |
SUMO2 | -9364 |
MITF | -11131 |
GeneID | Gene Rank |
---|---|
TFAP2B | 6766 |
FOXL2 | 5473 |
CDKN2A | 5275 |
TFAP2C | 5055 |
TFAP2A | 4444 |
PIAS1 | 3447 |
PIAS4 | 1172 |
SUMO1 | -892 |
SP3 | -1179 |
MTA1 | -1387 |
PIAS3 | -1918 |
TP53BP1 | -2215 |
MDM2 | -2760 |
UBE2I | -3490 |
TP53 | -3641 |
HIC1 | -5035 |
SUMO3 | -5475 |
PIAS2 | -9001 |
SUMO2 | -9364 |
MITF | -11131 |
REACTOME_PROSTANOID_LIGAND_RECEPTORS
661 | |
---|---|
set | REACTOME_PROSTANOID_LIGAND_RECEPTORS |
setSize | 9 |
pANOVA | 0.00697 |
s.dist | 0.519 |
p.adjustANOVA | 0.02 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PTGIR | 5819 |
PTGER2 | 5330 |
PTGDR | 4456 |
PTGER1 | 4399 |
PTGDR2 | 2791 |
TBXA2R | 2508 |
PTGER4 | -8568 |
PTGFR | -12681 |
PTGER3 | -15790 |
GeneID | Gene Rank |
---|---|
PTGIR | 5819 |
PTGER2 | 5330 |
PTGDR | 4456 |
PTGER1 | 4399 |
PTGDR2 | 2791 |
TBXA2R | 2508 |
PTGER4 | -8568 |
PTGFR | -12681 |
PTGER3 | -15790 |
REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K
1405 | |
---|---|
set | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K |
setSize | 7 |
pANOVA | 0.0175 |
s.dist | 0.519 |
p.adjustANOVA | 0.0414 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PIK3R1 | 5150 |
GAB1 | 2930 |
NTRK2 | 2104 |
BDNF | 1588 |
PIK3CA | -2570 |
NTF4 | -7256 |
GRB2 | -11144 |
GeneID | Gene Rank |
---|---|
PIK3R1 | 5150 |
GAB1 | 2930 |
NTRK2 | 2104 |
BDNF | 1588 |
PIK3CA | -2570 |
NTF4 | -7256 |
GRB2 | -11144 |
REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS
1241 | |
---|---|
set | REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS |
setSize | 10 |
pANOVA | 0.00453 |
s.dist | 0.518 |
p.adjustANOVA | 0.0144 |
Top enriched genes
GeneID | Gene Rank |
---|---|
TFAP2B | 6766 |
TFAP2D | 5843 |
TFAP2C | 5055 |
KCTD15 | 4802 |
TFAP2A | 4444 |
SUMO1 | -892 |
TFAP2E | -3401 |
UBE2I | -3490 |
KCTD1 | -15187 |
WWOX | -17155 |
GeneID | Gene Rank |
---|---|
TFAP2B | 6766 |
TFAP2D | 5843 |
TFAP2C | 5055 |
KCTD15 | 4802 |
TFAP2A | 4444 |
SUMO1 | -892 |
TFAP2E | -3401 |
UBE2I | -3490 |
KCTD1 | -15187 |
WWOX | -17155 |
REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION
544 | |
---|---|
set | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION |
setSize | 5 |
pANOVA | 0.0449 |
s.dist | 0.518 |
p.adjustANOVA | 0.0861 |
Top enriched genes
GeneID | Gene Rank |
---|---|
LRRFIP1 | 3090 |
CREBBP | 1997 |
IRF3 | -1407 |
CTNNB1 | -4457 |
EP300 | -5855 |
GeneID | Gene Rank |
---|---|
LRRFIP1 | 3090 |
CREBBP | 1997 |
IRF3 | -1407 |
CTNNB1 | -4457 |
EP300 | -5855 |
REACTOME_SENSORY_PERCEPTION
1569 | |
---|---|
set | REACTOME_SENSORY_PERCEPTION |
setSize | 576 |
pANOVA | 6.7e-100 |
s.dist | -0.513 |
p.adjustANOVA | 5.46e-97 |
Top enriched genes
GeneID | Gene Rank |
---|---|
OR6Q1 | -27075 |
OR9I1 | -27072 |
OR1S2 | -27041 |
OR51I1 | -27031 |
OR2T29 | -27025 |
OR10W1 | -27007 |
OR5H6 | -27002 |
TAS2R1 | -26986 |
OR5H1 | -26981 |
OR10K2 | -26949 |
TAS2R16 | -26942 |
OR10J3 | -26927 |
OR52D1 | -26926 |
OR2M7 | -26892 |
OR2M4 | -26891 |
OR4C3 | -26890 |
OR10Z1 | -26873 |
OR52A5 | -26870 |
OR5AC2 | -26867 |
OR10G9 | -26861 |
GeneID | Gene Rank |
---|---|
OR6Q1 | -27075 |
OR9I1 | -27072 |
OR1S2 | -27041 |
OR51I1 | -27031 |
OR2T29 | -27025 |
OR10W1 | -27007 |
OR5H6 | -27002 |
TAS2R1 | -26986 |
OR5H1 | -26981 |
OR10K2 | -26949 |
TAS2R16 | -26942 |
OR10J3 | -26927 |
OR52D1 | -26926 |
OR2M7 | -26892 |
OR2M4 | -26891 |
OR4C3 | -26890 |
OR10Z1 | -26873 |
OR52A5 | -26870 |
OR5AC2 | -26867 |
OR10G9 | -26861 |
OR5H14 | -26853 |
OR6P1 | -26791 |
OR10J1 | -26778 |
OR2L5 | -26767 |
OR6Y1 | -26756 |
OR4D1 | -26737 |
OR1B1 | -26699 |
OR56A1 | -26691 |
OR8B8 | -26689 |
OR6K2 | -26687 |
OR5W2 | -26655 |
OR5J2 | -26648 |
OR2T5 | -26641 |
OR56B1 | -26639 |
OR1S1 | -26635 |
OR8H2 | -26633 |
OR5B17 | -26614 |
OR14I1 | -26595 |
OR4C46 | -26594 |
OR51F1 | -26587 |
OR2M5 | -26579 |
OR14J1 | -26576 |
OR52E2 | -26553 |
OR1L1 | -26548 |
OR1N1 | -26544 |
OR8U1 | -26518 |
OR13G1 | -26513 |
OR14A2 | -26512 |
OR2AP1 | -26510 |
OR14K1 | -26497 |
OR8B12 | -26492 |
OR4D11 | -26491 |
OR5I1 | -26481 |
OR5B2 | -26474 |
OR10J5 | -26471 |
OR5B21 | -26467 |
OR5AS1 | -26464 |
OR2B11 | -26463 |
OR6N1 | -26451 |
OR2G2 | -26428 |
OR4D9 | -26393 |
OR8B4 | -26387 |
OR8K3 | -26383 |
OR3A2 | -26381 |
OR52E6 | -26372 |
OR52N4 | -26355 |
OR10G8 | -26345 |
OR2T34 | -26340 |
OR5T3 | -26329 |
OR4D10 | -26322 |
OR6F1 | -26309 |
OR51J1 | -26302 |
GRXCR1 | -26299 |
OR8K5 | -26278 |
OR51B6 | -26274 |
OR4A16 | -26270 |
OR51B5 | -26216 |
OR5B3 | -26211 |
OR5T2 | -26199 |
OR52R1 | -26167 |
OR2F1 | -26162 |
OR2T6 | -26133 |
OR10AG1 | -26132 |
OR51F2 | -26110 |
OR5B12 | -26091 |
OR4D6 | -26090 |
OR10G4 | -26076 |
OR4A47 | -26070 |
OR8H3 | -26065 |
OR10C1 | -26063 |
OR8J1 | -26059 |
OR5P2 | -26050 |
OR2A25 | -26047 |
OR51A7 | -26045 |
OR8A1 | -26043 |
OR4C16 | -26039 |
OR6B1 | -26030 |
OR6N2 | -26025 |
OR11H7 | -26024 |
OR5AU1 | -26016 |
OR51B2 | -26008 |
OR52E4 | -26003 |
OR5M8 | -25980 |
OR5AP2 | -25966 |
OR9G1 | -25965 |
OR11L1 | -25958 |
OR5M3 | -25955 |
OR8J3 | -25950 |
OR12D2 | -25903 |
OR10A5 | -25896 |
OR8D1 | -25889 |
OR4F15 | -25863 |
OR52J3 | -25827 |
OR52H1 | -25808 |
OR9Q2 | -25789 |
OR5AR1 | -25784 |
OR2G3 | -25774 |
OR2T12 | -25771 |
OR2A2 | -25748 |
OR2A4 | -25735 |
OR5F1 | -25728 |
OR52L1 | -25709 |
OR2L8 | -25693 |
OR51T1 | -25681 |
OR4F4 | -25666 |
OR1C1 | -25646 |
OR2AG2 | -25645 |
OR2M3 | -25628 |
OR51I2 | -25624 |
OR10K1 | -25600 |
OR5L1 | -25584 |
OR4A15 | -25565 |
OR2G6 | -25557 |
OR51B4 | -25553 |
OR2W1 | -25547 |
OR2T3 | -25531 |
OR5H15 | -25522 |
OR2T33 | -25513 |
OR6C75 | -25511 |
OR10X1 | -25493 |
OR9G4 | -25490 |
OR6K6 | -25483 |
OR51Q1 | -25479 |
OR52N1 | -25470 |
OR10T2 | -25467 |
OR8B2 | -25455 |
OR4E2 | -25445 |
OR51G2 | -25404 |
OR4C15 | -25380 |
OR5D13 | -25372 |
OR2M2 | -25363 |
OR9A2 | -25348 |
OR14C36 | -25346 |
OR4X2 | -25342 |
OR2W3 | -25327 |
OR51A2 | -25317 |
OR52A1 | -25223 |
XIRP2 | -25210 |
OR10S1 | -25208 |
OR14A16 | -25197 |
OR4D5 | -25172 |
OR2B3 | -25161 |
OR2T35 | -25160 |
OR5AK2 | -25154 |
OR10A4 | -25147 |
OR10D3 | -25137 |
OR7G3 | -25121 |
OR10Q1 | -25054 |
OR3A3 | -25044 |
OR52B2 | -25043 |
SDR9C7 | -25023 |
OR2D2 | -25015 |
OR2J2 | -25008 |
OR52E8 | -24969 |
OR1L6 | -24949 |
OR10R2 | -24927 |
OR5T1 | -24925 |
OR51G1 | -24906 |
OR8K1 | -24884 |
OR5V1 | -24874 |
OR5M9 | -24862 |
OR4C12 | -24830 |
OR1L4 | -24822 |
OR8B3 | -24811 |
OR5L2 | -24802 |
OR51D1 | -24757 |
OR2AT4 | -24742 |
OR4C6 | -24737 |
OR2AE1 | -24729 |
OR5D14 | -24686 |
OR1J2 | -24649 |
OR4S1 | -24591 |
OR9Q1 | -24586 |
OR51E1 | -24583 |
OR52N2 | -24577 |
TAS2R39 | -24547 |
OR2Z1 | -24527 |
OR5A1 | -24509 |
OR2A12 | -24485 |
OR52B6 | -24482 |
OR12D3 | -24430 |
OR56A4 | -24423 |
OR1K1 | -24422 |
OR8D2 | -24418 |
OR2L2 | -24412 |
GUCA1C | -24404 |
OR8I2 | -24396 |
OR56A3 | -24384 |
OR9K2 | -24369 |
OR2J3 | -24364 |
OR5M1 | -24348 |
OR2T2 | -24325 |
TAS2R41 | -24318 |
OR2T8 | -24315 |
TAS2R40 | -24313 |
OR4B1 | -24302 |
OR5H2 | -24301 |
ANO2 | -24251 |
OR1L8 | -24179 |
OR5A2 | -24172 |
OR5AN1 | -24159 |
OR4K5 | -24157 |
OR2T1 | -24141 |
OR11A1 | -24082 |
OR2S2 | -24078 |
OR56B4 | -24073 |
OR2Y1 | -24055 |
OR1Q1 | -24052 |
OR4K13 | -24050 |
RHO | -24038 |
OR51S1 | -24030 |
OR4F6 | -24022 |
OR5D18 | -23989 |
OR2AJ1 | -23942 |
OR6X1 | -23891 |
OR52I2 | -23861 |
OR52K1 | -23825 |
OR4C5 | -23811 |
OR13D1 | -23794 |
OR1A2 | -23769 |
APOA4 | -23758 |
OR51L1 | -23730 |
OR10A3 | -23706 |
OR10A7 | -23683 |
OR6B2 | -23678 |
OR1M1 | -23656 |
OR6C6 | -23592 |
OR6C74 | -23558 |
OR2T27 | -23542 |
OR4N4 | -23484 |
OR5M11 | -23459 |
OR2K2 | -23451 |
OR51V1 | -23432 |
OR2J1 | -23357 |
OR7C2 | -23324 |
OR4D2 | -23304 |
OR10G7 | -23299 |
OR6C65 | -23279 |
OR5C1 | -23263 |
OR7D4 | -23255 |
OR2H1 | -23125 |
OR6T1 | -23103 |
OR8D4 | -23072 |
OR4K15 | -23036 |
OR2V1 | -23029 |
OR1E2 | -22991 |
GNAT3 | -22953 |
OR6C2 | -22933 |
OR1J4 | -22923 |
OR6C1 | -22890 |
OR7G2 | -22886 |
OR5D16 | -22863 |
OR1L3 | -22860 |
OR51M1 | -22856 |
OR2L13 | -22832 |
OR10V1 | -22821 |
TAS2R38 | -22779 |
TRPM5 | -22750 |
OR2D3 | -22709 |
OR10H5 | -22698 |
OR52K2 | -22693 |
OR2AG1 | -22630 |
OR1N2 | -22604 |
OR6K3 | -22553 |
OR2A5 | -22532 |
OR2F2 | -22463 |
OR10G2 | -22462 |
OR51E2 | -22440 |
OR10H3 | -22434 |
OR2AK2 | -22422 |
OR4F5 | -22417 |
OR1D5 | -22397 |
PNLIP | -22304 |
OR52W1 | -22296 |
TAS2R46 | -22256 |
OR8H1 | -22207 |
OR5P3 | -22206 |
TAS2R20 | -22190 |
AKR1B10 | -22144 |
OR7G1 | -22137 |
OR4X1 | -22113 |
AKR1C1 | -22086 |
OR7A17 | -22069 |
OR6C4 | -22031 |
OR2T4 | -22015 |
OR4M1 | -21987 |
OR13C2 | -21981 |
GRK7 | -21845 |
OR52I1 | -21746 |
RBP3 | -21729 |
OR7E24 | -21701 |
TAS1R2 | -21584 |
OR6J1 | -21535 |
OR10H4 | -21498 |
RDH16 | -21325 |
OR10H2 | -21152 |
OR52N5 | -21021 |
TAS2R30 | -21000 |
USH1C | -20986 |
OR1D2 | -20978 |
OR7D2 | -20975 |
RTP2 | -20915 |
RDH8 | -20829 |
OR10A6 | -20823 |
OR4A5 | -20652 |
TAS2R8 | -20602 |
OR10P1 | -20584 |
OR2A14 | -20581 |
OR4N2 | -20579 |
OTOG | -20530 |
OR52M1 | -20507 |
TAS2R10 | -20406 |
OR10H1 | -20346 |
OR2V2 | -20281 |
SCN2A | -20277 |
OR6A2 | -20122 |
OR1E1 | -19980 |
OR13A1 | -19947 |
OR2L3 | -19931 |
OR11G2 | -19918 |
OR10A2 | -19859 |
OR6C70 | -19711 |
OR4Q3 | -19699 |
TAS2R50 | -19623 |
OR1J1 | -19569 |
OR6V1 | -19505 |
OR5K3 | -19501 |
TAS2R7 | -19381 |
RPE65 | -19368 |
TTR | -19344 |
CLIC5 | -19202 |
OR1F1 | -19173 |
OR4C13 | -19153 |
TAS2R5 | -19078 |
CALHM3 | -19027 |
OR6C3 | -19009 |
GPC5 | -19008 |
DHRS9 | -18980 |
OR6C68 | -18942 |
OR13C9 | -18921 |
PCDH15 | -18856 |
OR9A4 | -18768 |
OR13J1 | -18720 |
SDC3 | -18685 |
GUCA1B | -18668 |
APOB | -18644 |
ESPNL | -18621 |
RDH12 | -18594 |
RGS9 | -18563 |
PLB1 | -18558 |
OR5K2 | -18542 |
CACNA2D2 | -18466 |
OR2H2 | -18442 |
GRXCR2 | -18431 |
OR2C1 | -18375 |
OR4K1 | -18347 |
OPN1SW | -18309 |
OR13C3 | -18264 |
APOC2 | -18157 |
APOC3 | -18059 |
OTOGL | -18027 |
TAS2R43 | -17968 |
OR5M10 | -17966 |
CALHM1 | -17953 |
SCN3A | -17916 |
OR5K4 | -17914 |
SCNN1D | -17901 |
GPIHBP1 | -17870 |
RBP2 | -17708 |
GPC1 | -17545 |
OR13F1 | -17538 |
TAS2R3 | -17491 |
REEP1 | -17480 |
OR4L1 | -17403 |
OR6B3 | -17400 |
OR2B6 | -17314 |
RLBP1 | -17264 |
RCVRN | -17198 |
ADCY3 | -17130 |
OR6M1 | -17083 |
CABP2 | -17031 |
OR5K1 | -17015 |
OR8S1 | -16954 |
CDH23 | -16928 |
OR4K17 | -16924 |
EBF1 | -16910 |
AKR1C3 | -16694 |
MYO7A | -16583 |
OR2B2 | -16491 |
GNAT1 | -16416 |
TAS2R31 | -16264 |
OR6S1 | -16034 |
CNGA1 | -16002 |
BSN | -15997 |
TAS1R3 | -15961 |
SDC1 | -15930 |
STRA6 | -15910 |
OR13C8 | -15760 |
GNB3 | -15593 |
OR4M2 | -15571 |
KCNMB1 | -15549 |
OR1A1 | -15376 |
PCLO | -15213 |
OR1G1 | -15049 |
AGRN | -14995 |
OR10AD1 | -14878 |
OR10G3 | -14801 |
CNGB1 | -14776 |
SCNN1A | -14746 |
OR3A1 | -14732 |
LRP1 | -14652 |
NAPEPLD | -14619 |
OR2T11 | -14600 |
TAS2R4 | -14547 |
ATP2B2 | -14515 |
LRP2 | -14478 |
SCN2B | -14460 |
TAS2R14 | -14312 |
GRK4 | -14057 |
MYO3B | -13922 |
OTOF | -13678 |
LHFPL5 | -13468 |
CIB2 | -13422 |
OR4Q2 | -13368 |
GPC2 | -13338 |
TMC1 | -13111 |
PRKCQ | -12970 |
LRP12 | -12825 |
GUCA1A | -12643 |
CNGA4 | -12546 |
SNAP25 | -12374 |
OR13C4 | -12351 |
CABP1 | -12317 |
OR4K2 | -12287 |
EPS8 | -12281 |
HSPG2 | -11900 |
STX1A | -11709 |
PLS1 | -11698 |
FNTB | -11692 |
OR1I1 | -11628 |
SDC4 | -11155 |
AKR1C4 | -10969 |
ABCA4 | -10931 |
EPB41L1 | -10891 |
OR4K14 | -10846 |
CAMKMT | -10806 |
SCN9A | -10621 |
KCNMA1 | -10551 |
SCNN1B | -10059 |
OR11H4 | -10012 |
PDE6A | -9939 |
RTP1 | -9900 |
FNTA | -9617 |
RAB3A | -9500 |
RDH11 | -9494 |
METAP1 | -9294 |
HSD17B1 | -9180 |
GNGT1 | -9159 |
RETSAT | -9053 |
SAG | -8983 |
TWF2 | -8722 |
OR2C3 | -8616 |
STRC | -8339 |
RDH10 | -8292 |
CHRNA9 | -8265 |
DNAJC5 | -8242 |
EZR | -8015 |
TAS2R13 | -7945 |
SCN4B | -7939 |
KCNQ4 | -7886 |
OR7C1 | -7784 |
APOA1 | -7772 |
SCN1B | -7745 |
EPB41L3 | -7662 |
BCO2 | -7587 |
PRKCA | -7543 |
GSN | -7503 |
KCNN2 | -7054 |
ATP2B1 | -6983 |
CACNB2 | -6963 |
TWF1 | -6854 |
SCNN1G | -6727 |
CALM1 | -6273 |
SDC2 | -6139 |
LRP8 | -6128 |
SLC17A8 | -5923 |
RBP1 | -5871 |
GRM4 | -5852 |
ACTB | -5763 |
MYO15A | -5646 |
GNAL | -5571 |
CHRNA10 | -5520 |
CAPZA1 | -5325 |
CACNA1D | -5281 |
NMT2 | -5174 |
KCNJ2 | -5168 |
SLC26A5 | -5044 |
ITPR3 | -5029 |
DHRS3 | -4925 |
TRIOBP | -4905 |
TPRN | -4499 |
RDX | -4271 |
LPL | -4118 |
APOE | -3951 |
APOM | -3787 |
EPS8L2 | -3582 |
GRK1 | -2842 |
ACTG1 | -2579 |
CYP4V2 | -2524 |
OR11H6 | -2410 |
PDE6B | -2219 |
OR2A1 | -2197 |
OR4N5 | -2180 |
METAP2 | -1993 |
NMT1 | -1680 |
OR7A10 | -1468 |
PLCB2 | -1403 |
APOA2 | -1397 |
TMIE | -1337 |
GNB5 | -1201 |
MYO3A | -1193 |
CTBP2 | -535 |
TMC2 | -369 |
SLC24A1 | -289 |
GPC6 | 254 |
GNG13 | 702 |
CAPZA2 | 716 |
HSD17B6 | 732 |
GUCY2D | 1026 |
LRP10 | 1080 |
PDE6G | 1409 |
FSCN2 | 2484 |
LDLR | 2825 |
CAPZB | 3288 |
MYO1C | 3414 |
RDH5 | 3444 |
TRPM4 | 3491 |
TAS1R1 | 3536 |
RGS9BP | 3658 |
CLPS | 3996 |
GNB1 | 3998 |
LDB1 | 4099 |
SPTAN1 | 4475 |
USH1G | 4515 |
MYH9 | 4865 |
SPTBN1 | 4908 |
RBP4 | 4926 |
OTOP1 | 5010 |
VAMP2 | 5090 |
GRM1 | 5212 |
OR7A5 | 5213 |
LRRC52 | 5364 |
LRAT | 5491 |
OR6C76 | 5608 |
ESPN | 5872 |
LHX2 | 6452 |
REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE
583 | |
---|---|
set | REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE |
setSize | 7 |
pANOVA | 0.0188 |
s.dist | 0.513 |
p.adjustANOVA | 0.044 |
Top enriched genes
GeneID | Gene Rank |
---|---|
BCAN | 4936 |
CSPG5 | 2240 |
NCAN | -886 |
CSPG4 | -1040 |
DCN | -2673 |
CHST14 | -5254 |
VCAN | -7220 |
GeneID | Gene Rank |
---|---|
BCAN | 4936 |
CSPG5 | 2240 |
NCAN | -886 |
CSPG4 | -1040 |
DCN | -2673 |
CHST14 | -5254 |
VCAN | -7220 |
REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS
826 | |
---|---|
set | REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS |
setSize | 14 |
pANOVA | 0.00102 |
s.dist | 0.507 |
p.adjustANOVA | 0.0043 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PPP2R1B | 5565 |
PPP2R1A | 2355 |
PPP2R5A | 2217 |
PPP2R5B | 1681 |
CSNK1A1 | 1273 |
PPP2R5E | 729 |
APC | -1391 |
PPP2CA | -1782 |
PPP2R5C | -2475 |
GSK3B | -3528 |
PPP2CB | -4338 |
CTNNB1 | -4457 |
PPP2R5D | -8395 |
AXIN1 | -8661 |
GeneID | Gene Rank |
---|---|
PPP2R1B | 5565 |
PPP2R1A | 2355 |
PPP2R5A | 2217 |
PPP2R5B | 1681 |
CSNK1A1 | 1273 |
PPP2R5E | 729 |
APC | -1391 |
PPP2CA | -1782 |
PPP2R5C | -2475 |
GSK3B | -3528 |
PPP2CB | -4338 |
CTNNB1 | -4457 |
PPP2R5D | -8395 |
AXIN1 | -8661 |
REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING
742 | |
---|---|
set | REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING |
setSize | 8 |
pANOVA | 0.0132 |
s.dist | 0.506 |
p.adjustANOVA | 0.0331 |
Top enriched genes
GeneID | Gene Rank |
---|---|
SLIT2 | 4737 |
ABL1 | 3389 |
ROBO1 | 2528 |
CLASP2 | 585 |
CAP2 | -518 |
CAP1 | -5389 |
ABL2 | -7671 |
CLASP1 | -9906 |
GeneID | Gene Rank |
---|---|
SLIT2 | 4737 |
ABL1 | 3389 |
ROBO1 | 2528 |
CLASP2 | 585 |
CAP2 | -518 |
CAP1 | -5389 |
ABL2 | -7671 |
CLASP1 | -9906 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.3.2 (2023-10-31)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.3 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.3.3
## [2] GGally_2.1.2
## [3] ggplot2_3.4.4
## [4] reshape2_1.4.4
## [5] gplots_3.1.3
## [6] gtools_3.9.4
## [7] tibble_3.2.1
## [8] dplyr_1.1.3
## [9] echarts4r_0.4.5
## [10] png_0.1-8
## [11] gridExtra_2.3
## [12] missMethyl_1.36.0
## [13] IlluminaHumanMethylation450kanno.ilmn12.hg19_0.6.1
## [14] beeswarm_0.4.0
## [15] kableExtra_1.3.4
## [16] tictoc_1.2
## [17] IlluminaHumanMethylationEPICanno.ilm10b4.hg19_0.6.0
## [18] IlluminaHumanMethylation450kmanifest_0.4.0
## [19] minfi_1.48.0
## [20] bumphunter_1.44.0
## [21] locfit_1.5-9.8
## [22] iterators_1.0.14
## [23] foreach_1.5.2
## [24] Biostrings_2.70.1
## [25] XVector_0.42.0
## [26] SummarizedExperiment_1.32.0
## [27] Biobase_2.62.0
## [28] MatrixGenerics_1.14.0
## [29] matrixStats_1.1.0
## [30] GenomicRanges_1.54.1
## [31] GenomeInfoDb_1.38.1
## [32] IRanges_2.36.0
## [33] S4Vectors_0.40.1
## [34] BiocGenerics_0.48.1
## [35] eulerr_7.0.0
## [36] limma_3.58.1
## [37] mitch_1.15.0
##
## loaded via a namespace (and not attached):
## [1] splines_4.3.2 later_1.3.1
## [3] BiocIO_1.12.0 bitops_1.0-7
## [5] filelock_1.0.2 preprocessCore_1.64.0
## [7] XML_3.99-0.15 lifecycle_1.0.4
## [9] lattice_0.22-5 MASS_7.3-60
## [11] base64_2.0.1 scrime_1.3.5
## [13] magrittr_2.0.3 sass_0.4.7
## [15] rmarkdown_2.25 jquerylib_0.1.4
## [17] yaml_2.3.7 httpuv_1.6.12
## [19] doRNG_1.8.6 askpass_1.2.0
## [21] DBI_1.1.3 RColorBrewer_1.1-3
## [23] abind_1.4-5 zlibbioc_1.48.0
## [25] quadprog_1.5-8 rvest_1.0.3
## [27] purrr_1.0.2 RCurl_1.98-1.13
## [29] rappdirs_0.3.3 GenomeInfoDbData_1.2.11
## [31] genefilter_1.84.0 annotate_1.80.0
## [33] svglite_2.1.2 DelayedMatrixStats_1.24.0
## [35] codetools_0.2-19 DelayedArray_0.28.0
## [37] xml2_1.3.5 tidyselect_1.2.0
## [39] beanplot_1.3.1 BiocFileCache_2.10.1
## [41] illuminaio_0.44.0 webshot_0.5.5
## [43] GenomicAlignments_1.38.0 jsonlite_1.8.7
## [45] multtest_2.58.0 ellipsis_0.3.2
## [47] survival_3.5-7 systemfonts_1.0.5
## [49] tools_4.3.2 progress_1.2.2
## [51] Rcpp_1.0.11 glue_1.6.2
## [53] SparseArray_1.2.2 xfun_0.41
## [55] HDF5Array_1.30.0 withr_2.5.2
## [57] fastmap_1.1.1 rhdf5filters_1.14.1
## [59] fansi_1.0.5 openssl_2.1.1
## [61] caTools_1.18.2 digest_0.6.33
## [63] R6_2.5.1 mime_0.12
## [65] colorspace_2.1-0 biomaRt_2.58.0
## [67] RSQLite_2.3.3 tidyr_1.3.0
## [69] utf8_1.2.4 generics_0.1.3
## [71] data.table_1.14.8 rtracklayer_1.62.0
## [73] prettyunits_1.2.0 httr_1.4.7
## [75] htmlwidgets_1.6.2 S4Arrays_1.2.0
## [77] pkgconfig_2.0.3 gtable_0.3.4
## [79] blob_1.2.4 siggenes_1.76.0
## [81] htmltools_0.5.7 scales_1.2.1
## [83] knitr_1.45 rstudioapi_0.15.0
## [85] tzdb_0.4.0 rjson_0.2.21
## [87] nlme_3.1-163 curl_5.1.0
## [89] org.Hs.eg.db_3.18.0 cachem_1.0.8
## [91] rhdf5_2.46.0 stringr_1.5.0
## [93] KernSmooth_2.23-22 AnnotationDbi_1.64.1
## [95] restfulr_0.0.15 GEOquery_2.70.0
## [97] pillar_1.9.0 grid_4.3.2
## [99] reshape_0.8.9 vctrs_0.6.4
## [101] promises_1.2.1 dbplyr_2.4.0
## [103] xtable_1.8-4 evaluate_0.23
## [105] readr_2.1.4 GenomicFeatures_1.54.1
## [107] cli_3.6.1 compiler_4.3.2
## [109] Rsamtools_2.18.0 rlang_1.1.2
## [111] crayon_1.5.2 rngtools_1.5.2
## [113] nor1mix_1.3-0 mclust_6.0.0
## [115] plyr_1.8.9 stringi_1.7.12
## [117] viridisLite_0.4.2 BiocParallel_1.36.0
## [119] munsell_0.5.0 Matrix_1.6-2
## [121] hms_1.1.3 sparseMatrixStats_1.14.0
## [123] bit64_4.0.5 Rhdf5lib_1.24.0
## [125] KEGGREST_1.42.0 statmod_1.5.0
## [127] shiny_1.7.5.1 highr_0.10
## [129] memoise_2.0.1 bslib_0.5.1
## [131] bit_4.0.5
END of report